Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,24966,-0.210957927522206,0.00466002845363434,-0.220091583291329,-0.201824271753083,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,29786,0.174053083600464,0.00364377922975473,0.166911276310145,0.181194890890784,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,24951,-0.0769977475481874,0.00173129317040482,-0.0803910821621808,-0.073604412934194,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,29218,0.0919381806788054,0.00205943868807725,0.087901680850174,0.0959746805074368,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C9,Complement component C9,24951,-0.154428044965644,0.00369577379101326,-0.16167176159603,-0.147184328335258,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,29566,-0.146743270808665,0.00218524142844047,-0.151026344008409,-0.142460197608922,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,28797,0.483423692001532,0.00843898620666286,0.466883279036472,0.499964104966591,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,29761,-0.374999958099968,0.00844395036879132,-0.391550100822799,-0.358449815377137,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,24922,0.294133638701843,0.00565012999749613,0.283059383906751,0.305207893496936,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,29443,0.114453068925727,0.00287556134917367,0.108816968681346,0.120089169170107,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,29500,0.183144975267786,0.00361643899737945,0.176056754832923,0.19023319570265,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,29478,-0.142908644450016,0.00325881519086986,-0.149295922224121,-0.136521366675911,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,29443,0.191055262598142,0.0029297635162958,0.185312926106203,0.196797599090082,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,29725,0.230084831810531,0.00451302786426143,0.221239297196578,0.238930366424483,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,29694,0.384421461487346,0.00968896183557261,0.365431096289624,0.403411826685068,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,29443,-0.126121767912902,0.00215394508955842,-0.130343500288437,-0.121900035537368,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,29581,-0.10399326318959,0.00193605669503398,-0.107787934311857,-0.100198592067324,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,24938,0.156073176830342,0.0027576828264996,0.150668118490403,0.161478235170282,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,29347,0.149348257191072,0.00280194455041464,0.143856445872259,0.154840068509885,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,24111,0.289056456171904,0.00672797367981314,0.27586962775947,0.302243284584338,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,29349,0.257162989360234,0.00628894816199921,0.244836650962715,0.269489327757752,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,24381,-0.0823812438705249,0.00213651525108499,-0.0865688137626515,-0.0781936739783983,1.11253697340583e-308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,24793,0.149016600618098,0.0038729122585632,0.141425692591314,0.156607508644882,1.1125375451772e-308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,29489,0.215986772798297,0.00563641547961237,0.204939398458256,0.227034147138337,1.11254407764343e-308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,28916,0.176800509257663,0.00462336902908608,0.167738705960654,0.185862312554672,1.11271757527434e-308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,29545,-0.0730235459171184,0.00194039384834987,-0.0768267178598841,-0.0692203739743527,8.79196235919267e-303
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,29702,-0.0937382961386108,0.00250869521119949,-0.0986553387525618,-0.0888212535246598,1.19569305594519e-298
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,29725,0.0878143669299528,0.00236395055630159,0.0831810238396017,0.0924477100203039,2.79058282952658e-295
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,29434,0.137277969984873,0.0037305587950012,0.129966074746671,0.144589865223076,7.42161451717379e-290
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,29584,0.0856277823339056,0.00239810835346259,0.0809274899611189,0.0903280747066923,2.03798098360784e-273
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,29628,0.117260022928327,0.00330826514310668,0.110775823247838,0.123744222608816,1.5249130570308e-269
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,29454,0.134445101240858,0.00382742081825259,0.126943356437083,0.141946846044633,7.78319216092604e-265
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,29536,0.0817872041709966,0.00233266355273822,0.0772151836076297,0.0863592247343635,6.75276127204132e-264
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,29478,0.150666700330999,0.00432264328091274,0.14219431950041,0.159139081161588,7.12173169662539e-261
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FURIN,Furin,29566,0.0811912033974247,0.00234838991550238,0.07658835916304,0.0857940476318093,8.44857061853905e-257
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,29674,0.286111029701577,0.00830563455939772,0.269831985965158,0.302390073437997,5.19735778927357e-255
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,29301,0.1820365431125,0.00529689264388131,0.171654633530492,0.192418452694507,8.80533610092608e-254
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,28931,0.189670565125078,0.00558396834040615,0.178725987177882,0.200615143072274,5.16422805634793e-248
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,29443,-0.0887880111131912,0.00263353268885674,-0.0939497351833505,-0.083626287043032,1.60825749014497e-244
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,24922,0.21567409964685,0.0064233160873405,0.203084400115663,0.228263799178038,8.96120820798509e-242
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,29725,-0.0835454564835626,0.00250044355903586,-0.0884463258592729,-0.0786445871078523,2.57342581935126e-240
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,29694,-0.0507692912115774,0.00152205284098238,-0.0537525147799029,-0.0477860676432519,1.60186954467523e-239
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,29435,-0.105353991509672,0.00316886067940226,-0.111564958441301,-0.099143024578044,5.82520167857921e-238
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,0.193149503855995,0.00587773090865634,0.181629151275028,0.204669856436961,1.50817622074183e-232
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,29820,0.120022169299344,0.00367470451374271,0.112819748452409,0.12722459014628,6.2263687274903e-230
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,29034,-0.122077314754669,0.00377040124775422,-0.129467301200268,-0.114687328309071,5.94214056732249e-226
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,23787,-0.0982175798750281,0.0030575010076309,-0.104210281849985,-0.0922248779000716,1.12911299705191e-221
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,0.123547651671159,0.00388070216849796,0.115941475420903,0.131153827921415,1.21395022557924e-218
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,29594,-0.0741867440969302,0.00234261389689786,-0.07877826733485,-0.0695952208590104,1.75679454240138e-216
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,24195,0.180215367663654,0.00570261312435287,0.169038245939922,0.191392489387386,8.01700885815338e-215
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,29379,0.119510700623455,0.0037953761068357,0.112071763454057,0.126949637792853,4.55698188605381e-214
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,0.0726188468900199,0.00231065559404608,0.0680899619256896,0.0771477318543502,3.02454111793961e-213
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,29443,-0.0594463788621432,0.00189878738782131,-0.063168002142273,-0.0557247555820135,1.09897147297331e-211
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,24579,0.057692273841687,0.00184044100467334,0.0540850094725272,0.0612995382108467,1.56623666269617e-211
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,24951,-0.113656336552988,0.00363947836523726,-0.120789714148853,-0.106522958957123,4.80666602128169e-210
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,23825,0.070571771463312,0.00226312453217916,0.0661360473802409,0.0750074955463832,2.88319861364139e-209
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,29400,0.222832679814372,0.00716074901882808,0.208797611737469,0.236867747891275,3.36726135057347e-209
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,29383,0.065335041080888,0.00210458211892579,0.0612100601277934,0.0694600220339825,3.18446019519072e-208
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,24381,0.0628378171349494,0.00202538027991923,0.0588680717863077,0.0668075624835911,2.64933972871437e-207
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,29725,0.0704803975521352,0.00231148075392953,0.0659498952744333,0.0750108998298371,4.26976477391053e-201
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,27442,0.0872928393627346,0.00286451041474698,0.0816783989498305,0.0929072797756387,1.28128705782456e-200
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,29820,-0.0727238666140759,0.00240358339912206,-0.0774348900763551,-0.0680128431517966,4.27573453155042e-198
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,29426,0.178894201437479,0.00593312890510774,0.167265268783467,0.19052313409149,1.0086893345133e-196
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,28916,0.109309128738319,0.00364352354280474,0.102167822594422,0.116450434882216,9.28368432486334e-195
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",28774,0.111688646517073,0.00372689628342491,0.10438392980156,0.118993363232586,2.48381069919643e-194
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,29545,0.0380813474530708,0.00128201518212686,0.0355685976961021,0.0405940972100394,4.3942685015461e-191
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,29036,0.305921272189594,0.010386582584138,0.285563570324683,0.326278974054504,6.63838022670093e-188
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,0.13135689315801,0.00446896782034219,0.122597716230139,0.140116070085881,3.93182190359769e-187
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,29683,0.0414908898613814,0.00141833911568757,0.0387109451946338,0.044270834528129,1.7691784126036e-185
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,29757,-0.126453108061825,0.00439043544310254,-0.135058361530306,-0.117847854593344,6.01508591045835e-180
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,29349,0.113808139293677,0.00396119681577568,0.106044193534756,0.121572085052597,4.7775530050487e-179
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,29507,-0.0401177493172269,0.00139803759534384,-0.0428579030041008,-0.0373775956303529,1.23337462484042e-178
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,24804,0.172462908268285,0.00601427076108453,0.16067493757656,0.184250878960011,6.17026350160632e-178
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,29545,-0.0595100231034358,0.00207837942374702,-0.0635836467739799,-0.0554363994328916,7.08411641325786e-178
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,0.119255286666168,0.00417715161366586,0.111068069503383,0.127442503828953,8.34386339291926e-177
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,0.136284390431217,0.00480373970217882,0.126869060614946,0.145699720247487,1.07361074951216e-174
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,29655,0.0628826756244792,0.00221716122176943,0.0585370396298111,0.0672283116191473,1.29168251240785e-174
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,0.0696463725656725,0.00246311622171986,0.0648186647711016,0.0744740803602434,1.41273302394889e-173
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,28774,0.102834431838972,0.00363769400600938,0.095704551587194,0.109964312090751,1.9561711875873e-173
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,29478,-0.0539131164103761,0.00191759032921769,-0.0576715934556428,-0.0501546393651094,1.18882356473756e-171
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,29478,0.0604379328751024,0.00215114248017863,0.0562216936139523,0.0646541721362525,2.01740875982871e-171
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,0.157740961599994,0.00561606176823628,0.146733480534251,0.168748442665737,2.5876899398848e-171
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AFM,Afamin,24966,0.0384884056075099,0.00137713053732475,0.0357892297543534,0.0411875814606664,2.80250792816938e-169
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,24329,0.073630472409807,0.00266141735056379,0.068414094402702,0.0788468504169121,6.6631857909833e-166
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,24240,0.0999953530961798,0.00361988602086236,0.0929003764952895,0.10709032969707,2.10039385013707e-165
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,29786,0.0669718967658616,0.00242941517171281,0.0622102430293045,0.0717335505024187,3.29301590570324e-165
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,28797,0.149070028375653,0.00540949114853937,0.138467425724516,0.15967263102679,5.05849871809003e-165
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,29478,0.11914841767632,0.0043297063876727,0.110662193156482,0.127634642196159,1.26621827443863e-164
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,0.148415046990923,0.00539029732978673,0.137850064224541,0.158980029757305,2.04269404815643e-164
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,29786,0.0550493103496239,0.0020031422366152,0.0511231515658581,0.0589754691333897,3.28726178994078e-164
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,29786,0.0509272626614941,0.00185352970694224,0.0472943444358873,0.0545601808871009,3.82551890251629e-164
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,29349,0.133994308489641,0.00488612177957902,0.124417509801666,0.143571107177616,1.66839626368292e-163
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,0.0692187872437064,0.00253449529048256,0.0642511764743606,0.0741863980130523,3.283332138911e-162
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,24938,-0.114266933696792,0.00418411709870015,-0.122467803210244,-0.10606606418334,7.84729228953903e-162
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,0.0905255325726311,0.00334678887467557,0.083965826378267,0.0970852387669952,3.71987477260013e-159
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,29559,0.0445207514240556,0.00165409868465539,0.041278718002131,0.0477627848459801,1.15932882900734e-157
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",29349,0.15454958762835,0.00574588763145886,0.14328764787069,0.165811527386009,1.91879225304737e-157
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,0.0599145156971304,0.00224809094731457,0.0555082574403939,0.064320773953867,1.20431516069364e-154
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MME,Neprilysin,29349,0.150408297524482,0.0056767326637654,0.139281901503502,0.161534693545462,6.88639201270823e-153
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,29544,0.0573337748959736,0.00216662987214271,0.0530871803465739,0.0615803694453733,1.59153245602698e-152
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,29559,0.0608001876220891,0.00230617383181842,0.056280086911725,0.0653202883324532,2.00357292755135e-151
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,24381,0.0752325708159785,0.0028570386999217,0.0696327749641319,0.080832366667825,1.04957451999308e-150
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,28967,0.081217132070143,0.00310295665280067,0.0751353370306537,0.0872989271096323,2.86506571670815e-149
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,24381,0.0692923197434274,0.00265965176794737,0.0640794022782506,0.0745052372086043,1.3019171093811e-147
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,29632,0.0889866680210215,0.00342480211923248,0.0822740558673258,0.0956992801747171,3.44818816707627e-147
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,28797,0.149985422484677,0.00581299690915922,0.138591948542725,0.161378896426629,3.79926842283042e-145
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,24922,0.051647041296764,0.00200934283111573,0.0477087293477771,0.0555853532457508,8.02639334790848e-144
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,24888,-0.0890263102895645,0.00346754847358154,-0.0958227052977844,-0.0822299152813447,1.68307486463008e-143
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,29349,0.156833094016161,0.00614845579332933,0.144782120661235,0.168884067371086,5.72669126664009e-142
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,24805,0.130008339947167,0.00510540324413614,0.120001749588661,0.140014930305674,3.16240110870429e-141
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,29786,0.0545218411103416,0.00214719420394283,0.0503133404706137,0.0587303417500696,9.72256392433411e-141
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,0.189779880654279,0.00748558619346677,0.175108131715084,0.204451629593474,2.72616403175058e-140
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,0.0692396598015989,0.00274941191758881,0.0638508124431248,0.0746285071600729,1.71785547539758e-138
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,29604,0.106298257154207,0.00422601555396537,0.0980152666684345,0.114581247639979,3.68824734139623e-138
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,29750,-0.0960714948119802,0.00382177899789586,-0.103562181647856,-0.0885808079761043,5.30618369823752e-138
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,28935,0.13986861680867,0.00558066356194211,0.128930516227263,0.150806717390076,3.66709234242378e-137
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,29581,0.0736866925703263,0.00294247248533903,0.0679194464990618,0.0794539386415908,5.66243929326733e-137
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,24707,0.0449746107097306,0.00179828700017815,0.0414499681893814,0.0484992532300797,2.38761129346645e-136
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,29443,0.0977747457126054,0.00397315931663654,0.0899873534519978,0.105562137973213,2.21968687469547e-132
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,29820,0.0774894478311138,0.00314976089559265,0.0713159164757522,0.0836629791864754,2.53693200594855e-132
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,0.0957655728683335,0.00389476649046968,0.0881318305470129,0.103399315189654,3.85222669772281e-132
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,24867,0.07715547696679,0.0031416992470092,0.070997746442652,0.083313207490928,1.30036819141122e-131
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,-0.0678606333208479,0.00277347586015145,-0.0732966460067447,-0.062424620634951,6.64664273959349e-131
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,29577,0.112880394870652,0.00462208604603526,0.103821106220423,0.121939683520881,1.96491799350481e-130
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,29218,0.0627173054778736,0.00256854085746146,0.0576829653972491,0.067751645558498,2.26786009051735e-130
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,24805,0.192088144012072,0.00787515705924911,0.176652836175944,0.2075234518482,7.12154784392177e-130
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,0.0650052860927198,0.00269191331028575,0.0597291360045597,0.0702814361808799,1.31447970711342e-127
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,29581,-0.0738066815392898,0.003059537403173,-0.0798033748495089,-0.0678099882290708,2.41745567088574e-127
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,24938,0.0562050917943552,0.0023318665862461,0.0516346332853128,0.0607755503033975,6.5877647931037e-127
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,0.0972684813295333,0.00407029622735474,0.089290700723918,0.105246261935149,9.11624855569934e-125
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELE,E-selectin,29820,0.0851451052553166,0.00356866288281002,0.078150526005009,0.0921396845056243,1.204102791575e-124
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,0.0949814932722055,0.00398161943455402,0.0871775191804796,0.102785467363931,1.4007651464676e-124
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,24914,0.0477287382467015,0.00200211061181826,0.0438046014475377,0.0516528750458653,3.23215286437257e-124
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,29434,0.0806164942885352,0.00339038904621145,0.0739713317579608,0.0872616568191097,8.33483815516783e-124
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,0.122341567286854,0.00514773075124866,0.112252015014407,0.132431119559302,1.77483437832097e-123
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,24914,-0.0631908139238144,0.00265949448730297,-0.0684034231189282,-0.0579782047287006,2.02659542179787e-123
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,29786,0.0551693375372792,0.00232436210065809,0.0506135878199893,0.059725087254569,2.18902409936509e-123
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,29443,0.0539132830312032,0.00228462851040454,0.0494354111508103,0.058391154911596,5.46544464254023e-122
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,0.0825828397152566,0.00351581143297657,0.0756918493066225,0.0894738301238907,1.1593769820952e-120
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,0.152769814396305,0.00650973221802041,0.140010739248985,0.165528889543625,1.16859716582919e-120
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,29566,0.0366476195243952,0.00156384257979414,0.0335824880679987,0.0397127509807917,2.39548647503562e-120
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,29628,-0.0460928613327809,0.00197146621762031,-0.0499569351193167,-0.0422287875462451,8.3286243918615e-120
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,29480,-0.0866887830270812,0.00372311540906167,-0.0939860892288421,-0.0793914768253204,7.6447651366159e-119
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,24240,0.106006935035672,0.00455466193870726,0.0970797976358063,0.114934072435539,1.6102996252614e-118
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,29820,0.0725172385770654,0.00312359538555498,0.0663949916213777,0.0786394855327532,3.52163127412623e-118
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,29443,-0.0443777935513879,0.00191150828616903,-0.0481243497922792,-0.0406312373104966,3.61757494985422e-118
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,29434,-0.0562730509031631,0.00243184545930571,-0.0610394680034022,-0.0515066338029239,2.05099313294e-117
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,29163,0.118751134168252,0.00515414909596376,0.108649001940163,0.128853266396341,2.04030429513226e-116
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,24240,0.0883455279952874,0.0038370176741572,0.0808249733539393,0.0958660826366355,4.66691017391007e-116
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,29725,-0.0270103315095896,0.00117823570728452,-0.0293196734958672,-0.0247009895233119,2.66240438448554e-115
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,29694,0.0561799867678164,0.00245936200895953,0.0513596372302557,0.0610003363053771,1.65784287456336e-114
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,0.0768010685332724,0.00336007644174024,0.0702153187074615,0.0833868183590832,1.99613347512503e-114
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,28764,0.0962596861624593,0.00422079511116098,0.0879869277445838,0.104532444580335,4.1173631943845e-114
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,29443,0.0378633965032464,0.00166669710933972,0.0345966701689406,0.0411301228375523,2.83282883683431e-113
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POSTN,Periostin,24938,-0.0611525653677878,0.0026921086772844,-0.0664290983752653,-0.0558760323603104,4.43344099585092e-113
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,29333,-0.10114205048223,0.00447148490876601,-0.109906160903411,-0.0923779400610485,2.56189272867081e-112
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,0.0545654340286849,0.00242589184190639,0.0498106860185484,0.0593201820388214,4.12870940810797e-111
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,29736,0.0800805459083545,0.00356326252685139,0.0730965513557257,0.0870645404609832,6.28404918424272e-111
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REN,Renin,29478,0.121333151874002,0.00540199378578573,0.110745244053862,0.131921059694142,8.55965568226028e-111
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,29435,-0.0504255362637436,0.00224696212199475,-0.0548295820228533,-0.0460214905046339,1.31169902469287e-110
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,24381,-0.036239052562125,0.00161409354287489,-0.0394026759061598,-0.0330754292180903,1.6304347990392e-110
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,24922,0.104634942859304,0.00468617969610752,0.095450030654933,0.113819855063674,2.31881654703896e-109
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,0.0694163515480433,0.00311284306451228,0.0633151791415993,0.0755175239544874,3.08653931953787e-109
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,29694,0.0956431568860402,0.00431228210616004,0.0871910839579665,0.104095229814114,4.12484919207513e-108
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,29478,0.0999703654197261,0.00450829298182636,0.0911341111753464,0.108806619664106,4.61571948187498e-108
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,24793,0.0825465755848272,0.00372645468788333,0.0752427243965758,0.0898504267730785,1.12046503469217e-107
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,0.107360502959052,0.00484617006832945,0.0978620096251267,0.116858996292978,1.14296048565417e-107
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,29527,-0.0610344985261939,0.00276430379528523,-0.066452533964953,-0.0556164630874349,3.6730268817265e-107
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,0.061782512221989,0.00281160252390854,0.0562717712751283,0.0672932531688498,3.6648649089222e-106
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,-0.0593413072098079,0.0027073670783609,-0.0646477466833953,-0.0540348677362206,1.20288074675931e-105
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEP,Leptin,29478,0.104295388570198,0.00476971801993666,0.0949467412511225,0.113644035889274,3.74829508548289e-105
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,29725,0.0442583598842036,0.00202932286709737,0.0402808870646928,0.0482358327037145,1.25198311058761e-104
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,29725,0.197424896716064,0.00908240063352424,0.179623391474356,0.215226401957771,5.91986790635738e-104
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,29820,0.0908384829404565,0.00419169028125805,0.0826227699891908,0.0990541958917223,2.41797090000601e-103
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,29604,0.0916451280561597,0.00423904740935483,0.0833365951338242,0.0999536609784952,7.40803184202159e-103
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,29725,0.056625216321829,0.00262171057369677,0.0514866635973834,0.0617637690462747,1.1432322320842e-102
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,24240,-0.0932118854247774,0.00433355341215859,-0.101705650112608,-0.0847181207369466,1.13806617098614e-101
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,29697,0.0404791161904583,0.00188693307700297,0.0367807273595325,0.0441775050213841,2.55796768836591e-101
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,29786,0.116812540915525,0.00545303441521474,0.106124593461704,0.127500488369345,4.87868552711444e-101
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,0.0837521798569824,0.00391290771958255,0.0760828807266006,0.0914214789873642,7.56636859312127e-101
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,0.0789613461843665,0.00370349079992718,0.0717025042165093,0.0862201881522238,4.10993015831101e-100
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,29545,0.049881665091701,0.00234576427143116,0.0452839671196959,0.0544793630637061,1.35126176015816e-99
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,29433,0.0450029907284831,0.00211886173343007,0.0408500217309601,0.049155959726006,2.31417497060903e-99
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,29786,0.0681917846944111,0.00322039300267043,0.0618798144091771,0.0745037549796452,8.70531768669551e-99
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,29530,0.0424229538313218,0.00201491495861495,0.0384737205124365,0.0463721871502071,1.08954260761211e-97
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,29349,0.0530115408986371,0.00253504850745648,0.0480428458240224,0.0579802359732518,2.13067615842938e-96
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGRN,Agrin,29581,0.051075867259092,0.00244509750121089,0.0462834761567187,0.0558682583614653,3.33802535970244e-96
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,29434,0.0411344465651884,0.00197190032564166,0.0372695219269308,0.0449993712034461,6.09071591303233e-96
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,29349,0.0673632038486266,0.00324978086628421,0.0609936333507095,0.0737327743465436,9.16383933802475e-95
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,29595,0.0999169338992959,0.00483291092475669,0.0904444284867728,0.109389439311819,2.74451293641429e-94
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,28553,0.1481391705018,0.00717985903343324,0.134066646796271,0.162211694207329,6.78810347410309e-94
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,29581,0.0425170930518848,0.00206438026006052,0.0384709077421662,0.0465632783616034,1.36679237601424e-93
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,29674,0.0614124821172264,0.002991962129608,0.0555482363431947,0.0672767278912581,5.61283439626394e-93
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,29433,-0.258671956800828,0.0126096696638161,-0.283386909341908,-0.233957004259749,7.25275224196313e-93
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,29542,-0.0451099831115495,0.00220103953286179,-0.0494240205959586,-0.0407959456271404,1.05844015968905e-92
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,29725,0.0670374436041963,0.00327386663690408,0.0606206649958643,0.0734542222125283,1.51991136761377e-92
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,29478,0.0381881524002974,0.00187256515318341,0.0345179247000579,0.0418583801005369,8.23195760973872e-92
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,24381,0.0396145358070431,0.0019426581831692,0.0358069257680315,0.0434221458460547,1.14941776555134e-91
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,29434,-0.0506265985297207,0.00248540051629505,-0.055497983541659,-0.0457552135177824,1.33531165170653e-91
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,29683,0.0496848568772734,0.00244353573785578,0.0448955268310761,0.0544741869234708,2.74460128480034e-91
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,0.0441044039836192,0.00217155306871968,0.0398481599689286,0.0483606479983098,4.40533385762613e-91
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,0.0824000100155782,0.0040582657789953,0.0744458090887474,0.090354210942409,6.4838011760161e-91
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,29390,0.0723191259476537,0.00356910984100272,0.0653236706592884,0.0793145812360191,1.14943984383354e-90
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,29192,0.0532804073145539,0.00263365079220757,0.0481184517618271,0.0584423628672808,2.19681490852997e-90
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,24653,0.0393491646878586,0.00194411445241608,0.0355387003611231,0.0431596290145941,2.35701582651412e-90
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,24229,0.0644053193143737,0.00318257319125438,0.0581674758595151,0.0706431627692322,2.59116198716703e-90
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,29434,-0.0624810819623267,0.00309634246627285,-0.0685499131962215,-0.0564122507284319,6.09088405961246e-90
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,24557,0.0343337747039004,0.00170047668589218,0.0310008403995517,0.037666709008249,6.36013858301345e-90
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,0.0486396845883218,0.00241278350502625,0.0439106289184703,0.0533687402581733,9.02808576846587e-90
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,29434,0.0575248519817165,0.00285430710329325,0.0519304100592618,0.0631192939041713,1.00862659712783e-89
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,29594,0.0766744851789835,0.00380637287402443,0.0692139943458956,0.0841349760120714,1.22152723365292e-89
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,29693,0.0813512281234765,0.00403860590153492,0.0734355605564681,0.089266895690485,1.22372212986101e-89
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,29434,0.0730655557697745,0.0036463136698657,0.0659187809768377,0.0802123305627112,1.00135628764742e-88
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,24966,0.028410744198481,0.00141882377192697,0.0256298496055041,0.0311916387914578,1.68316151793594e-88
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,29443,-0.0570312697169564,0.00285970967784553,-0.0626363006855336,-0.0514262387483792,6.57082247135929e-88
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,29426,0.0656761537485493,0.00329848913715616,0.0592111150397232,0.0721411924573754,1.23675987170235e-87
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,29760,0.0541940585166451,0.00272235344834242,0.048858245757894,0.0595298712753963,1.31636306693206e-87
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,29487,0.0446865337983386,0.00224664271304233,0.0402831140807757,0.0490899535159016,1.85094369267758e-87
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OCLN,Occludin,24867,0.0622884824630639,0.00313065198214817,0.0561524045780535,0.0684245603480743,2.09973157085236e-87
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD248,Endosialin,24938,-0.0568202907668055,0.00286418997457209,-0.0624341031169668,-0.0512064784166442,6.53835863980717e-87
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,24644,0.0449746566888728,0.00226747205925672,0.0405304114527296,0.0494189019250159,7.12516557705851e-87
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,0.0313937191263543,0.00158513071330003,0.0282868629282863,0.0345005753244224,1.24696887622569e-86
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,29434,0.0531111423137215,0.0026883037726125,0.047842066919401,0.058380217708042,2.56795376227412e-86
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,29820,-0.0229699087705145,0.00116652944056492,-0.0252563064740217,-0.0206835110670072,9.08277380989042e-86
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,0.0544779970947605,0.00276662602889708,0.0490554100781222,0.0599005841113988,9.26067633576115e-86
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,24845,-0.0265908326238266,0.00136145692114526,-0.0292592881892713,-0.0239223770583819,2.56379273076089e-84
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,29433,0.0415730516580611,0.00213531895699442,0.037387826502352,0.0457582768137701,6.76052506277651e-84
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,0.093747820702497,0.00482131685429118,0.0842980396680863,0.103197601736908,1.11936624197061e-83
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,29192,-0.0391567601990682,0.00201566196764378,-0.04310745765565,-0.0352060627424864,1.5621704963421e-83
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,29434,0.0880273932634332,0.00453453416851438,0.079139706293145,0.0969150802337214,2.00848679498148e-83
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MLN,Promotilin,29434,0.122586644687315,0.00632623633050003,0.110187221479535,0.134986067895095,3.9455230637095e-83
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,29301,0.0355968675585385,0.00183812704888738,0.0319941385427193,0.0391995965743578,4.96115161635525e-83
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,29454,0.0381943364281987,0.0019784140253024,0.034316644938606,0.0420720279177914,1.56414642899799e-82
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,29169,0.0421203790297839,0.00218647236160318,0.0378348932010417,0.0464058648585262,3.49097756589782e-82
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",29820,0.0682886922314881,0.00355254639274549,0.0613257013017069,0.0752516831612692,7.52194324988368e-82
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,0.100361848799931,0.00523199782560896,0.090107133061737,0.110616564538124,1.65185343582182e-81
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,29683,0.0783793593211433,0.00410330735039381,0.0703368769143714,0.0864218417279151,7.50877803863844e-81
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,29694,0.0905284249855597,0.00474063674391921,0.0812367769674781,0.0998200730036414,8.28940374597132e-81
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,0.112130440035318,0.0058718491724257,0.100621615657364,0.123639264413272,8.57809852042837e-81
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,29468,-0.0522446523695394,0.00274742940722141,-0.0576296140076933,-0.0468596907313854,3.81527604595117e-80
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAST,Gastrin,24845,0.17657173762012,0.00928469151193912,0.15837374225672,0.194769732983521,4.53358032855185e-80
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PXN,Paxillin,28774,0.0694665736056641,0.0036657833288045,0.0622816382812072,0.0766515089301209,1.35069906593878e-79
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,24240,0.0813667199047433,0.004294205145134,0.0729500778202807,0.0897833619892059,1.72395253328167e-79
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,24229,0.112743837771187,0.00595923909938111,0.1010637291364,0.124423946405974,2.95999848174452e-79
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,24609,0.0429854285705531,0.00227283286168087,0.0385306761616586,0.0474401809794476,3.27314862172927e-79
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,29725,0.0357011003166427,0.00189018820871208,0.031996331427567,0.0394058692057184,4.19932983529332e-79
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,0.0591585232782212,0.0031352203438065,0.0530134914043605,0.065303555152082,6.02497311189887e-79
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,29349,0.0798862509069305,0.00423436472570346,0.0715868960445518,0.0881856057693093,6.35403529056331e-79
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,28797,0.14771892376675,0.00783385751912574,0.132364563029263,0.163073284504236,7.7739015415136e-79
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,-0.0449343501873612,0.00240195894902901,-0.049642189727458,-0.0402265106472643,1.21508913889964e-77
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,24951,-0.0353251574366456,0.00188934161781954,-0.0390282670075719,-0.0316220478657193,1.77280648726485e-77
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,28477,0.0534264390530106,0.00285924778118279,0.0478223134018923,0.0590305647041288,1.89095059053747e-77
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,24381,0.0849547857168277,0.00454620566954757,0.0760442226045145,0.093865348829141,2.19821194611791e-77
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,24793,0.0923078343876497,0.00494332389663287,0.0826189195502493,0.10199674922505,2.77541813953903e-77
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,24922,0.0751579462876465,0.00402793485933185,0.067263193963356,0.0830526986119369,3.57518949853472e-77
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,24845,-0.0489256823464574,0.00262795125618734,-0.0540764668085846,-0.0437748978843302,7.747700371711e-77
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,0.0365404645819909,0.00196278539253696,0.0326934052126184,0.0403875239513633,7.87582226994238e-77
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,0.0394225126102622,0.00212417118377189,0.0352591370900693,0.0435858881304551,1.88563005430106e-76
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,29434,0.0716935392949017,0.00386364508918626,0.0641207949200966,0.0792662836697068,1.99602433261768e-76
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,29820,0.0802174731912232,0.00432631669520944,0.0717378924686127,0.0886970539138337,2.55768396834072e-76
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,29349,0.0473460063355626,0.00255493347476198,0.0423383367250292,0.0523536759460961,3.15351050027208e-76
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,29349,0.16344110532478,0.00882969464748047,0.146134903815718,0.180747306833842,4.62150806629693e-76
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,24938,0.148792925726172,0.00803909336675682,0.133036302727329,0.164549548725016,5.6823956781457e-76
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",29454,0.123779818522876,0.00669360847956231,0.110660345902934,0.136899291142819,6.42443076584739e-76
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,29218,0.116342525888686,0.00629684795404478,0.104000703898759,0.128684347878614,8.67054022704968e-76
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,29370,0.026528692574443,0.00143991589286525,0.0237064574244271,0.0293509277244589,2.25498850735325e-75
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,24845,0.0619790643475148,0.00337136842339451,0.0553711822376616,0.0685869464573681,5.55844170941934e-75
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,29218,-0.0444352034133411,0.00242041682985657,-0.04917922039986,-0.0396911864268222,7.45324120883289e-75
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,24240,0.0789636280963521,0.00430115961518386,0.0705333552505918,0.0873939009421125,9.05042399978748e-75
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,29349,0.0883621811565257,0.00481717499978765,0.0789205181569419,0.0978038441561095,9.81045269721545e-75
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,29349,0.148430961473345,0.00809302909424715,0.132568624448621,0.16429329849807,1.02779470178417e-74
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,24966,-0.0359474076450914,0.00196060168014178,-0.0397901869381693,-0.0321046283520135,1.34798079705216e-74
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,24922,0.106661758505356,0.00582255090697879,0.0952495587276777,0.118073958283035,1.81036294045957e-74
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,0.0734941182556079,0.0040133497395563,0.0656279527660776,0.0813602837451383,2.10774348485203e-74
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,29566,0.118604037287478,0.00649317605416504,0.105877412221314,0.131330662353641,3.95627052266695e-74
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,0.0566537600085016,0.00310777190018147,0.0505625270841459,0.0627449929328573,7.67661133095742e-74
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,29435,0.0436222607965718,0.00240017285738273,0.0389179219961017,0.048326599597042,2.06902772153993e-73
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,28797,0.0463010755744823,0.00254981832616733,0.0413034316551944,0.0512987194937703,2.81980540713849e-73
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,24194,0.0357195286828871,0.00196757718411726,0.0318630774020173,0.039575979963757,3.65315410608473e-73
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,24381,0.0593164562598346,0.003269359510723,0.0529085116188175,0.0657244009008517,4.40740946284415e-73
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,24229,0.110453744461098,0.00608804195452498,0.0985211822302286,0.122386306691966,4.47034731771312e-73
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,-0.0317549737253402,0.00175434966935306,-0.0351934990772722,-0.0283164483734082,7.73207248170365e-73
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,29652,0.0479382388095857,0.00264999102793668,0.0427442563948298,0.0531322212243416,9.42497710011028e-73
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELN,Elastin,24922,0.0453185536693603,0.00250566291862655,0.0404074543488522,0.0502296529898683,1.18943917547466e-72
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,29115,0.0465182450619856,0.00257353395552292,0.0414741185091606,0.0515623716148105,1.23911186965656e-72
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,29349,0.089668596597806,0.00496581605702727,0.0799355971260326,0.0994015960695795,1.71244631768108e-72
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,0.124904743957406,0.0069286029969199,0.111324682083443,0.138484805831369,2.91739801791093e-72
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,29443,0.0547715456860482,0.00304497894235049,0.0488033869590413,0.0607397044130552,5.93509023878779e-72
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,-0.0332353911829354,0.00185112905282206,-0.0368636041264666,-0.0296071782394041,1.06538233674664e-71
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,29786,0.0442286732284747,0.00246682351611834,0.0393936991368828,0.0490636473200667,1.65432013186622e-71
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,29443,0.0676163828103273,0.00378426178680276,0.0601992297081939,0.0750335359124607,4.99169184595783e-71
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,29453,0.0405539232615588,0.00227001518335637,0.0361046935021803,0.0450031530209372,5.23881767411303e-71
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,0.132770817341259,0.00745968652753913,0.118149831747282,0.147391802935236,1.70968026230202e-70
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,29820,-0.0345405948472335,0.00194237702141184,-0.0383476538092007,-0.0307335358852663,2.2271913561896e-70
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,29400,0.11607507935702,0.00653208255728828,0.103272197544735,0.128877961169305,2.81719889462712e-70
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,-0.0322899864615037,0.00181831440472995,-0.0358538826947744,-0.028726090228233,3.47039298733538e-70
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,29497,0.0628081468493358,0.00354187065414866,0.0558660803672045,0.0697502133314672,5.38727900404319e-70
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,24867,0.0732998227114757,0.00413225840963184,0.0652005962285973,0.0813990491943541,5.72018235818836e-70
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,29349,0.0915066242515016,0.00516253257362564,0.0813880604071953,0.101625188095808,6.21692338208414e-70
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,24229,0.100645280664176,0.00567917661807237,0.0895140944927542,0.111776466835598,7.86169384065403e-70
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,29725,0.0698375818221773,0.00394875682109448,0.0620980184528322,0.0775771451915225,1.22468540213998e-69
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,24922,0.0333457018200695,0.00188616024025942,0.0296488277491611,0.037042575890978,1.61529717809694e-69
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,29786,0.0519433952685633,0.00294036325124209,0.0461802832961288,0.0577065072409978,1.74668761054262e-69
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,24820,0.137491226696503,0.00778856316866719,0.122225642885915,0.15275681050709,2.5644448612356e-69
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,29725,0.0813993179657657,0.00461593003922445,0.0723520950888858,0.0904465408426456,3.02273290411701e-69
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",29378,0.0849407068619198,0.0048302439773878,0.0754734286662397,0.0944079850575999,7.21939441479135e-69
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,29349,0.0972830319548187,0.0055321256557529,0.086440065669543,0.108125998240094,7.2340644938865e-69
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,24381,0.0948418237438111,0.00539951640918266,0.0842587715818131,0.105424875905809,1.21312848963088e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,29478,0.0451067253444119,0.0025708944671173,0.040067772188862,0.0501456784999618,1.44707701009786e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,24111,0.0780807393170919,0.00445343076331493,0.0693520150209946,0.0868094636131891,2.14475941101552e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,-0.0397093796091807,0.0022672654262116,-0.0441532198445554,-0.0352655393738059,2.45665912713036e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,29701,0.0297627261716999,0.00169975905254463,0.0264311984287124,0.0330942539146874,2.65339977772457e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,29478,-0.0387537994599591,0.0022133412269315,-0.0430919482647449,-0.0344156506551734,2.70583433771122e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,24922,0.113681128297743,0.00651440186019986,0.100912900651751,0.126449355943735,8.60681175183829e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASPN,Asporin,24922,-0.0342737061038804,0.00196637512822978,-0.0381278013552108,-0.03041961085255,1.2340958855615e-67
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,29820,0.0829052781999244,0.0047688936193998,0.0735582467059007,0.092252309693948,2.32217926722456e-67
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,29434,0.0578279799528609,0.0033280380004815,0.0513050254719172,0.0643509344338047,2.7206249844235e-67
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,24922,0.0849081879235778,0.00488432823387592,0.075334904585181,0.0944814712619746,2.73355056043107e-67
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,29786,0.0673402451246526,0.0038775265461599,0.0597402930941792,0.074940197155126,3.15939620632129e-67
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,0.104719071893207,0.00603648414395477,0.0928875629710552,0.116550580815358,5.22015311831523e-67
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,0.0524134878834404,0.00302765579400085,0.0464792825271987,0.0583476932396821,8.21900645448652e-67
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,29434,0.0935096404796211,0.00540703108547324,0.0829118595520936,0.104107421407149,1.11468184057598e-66
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,28916,0.0659457098016071,0.00381758859206401,0.0584632361611617,0.0734281834420526,1.58997291668851e-66
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,24528,0.0345687514385664,0.0020050818384335,0.0306387910352367,0.038498711841896,3.23953610349538e-66
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,28774,0.0343352428392039,0.00199293177220217,0.0304290965656876,0.0382413891127201,3.48999898646374e-66
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,29478,-0.0630730530532815,0.00366697728627324,-0.0702603285343771,-0.0558857775721859,5.55315109935904e-66
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,29478,0.043369675022101,0.00252155125094421,0.0384274345702504,0.0483119154739517,5.61841049718811e-66
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,29434,-0.0567055675357146,0.00329891871536281,-0.0631714482178257,-0.0502396868536035,6.72525866374523e-66
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,0.0350623102781355,0.00204270528180953,0.0310586079257888,0.0390660126304822,1.02121992348926e-65
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,29694,0.0452482757304699,0.00263643635187372,0.0400808604807975,0.0504156909801424,1.04974529403138e-65
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,0.0622904440231125,0.00363121451163275,0.0551732635803123,0.0694076244659127,1.2412062917856e-65
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,0.108861303216488,0.00635738392758532,0.0964008307184212,0.121321775714556,2.06861214635204e-65
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,29434,0.0748636227576564,0.00438009906723091,0.0662786285858838,0.083448616929429,3.53030185044409e-65
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,28762,0.0386844393655679,0.0022645973471861,0.0342458285650831,0.0431230501660526,4.21882395876944e-65
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,29434,0.0680868988666783,0.00398692961329841,0.0602725168246134,0.0759012809087431,4.49540937127254e-65
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,0.0248289055623651,0.00145903956919384,0.0219691880067452,0.0276886231179851,1.23803167491802e-64
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,23693,0.0284846960229155,0.00167360042316111,0.0252044391935197,0.0317649528523113,1.41388900418906e-64
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,29511,-0.0448678547219283,0.0026394977526342,-0.0500412703170914,-0.0396944391267653,1.70616616188405e-64
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,29081,0.0437512094128871,0.00257766182604638,0.0386989922338362,0.048803426591938,2.64753604796407e-64
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,-0.028947967815095,0.00170587495136079,-0.0322914827197622,-0.0256044529104279,2.78273299638633e-64
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,29443,-0.0633713236692747,0.00373472882182669,-0.070691392160055,-0.0560512551784944,2.86007076075221e-64
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,24805,0.12939647310169,0.00762802127003692,0.114445551412417,0.144347394790962,3.53462686371294e-64
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",24867,0.0757466949804305,0.00446725868127099,0.0669908679651394,0.0845025219957217,3.99093330485738e-64
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,29434,0.0883492172744477,0.00524238718101557,0.0780741383996572,0.0986242961492382,1.98477249858266e-63
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,0.053728644081304,0.0031913113851473,0.0474736737664153,0.0599836143961927,3.04933218930432e-63
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,0.0715082526641669,0.0042540699814446,0.0631702755005355,0.0798462298277983,4.65897423217207e-63
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,28797,0.0764870639459151,0.00455344103230703,0.0675623195225933,0.0854118083692369,5.07258772552106e-63
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,24805,0.117133308787223,0.00697955134631687,0.103453388148442,0.130813229426004,7.30875380041433e-63
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,29786,0.0903024304947139,0.00538448864950269,0.0797488327416886,0.100856028247739,7.75302922785276e-63
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,28931,0.0836683881974287,0.00499800094578211,0.0738723063436957,0.0934644700511616,1.31330016338248e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,-0.0503983961471612,0.00301165189635634,-0.0563012338640196,-0.0444955584303027,1.43491934695444e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,29349,0.100609305480627,0.00602085010934798,0.0888084392663051,0.112410171694949,2.14981489112367e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,29291,0.0362772776207272,0.00217400307350455,0.0320162315966582,0.0405383236447961,3.16878826576854e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,0.0506523301067213,0.00303645760919501,0.0447008731926991,0.0566037870207435,3.45514265406208e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,29694,0.0515538156426385,0.00309276288198223,0.0454920003939533,0.0576156308913237,4.2103839317844e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,29173,0.0337126478565375,0.00202355057786935,0.0297464887239136,0.0376788069891614,4.94682030005304e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,0.096717381716653,0.00580543415629701,0.0853387307703108,0.108096032662995,5.58483227208486e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,-0.0517778377253954,0.00311663009396851,-0.0578864327095737,-0.0456692427412171,1.06181871855205e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,24905,-0.0408572387480135,0.00246069719941558,-0.045680205258868,-0.036034272237159,1.40037908560939e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,29694,-0.0441866161371323,0.00266287544908014,-0.0494058520173294,-0.0389673802569353,1.46999825772626e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,0.134678576466639,0.0081345181055622,0.118734920979737,0.150622231953541,2.72657191055265e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,0.084242164382871,0.00508941605726439,0.0742669089106328,0.0942174198551092,2.95361573988076e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,0.0231122995580379,0.00139690907303408,0.0203743577748911,0.0258502413411847,3.335263434217e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,24828,0.036363733080976,0.0021984435978707,0.0320547836291494,0.0406726825328026,3.97359674915616e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,0.068060242856402,0.00412305774466872,0.0599790496768513,0.0761414360359527,6.10003978336949e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,29820,0.0411404306837057,0.00249447409541003,0.036251261456702,0.0460295999107094,7.71627770243476e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,24892,-0.0863408032276548,0.00523511763892357,-0.096601633799945,-0.0760799726553646,8.72026719663711e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,28931,0.0998669709294406,0.00606180484717733,0.087985833428973,0.111748108429908,1.05343130763075e-60
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,29349,-0.0281487274282056,0.00171083024500383,-0.0315019547084131,-0.0247955001479981,1.48531906000613e-60
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,29454,-0.04016064445245,0.00244176188289717,-0.0449464977429284,-0.0353747911619715,1.63092277977457e-60
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,29434,0.06688391358209,0.00406796171170619,0.0589107086271459,0.0748571185370341,1.79325185204338e-60
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,0.0603054773301675,0.00368297648506894,0.0530868434194324,0.0675241112409026,5.47254726187656e-60
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,0.10075303036735,0.00616955067366364,0.0886607110469695,0.112845349687731,1.22207550202283e-59
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,29478,0.101058277555066,0.00619091555765174,0.0889240830620687,0.113192472048064,1.22520990743782e-59
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,0.086579028668462,0.00531307755838322,0.0761653966540309,0.0969926606828931,2.20965167301649e-59
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,29443,-0.0331815248232071,0.00204197588177756,-0.0371837975514911,-0.0291792520949231,4.06144915083843e-59
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,24951,0.0319601617100259,0.00196915584116637,0.0281006162613398,0.035819707158712,6.16825313919571e-59
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,0.112447092742193,0.00693943394628671,0.0988458022074708,0.126048383276915,8.48702320214725e-59
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,29351,0.0368482134506546,0.00227585405993001,0.0323875394931918,0.0413088874081174,1.05048913739052e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,28797,0.0570190307344548,0.00352444375302774,0.0501111209785204,0.0639269404903891,1.30491023721121e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,29349,0.0601751549992616,0.00372513198921466,0.0528738963004009,0.0674764136981223,1.90857746823057e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,0.0799367379554551,0.00495690793668353,0.0702211983995554,0.0896522775113548,3.34977202066879e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,29566,-0.0484981005403759,0.00301469192299691,-0.0544068967094499,-0.042589304371302,5.52987101893857e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,24793,0.0914270324995275,0.00568105901180838,0.080292156836383,0.102561908162672,5.59520033989147e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,29453,0.0571475127838471,0.00355655500992129,0.0501766649644014,0.0641183606032928,7.51394172696791e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TREH,Trehalase,24938,0.0858312088575349,0.00534680007313009,0.0753514807141999,0.0963109370008698,1.06396855035061e-57
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,29694,0.109409659596284,0.00682639720020036,0.096029921083891,0.122789398108676,1.43468443248146e-57
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,29434,0.120948789455129,0.00755610407640619,0.106138825465373,0.135758753444885,2.00442248242036e-57
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,29434,0.0688132761829144,0.00431011767168699,0.0603654455464079,0.0772611068194209,3.86343347978647e-57
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,24793,0.11312658702358,0.00708682282784099,0.0992364142810113,0.127016759766148,4.46063862018448e-57
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,29566,0.0301286716519084,0.0018908315318099,0.026422641849561,0.0338347014542558,6.34808407750471e-57
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,29566,0.0608314047562226,0.00381884461504486,0.0533464693107346,0.0683163402017105,6.85191537178038e-57
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,29725,-0.0522665251474096,0.00328767674955017,-0.0587103715765279,-0.0458226787182912,1.1263658938481e-56
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,29293,0.0802169864193539,0.00506487139452541,0.0702898384860841,0.0901441343526237,2.91932250858404e-56
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,0.04525006730726,0.00285940053765508,0.039645642253456,0.0508544923610639,3.93549996417202e-56
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,0.0439313643444252,0.00278431162622911,0.0384741135570161,0.0493886151318342,8.3436580454464e-56
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,28797,0.0834361871696149,0.00529655561929625,0.0730549381557943,0.0938174361834356,1.12110668308319e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,0.0443095539226555,0.00281356060637501,0.0387949751341605,0.0498241327111505,1.17840725601344e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,29632,0.0814334310104295,0.00517088855935014,0.0712984894341032,0.0915683725867557,1.18464863558587e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EZR,Ezrin,29694,0.0269362770522561,0.00171073589108031,0.0235832347057387,0.0302893193987735,1.24051021612827e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,24922,0.0503714995256979,0.00320510237474282,0.0440894988712019,0.0566535001801938,2.16852402745572e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,29434,0.0734081885368407,0.00467351036931116,0.0642481082129909,0.0825682688606906,2.26437231067346e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,28795,0.0556591193651216,0.00354585185886249,0.0487092497217511,0.0626089890084921,2.69158109248968e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,29434,0.102298917886837,0.00652553661194511,0.0895088661274249,0.11508896964625,3.6516444436981e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,29704,0.091309563865149,0.00582656324922737,0.0798894998966634,0.102729627833635,3.95739786660919e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,24229,0.104209531212713,0.00665096607914393,0.0911736376975913,0.117245424727836,4.64371950752024e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,24195,0.135265035880315,0.00864215113289927,0.118326419659832,0.152203652100797,6.01356322550978e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,28931,0.0528647324730752,0.00338029365048675,0.0462393569181212,0.0594901080280293,6.6220227655992e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,0.0434232439813689,0.00277728610057928,0.0379797632242335,0.0488667247385043,6.97891231089061e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,28797,0.0677768885373058,0.00433541739267054,0.0592794704476715,0.07627430662694,7.26436786038498e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,0.0456512671582038,0.00292475314440224,0.0399187509951754,0.0513837833212322,1.05577916412611e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,28765,0.043966944986505,0.00281904851014763,0.0384416099066156,0.0494922800663943,1.29048088511759e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,0.0569108782444824,0.0036526771969831,0.0497516309383955,0.0640701255505693,1.78877869015235e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,29566,0.0631621535914872,0.00405761255375813,0.0552092329861213,0.0711150741968532,2.02852110304599e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,29343,0.0342242108280578,0.00219861122099765,0.0299149328349024,0.0385334888212132,2.03770534059181e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,-0.0294885802253797,0.00189590313461806,-0.0332045503692311,-0.0257726100815283,2.47077506594657e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,24919,0.0623460791173948,0.00400943558039908,0.0544875853798127,0.0702045728549771,2.87153979178665e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,0.0556135945081187,0.00358871349637162,0.0485797160552303,0.0626474729610071,6.63416669744504e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,29169,0.0565494727227516,0.00365404819305175,0.0493875382643701,0.063711407181133,8.27149371156041e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,0.0918480999757362,0.00593610182204794,0.0802133404045222,0.10348285954695,9.54447315065698e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,29163,0.0682334350929846,0.00442424716036956,0.0595619106586603,0.076904959527309,1.87657264750342e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,29495,0.0511781498571589,0.00331954864668918,0.0446718345096481,0.0576844652046697,2.02802551818806e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,25976,-0.0343354824643069,0.00222809993471921,-0.0387025583363565,-0.0299684065922572,2.40866296970954e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,0.0762213713452124,0.00494815279840016,0.0665229918603481,0.0859197508300767,2.71490863471501e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,29725,-0.0373827818240112,0.0024294263134686,-0.0421444573984096,-0.0326211062496127,3.18739668341833e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,0.11990374493282,0.00779361873568468,0.104628252210878,0.135179237654762,3.64838549005875e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,-0.0216674465985706,0.00140994775731873,-0.0244309442029153,-0.0189039489942259,4.3522849609563e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,29581,0.0445859823831642,0.00290903547813527,0.038884272846019,0.0502876919203093,8.09509042423017e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,29434,0.10377115568276,0.00677499338773723,0.0904921686427955,0.117050142722725,9.44235082873986e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,0.0820558147425554,0.00536381208314005,0.0715427430596009,0.0925688864255099,1.36701389693708e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,29566,0.0901364764388748,0.00589641085551946,0.0785795111620567,0.101693441715693,1.49148829533426e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,24240,0.0793166554679253,0.00518643937481552,0.0691512342932869,0.0894820766425637,1.49696487632532e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,28990,-0.0326184809558387,0.00213977373235609,-0.0368124374712566,-0.0284245244404207,2.88483332916302e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,29624,0.073813065334843,0.00484302695638804,0.0643207325003225,0.0833053981693636,2.97994135733413e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,29474,-0.0236148571663859,0.0015503689487301,-0.0266535803058969,-0.0205761340268749,3.44163916175152e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,0.045733340792277,0.00300426133578143,0.0398449885741454,0.0516216930104086,3.93450267560731e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,29786,0.0454947744659418,0.00299146031819313,0.0396315122422832,0.0513580366896003,4.8957020600567e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,29434,0.0545988057211552,0.00359186039719977,0.0475587593426436,0.0616388520996667,5.51536220254304e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,29434,0.0609615755043448,0.00401648964768007,0.0530892557948918,0.0688338952137977,7.79772213366934e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,28797,0.068172082759449,0.00449178721520834,0.0593681798176406,0.0769759857012573,7.96848863238732e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,29594,-0.0327164330388988,0.00215690244462576,-0.0369439618303653,-0.0284889042474323,8.99068432679618e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,28774,0.0664272787598117,0.00438217727476797,0.0578382113012664,0.0750163462183569,1.05492369597004e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,0.0658824762085747,0.00436724763527806,0.0573226708434297,0.0744422815737197,3.1341510641134e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,28797,0.0688770455119101,0.00456562014799307,0.0599284300218437,0.0778256610019765,3.14358320046264e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,0.036461821958857,0.00241783936068079,0.0317228568119227,0.0412007871057914,3.38794798356599e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,0.150719728920553,0.00999576035355676,0.131128038627582,0.170311419213525,3.79066687457171e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,29218,0.0567895095667448,0.00377054566789916,0.0493992400576624,0.0641797790758271,4.52454798136047e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,24793,0.0478269167185697,0.00318022510571811,0.0415936755113622,0.0540601579257772,6.85569325935909e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,0.104907778730808,0.00697687206156111,0.0912331094901483,0.118582447971468,7.0892288637902e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,29694,0.0634601756223897,0.00422430705115301,0.0551805338021298,0.0717398174426496,8.02943510247324e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,29218,0.0714817985387231,0.00476005564912189,0.0621520894664442,0.080811507611002,8.79471906825663e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,0.0321762847167052,0.0021423039931435,0.0279773688901439,0.0363752005432664,9.15755270441118e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,-0.048993733160463,0.00326607842117546,-0.0553952468659669,-0.0425922194549591,1.11333450137336e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,29434,0.0916413751869229,0.00611715645787697,0.079651748529484,0.103631001844362,1.50097647557407e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,29478,0.0823352321769045,0.0054995966731487,0.071556022697533,0.093114441656276,1.73897048748444e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,0.0851597765162622,0.00569265604751111,0.0740021706631404,0.0963173823693839,2.23620368218552e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,24111,0.0723425010116102,0.004838569158133,0.0628589054616695,0.0818260965615509,2.57187420004441e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,24240,0.0341286225866666,0.0022861609271446,0.0296477471694632,0.03860949800387,3.6032218988435e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,29694,0.0614833931449573,0.00412190872506559,0.0534044520438288,0.0695623342460859,3.92766030888988e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,0.120121558525936,0.00806058152185631,0.104322818743097,0.135920298308774,5.27892002556866e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,28774,0.0684022376875374,0.00460181600292145,0.0593826783218114,0.0774217970532635,8.61974316469243e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,0.0740193563101865,0.00498287866092681,0.06425291413477,0.083785798485603,1.07321563510578e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,28774,0.08995141781069,0.00606430739611893,0.0780653753142969,0.101837460307083,1.36909665298822e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,29218,0.0549562127659925,0.0037133910114367,0.0476779663835766,0.0622344591484084,2.22996533151007e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,29581,0.0704045169153821,0.00476245914448254,0.0610700969921963,0.0797389368385679,2.81929929283109e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,0.0304913098157695,0.00206252477307887,0.0264487612605349,0.0345338583710041,3.0608328814061e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,29434,0.0412778974649094,0.00280128014737751,0.0357873883760495,0.0467684065537694,5.71363830531246e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,28705,0.0730804124694128,0.00496550274534718,0.0633480270885324,0.0828127978502933,7.48984764191195e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,28774,0.0828976485758036,0.00563527177884981,0.071852515889258,0.0939427812623492,8.30749598318612e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,29335,0.0481892059817089,0.00327719274534924,0.0417659082008244,0.0546125037625934,9.01203276236931e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,29434,0.0850133787890002,0.0057864317129287,0.07367197263166,0.0963547849463405,1.08204084479395e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,29434,0.0958432210848906,0.00652535444988596,0.0830535263631141,0.108632915806667,1.14785061911917e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",28774,0.0533826817648871,0.00363606654145603,0.0462559913436333,0.0605093721861409,1.27175764558399e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,0.080802587000981,0.00550452017937396,0.070013727449408,0.0915914465525539,1.39624366863755e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,28774,0.0640872126970872,0.00436829852730118,0.0555253475835769,0.0726490778105975,1.48209131449265e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,0.0558707821892369,0.00380968062607671,0.0484038081621265,0.0633377562163472,1.59649918310782e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,0.0623794150746259,0.00425554189088758,0.0540385529684862,0.0707202771807655,1.89996903534539e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,29566,0.03415457784117,0.00233712855914023,0.0295738058652552,0.0387353498170848,3.3741885467557e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,29581,0.0423085435667895,0.00289716315061236,0.0366301037915893,0.0479869833419897,3.92941625386107e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,29489,-0.0286474546753725,0.00196190788284723,-0.0324927941257531,-0.024802115224992,4.02710675562527e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,29349,0.106532598702442,0.00730183633853213,0.092220999478919,0.120844197925965,4.80452077753197e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,29786,0.097969026909749,0.00671672463974625,0.0848042466158464,0.111133807203652,5.06392902916818e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,29443,-0.0296899375033498,0.00203716919939064,-0.0336827891341554,-0.0256970858725441,6.03150373906944e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,24445,0.134175134464304,0.00920301849891129,0.116137218206438,0.15221305072217,6.03486540337717e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNST,Consortin,29478,0.112480476192627,0.00772257953616489,0.0973442203017435,0.12761673208351,6.8683505810606e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,0.099546045006233,0.00683566148162156,0.0861481485022547,0.112943941510211,7.16404460819003e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,29218,-0.0267285004343864,0.00183608596933895,-0.0303272289342907,-0.023129771934482,7.72042880967538e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,28916,-0.024251388432596,0.0016736279471893,-0.027531699209087,-0.0209710776561049,2.04642891049744e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,29218,0.0432100354617853,0.00298215315672216,0.0373650152746099,0.0490550556489608,2.06112076450874e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,24938,0.0385697263832882,0.00266228757818229,0.0333516427300509,0.0437878100365255,2.26679846385797e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,0.0288568170013201,0.00199340109953234,0.0249497508462367,0.0327638831564035,2.49613938091971e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,0.107018561278674,0.00739578198800364,0.092522828582187,0.121514293975161,2.717367084643e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,0.101856291607178,0.00704915864809161,0.0880399406569183,0.115672642557437,3.65173360161744e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,24804,0.0607409173182837,0.00420529747984082,0.0524985342577956,0.0689833003787717,4.25533112264316e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,29372,-0.0650292042393243,0.0045068894306603,-0.0738627075234185,-0.0561957009552301,4.93744876208092e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,29030,0.0437570152519515,0.00303411112247087,0.0378101574519085,0.0497038730519944,5.49657486324245e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,0.0284434382361883,0.00197441184278539,0.0245735910243289,0.0323132854480476,6.84906135629983e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,23389,0.0252080648967373,0.00174959290105844,0.0217788628106627,0.0286372669828118,7.32357788621961e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,29820,0.0419171693970469,0.00291255882731462,0.0362085540955103,0.0476257846985836,8.35565206605443e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,29674,0.0289857533737117,0.00201646333541155,0.0250334852363051,0.0329380215111184,1.07326519777362e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,24938,-0.0339268051404246,0.00236070035995034,-0.0385537778459273,-0.029299832434922,1.20050430603944e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,0.0820651804889655,0.00571097743822771,0.0708716647100392,0.0932586962678918,1.24734093413394e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,24938,0.0288548304271976,0.00201245023431069,0.0249104279679487,0.0327992328864466,1.93423112265412e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,28774,0.0581474116930584,0.00405768622645067,0.0501943466892151,0.0661004766969017,2.0486177370663e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,0.0880718968221359,0.00614912802272497,0.076019605897595,0.100124187746677,2.25980393839054e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,0.0618382863967563,0.00432077319600428,0.0533695709325879,0.0703070018609247,2.64311192939106e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,24793,0.116664298627002,0.00815200851732899,0.100686361933037,0.132642235320967,2.85281368955272e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,29443,-0.0263380484770905,0.00184179217529715,-0.0299479611406729,-0.0227281358135081,3.11684353322568e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,24111,0.0373078629866585,0.00261245950426378,0.0321874423583015,0.0424282836150155,4.44970956292611e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,28424,0.0933627955166465,0.00654404417825687,0.0805364689272631,0.10618912210603,5.08067949333067e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,0.0760322409181859,0.00532879124561167,0.0655878100767871,0.0864766717595848,5.30690510978916e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,0.0584660158985196,0.00410216935686461,0.050425763959065,0.0665062678379742,6.172107364196e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,29786,0.0382642605265749,0.00268506563952875,0.0330015318730986,0.0435269891800513,6.27977399093761e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,29434,0.0850704856270003,0.00597342238506043,0.0733625777522818,0.0967783935017187,7.19466657500032e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,29639,0.0586813075231665,0.00412170217186164,0.0506027712663177,0.0667598437800153,7.63440220411552e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,0.0734599316380243,0.00515910640276785,0.0633480830885993,0.0835717801874493,7.97145675183212e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,24966,0.0173839192741382,0.00122238892888525,0.0149880369735231,0.0197798015747533,1.02054645149468e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,29536,0.052595476602237,0.00370894514509542,0.04532594411785,0.059865009086624,1.7019094093272e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,29434,-0.0532384106916643,0.00375491768856715,-0.0605980493612559,-0.0458787720220726,1.76265337138568e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,0.0775693317970553,0.00547249032802088,0.0668432507541344,0.0882954128399762,1.86462733916287e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,29725,0.0405150210430527,0.00285909535496284,0.0349111941473256,0.0461188479387799,1.96011520986554e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,0.0368916694998748,0.00260658911412808,0.0317827548361838,0.0420005841635659,2.51265455660328e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,0.0672465356697121,0.00475722611479915,0.0579223724847057,0.0765706988547184,3.24489565177798e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,0.0236229493117343,0.0016713413419779,0.0203471202814577,0.026898778342011,3.29076588098718e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,-0.0267002028207904,0.00189161330021329,-0.0304077648892085,-0.0229926407523724,4.57742928567365e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HLA_E,,29434,0.0291906494089296,0.00207016152808886,0.0251331328138754,0.0332481660039838,5.27402091528322e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,0.0635254499881675,0.00451077218198247,0.0546843365114819,0.0723665634648532,7.18705559218271e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,29218,0.0383288728041473,0.00272396621129268,0.0329898990300136,0.0436678465782809,8.02564990101246e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,29265,0.0230715365348999,0.00164230419422603,0.0198526203142169,0.0262904527555829,1.10320341341072e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,24867,0.105191296762151,0.00749010473525982,0.0905106914810421,0.119871902043261,1.24170174617076e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,29566,0.0416302727701804,0.00296882026566535,0.0358113850494763,0.0474491604908845,1.5777549905916e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,0.0865173216543638,0.00617248669981373,0.0744192477227289,0.0986153955859987,1.73246690976546e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,29434,0.0814788539822812,0.00581631465584154,0.0700788772568318,0.0928788307077306,1.91725968627803e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,24229,0.123303433663259,0.00880533482237582,0.106044977411402,0.140561889915115,2.21841314428939e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,29443,-0.0290148456852921,0.00207544478472955,-0.033082717463362,-0.0249469739072222,2.85928020696944e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,29443,0.0509574872754468,0.00364640440481286,0.0438105346420136,0.05810443990888,3.08048672394794e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,0.0524138792352424,0.00374986533865162,0.0450641431714852,0.0597636152989996,3.17611973992801e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,29404,0.0197879465549825,0.00142007799483805,0.0170045936851,0.0225712994248651,5.40440638424928e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,24951,0.0243367594198197,0.00174741023685372,0.0209118353555864,0.0277616834840529,6.31458091997006e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,29566,0.0398144260287718,0.00286103913808811,0.0342067893181191,0.0454220627394245,6.96170437150987e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,29593,-0.0240642671137963,0.00173053040495005,-0.0274561067074984,-0.0206724275200942,8.03627783274676e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELP,P-selectin,29594,0.05610376840558,0.00405231581318006,0.0481612294117471,0.0640463073994129,1.86742481482625e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,0.0272474728785597,0.00196877316946667,0.0233886774664051,0.0311062682907144,2.00251640901595e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,29443,0.0548674869188099,0.00396777634229054,0.0470906452879204,0.0626443285496993,2.35246742360788e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,0.0588357816826006,0.00426031358143435,0.0504855670629893,0.0671859963022119,3.03542984132291e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,24381,0.030575353366629,0.00221338772747432,0.0262371134207793,0.0349135933124787,3.06230327917858e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,0.0433663507262229,0.0031415269398673,0.0372089579240829,0.0495237435283628,3.28582073702907e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,0.0276535853481242,0.00200358716195637,0.0237265545106897,0.0315806161855587,3.37720906709476e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,0.0623967817081259,0.00452402693244238,0.0535296889205388,0.071263874495713,3.86165320376392e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,24966,0.0299193209847747,0.00217206811849277,0.0256620674725289,0.0341765744970205,5.20961866021927e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,0.0478518418633209,0.00347611078741018,0.041038664719997,0.0546650190066449,5.58620548712403e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,29443,-0.0429491754032781,0.00312771649392692,-0.0490794997313749,-0.0368188510751813,8.87474564382219e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,24845,0.0618942714354037,0.00451321492196766,0.0530483701883471,0.0707401726824604,1.19744708638566e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,24845,0.0866409462756976,0.00632079457441886,0.0742521889098366,0.0990297036415585,1.31277857004499e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,0.0398602590814135,0.00290876968950974,0.0341590704899744,0.0455614476728526,1.38298469125328e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,29349,0.134225539719006,0.00979974633630957,0.11501803689984,0.153433042538173,1.43406851701933e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,0.0298638809785867,0.00218299904290165,0.0255852028544995,0.034142559102674,1.79466709735611e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,0.105531122097596,0.00771983917747528,0.0904002373097447,0.120662006885448,2.18099776719107e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,24805,0.0833960477519035,0.00610158065987451,0.0714369496585494,0.0953551458452575,2.24802268239637e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,29443,0.0435370626117384,0.00319326157894674,0.0372782699170028,0.049795855306474,3.37636447283148e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,24938,0.0397622594616513,0.00291770552363907,0.0340435566353187,0.0454809622879839,3.86979638631654e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,29434,0.0416351471010217,0.00306085425125354,0.0356358727685648,0.0476344214334786,5.18914802353685e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,24938,0.0246175748727495,0.00181032662586857,0.0210693346860472,0.0281658150594519,5.77775945219522e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,0.0446057888367212,0.00328266238753738,0.038171770557148,0.0510398071162945,6.28938444249745e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,24805,0.101242154798921,0.0074523894575866,0.0866354714620517,0.115848838135791,6.92542986464519e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,24240,0.030007090559265,0.00220986309435285,0.0256757588943334,0.0343384222241966,7.62231181646621e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,0.02868184926675,0.00211262875106191,0.0245410969146686,0.0328226016188313,7.79162911223795e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,24922,0.0724896737565455,0.00534301501815241,0.0620173643209667,0.0829619831921242,8.82493369366516e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,29491,0.0384730820039738,0.00283871905585836,0.0329091926544914,0.0440369713534562,1.01485922928821e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,29581,0.0261200881460549,0.00192845319281952,0.0223403198881286,0.0298998564039812,1.13598300920462e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,24381,0.0678855296491754,0.00501385969139599,0.0580583646540392,0.0777126946443115,1.29170427005589e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,0.0912216517651583,0.00674803096543731,0.0779955110729012,0.104447792457415,1.62718673716134e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,-0.0206546312725359,0.0015325027280689,-0.0236583366195509,-0.0176509259255208,2.81992385950983e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,29434,0.0820941777892245,0.00609437678359397,0.0701491992933803,0.0940391562850687,3.09274679350248e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COCH,Cochlin,24922,0.0445802242918175,0.00330961412642729,0.0380933806040201,0.051067067979615,3.27861732241529e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,0.0994366502970941,0.00739606435919398,0.0849403641530739,0.113932936441114,4.617754835203e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,24381,-0.0498288005317304,0.0037145931310643,-0.0571094030686164,-0.0425481979948444,6.96181050381135e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,29581,0.0453327514761909,0.00338251070760359,0.0387030304892879,0.0519624724630939,7.73566054546276e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,29786,-0.00849919062871332,0.000634662105496417,-0.0097431283554863,-0.00725525290194035,8.87754102331073e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,29594,0.0959259408713665,0.00716362153975744,0.0818852426534419,0.109966639089291,9.00977922507749e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,24381,0.0500316640989816,0.00374359677746075,0.0426942144151586,0.0573691137828047,1.35338713268406e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,24381,0.021862992190317,0.00163643139737486,0.0186555866514622,0.0250703977291717,1.4358319213437e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,28916,0.0551799266020088,0.00413543689773542,0.0470744702824474,0.0632853829215702,1.71055372813706e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,29394,0.0285479430606312,0.00214487514484355,0.0243439877767378,0.0327518983445245,2.65542316415744e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,29478,0.0540462916889549,0.00407181145022529,0.0460655412465133,0.0620270421313965,4.31277324527687e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,29345,0.040769713158545,0.00307576277305952,0.0347412181233483,0.0467982081937417,5.49090679044549e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,28835,0.0365765442497832,0.00276042496359729,0.0311661113211325,0.0419869771784339,5.88067292723139e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,29163,0.0757285122373675,0.00571561793923504,0.0645259010764668,0.0869311233982681,5.93563088174846e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,28797,0.0444939126557483,0.00336099477912834,0.0379063628886568,0.0510814624228399,6.89692651327905e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,0.0456406224761698,0.00344783726850671,0.0388828614298966,0.0523983835224429,7.28313210431187e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,24381,0.0739240765841279,0.00558955877666346,0.0629685413818675,0.0848796117863883,8.5880111171711e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,0.0654461530653972,0.00495027146525478,0.0557436209934979,0.0751486851372966,8.69315090200435e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,24381,-0.0270332006882657,0.00204567670274431,-0.0310427270256445,-0.0230236743508868,9.87656554587441e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,29518,-0.0335647602905784,0.00254308089820446,-0.0385491988510592,-0.0285803217300977,1.16021498735617e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,24229,-0.0306330004152291,0.00232058597114481,-0.0351813489186729,-0.0260846519117852,1.19420454926039e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,24805,0.0722180242283996,0.00548147586025589,0.061474331542298,0.0829617169145011,1.66135365287951e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,0.089108168890872,0.00678097377143678,0.0758174602988559,0.102398877482888,2.47444152060304e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,29349,0.0791063047522123,0.0060199031928534,0.0673072944942196,0.0909053150102049,2.4828917188545e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,29218,0.0541700158045554,0.00412372263888368,0.0460875194323433,0.0622525121767674,2.64059087758181e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,24111,0.0405126206493287,0.00308331959678791,0.0344693142396243,0.046555927059033,2.67670968085988e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,0.0598502360673793,0.00455683848819405,0.050918832630519,0.0687816395042396,2.83430418883222e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,24805,0.0780509091247082,0.00595494477973817,0.0663792173564214,0.089722600892995,4.0565178795838e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,29218,0.0570623063688299,0.00435678231776792,0.0485230130260048,0.065601599711655,4.39475336783058e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,0.0706014027738772,0.00539917940782434,0.0600190111345415,0.0811837944132129,5.78280221375572e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,24813,0.0696860381651067,0.00532882073658055,0.0592415495214088,0.0801305268088045,5.98200821644072e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,24867,0.0729024621853799,0.00558164438955247,0.0619624391818571,0.0838424851889028,7.375410673698e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,29694,0.0564280868523813,0.00432302576421861,0.0479549563545129,0.0649012173502498,7.82540779164794e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,24867,0.0494518624006657,0.00378918243437706,0.0420250648292867,0.0568786599720448,8.43672693964488e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,0.0503888085757532,0.00386199430302539,0.0428192997418234,0.0579583174096829,8.43867893699766e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,24966,0.0192856663241512,0.001481099149977,0.0163827119901963,0.0221886206581061,1.23927536979653e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,28774,0.0623344108594893,0.00478832018866832,0.0529493032896994,0.0717195184292792,1.24305558070025e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,28774,0.0537613521055911,0.00413197421554978,0.0456626826431136,0.0618600215680687,1.36081911603624e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,24565,0.102064116999369,0.00784565298715613,0.0866866371445429,0.117441596854195,1.45883590254667e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,24888,0.0413438927111416,0.00318048035214913,0.0351101512209293,0.0475776342013539,1.64938702100257e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,29286,0.0425237442360983,0.00327790146740541,0.0360990573599837,0.0489484311122129,2.22567498428263e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,24922,0.0760743535557142,0.0058767287093129,0.0645559652854609,0.0875927418259675,3.33025087158204e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,29433,0.0343683365311496,0.00265649820192399,0.0291616000553786,0.0395750730069207,3.51664085602725e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,29443,0.0345062224997544,0.00267044694692714,0.0292721464837772,0.0397402985157316,4.32152885906717e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,0.0538257019659228,0.00416610996904763,0.0456601264265895,0.0619912775052562,4.43885021965816e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,24845,0.0349513127528495,0.00270966105650405,0.0296403770821016,0.0402622484235975,6.05545892266709e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,24381,0.039441801407911,0.00306923747872893,0.0334260959496023,0.0454575068662197,1.13015936364814e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,0.0404368817203408,0.00314857052344,0.0342656834943984,0.0466080799462832,1.24770031454705e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,29820,0.0516662442422831,0.00402608538532374,0.0437751168870486,0.0595573715975176,1.34976485165769e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,28797,0.0371799307468258,0.002897507587902,0.0315008158745379,0.0428590456191138,1.38152989885773e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,29820,0.0509762061242012,0.00397566129400626,0.0431839099879489,0.0587685022604535,1.55050747135181e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,24922,0.0669110251883438,0.00521745546640844,0.0566848124741833,0.0771372379025043,1.57265870108951e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,24966,0.019827155925684,0.00154707846492923,0.0167948821344227,0.0228594297169453,1.75469653916989e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,0.0828054974969237,0.00646316987558186,0.0701376845407833,0.0954733104530642,1.84860502997523e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,29694,0.0593308143297577,0.00463388447893749,0.0502484007510402,0.0684132279084752,1.96438010426121e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,29349,0.0298721646202745,0.00233324242092849,0.0252990094752547,0.0344453197652943,1.9907850894686e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,29694,0.0206224722105416,0.00161154712100392,0.0174638398533739,0.0237811045677093,2.14852328567606e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,24396,0.05960685069083,0.00465766269178286,0.0504778318149356,0.0687358695667244,2.23131911741507e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,24381,0.0355946505956058,0.00278528645931031,0.0301354891353576,0.041053812055854,2.81104844489654e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,28797,0.0506611710034207,0.00397973653947142,0.0428608873860567,0.0584614546207847,5.08456856592889e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,24793,0.0193501226337486,0.00152200162012966,0.0163669994582945,0.0223332458092027,6.48146333191327e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,29581,0.113351873667094,0.00892678285406906,0.095855379273119,0.13084836806107,7.57634915930491e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,0.0527663373504199,0.00416140320419441,0.0446099870701989,0.060922687630641,9.9804265801951e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,0.0198511076422697,0.00156640207558977,0.0167809595741138,0.0229212557104257,1.0889326702391e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,29395,0.0750312322448422,0.0059256014913439,0.0634170533218082,0.0866454111678763,1.19402715555736e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,28797,0.0504542420849587,0.003990172651389,0.0426335036882362,0.0582749804816811,1.49866371572255e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,0.100612026750836,0.0079573245976039,0.0850156705395321,0.116208382962139,1.50728396953273e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,0.030080303443253,0.00237831580430335,0.0254188044668184,0.0347418024196875,1.50920895312956e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,29082,0.0424100511376867,0.00335822546995509,0.0358279292165748,0.0489921730587987,1.82881843918146e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,24938,0.0210590794492653,0.00166739660438002,0.0177909821046804,0.0243271767938501,1.8681711984136e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,24381,0.0373485574832176,0.00296572432758457,0.0315357378011519,0.0431613771652834,2.97779044259431e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,24381,0.045719643202705,0.0036309780652133,0.0386029261948869,0.052836360210523,3.04800301743897e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,29674,0.0515244996719679,0.00409571306439609,0.0434969020657516,0.0595520972781843,3.36163756471619e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,0.0514014235822328,0.00408901900338961,0.0433869463355892,0.0594159008288764,3.80992345401876e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,28774,0.0312316497330092,0.00249065845329336,0.0263499591645542,0.0361133403014642,5.63648234642702e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,29454,0.0235817234193173,0.00188330199657017,0.0198904515060397,0.0272729953325948,7.03225471802902e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,29349,0.0272950353504774,0.00218131623628558,0.0230196555273577,0.0315704151735971,7.81605945147535e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,24229,0.0411136666010304,0.00328893584397639,0.0346673523468367,0.0475599808552241,9.55384767783457e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,28797,0.0257954114758907,0.002065152326536,0.0217477129158802,0.0298431100359013,1.03734460623353e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,23906,0.0478017055622272,0.00382913213020145,0.0402966065870324,0.0553068045374221,1.18404799187614e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,28797,0.0871731310957549,0.00699600846198752,0.0734609545102594,0.10088530768125,1.516184826766e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,29319,0.0702005127306929,0.0056350683709618,0.0591557787236077,0.081245246737778,1.56062635290123e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,24867,0.0470099159879733,0.00377331443233746,0.0396142197005919,0.0544056122753547,1.60481927533725e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,29434,0.0521236794815841,0.00418803375352755,0.0439151333246701,0.0603322256384981,1.80946375771164e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,29786,0.0493056756436166,0.00396582237000935,0.0415326637983983,0.0570786874888349,2.12789534585894e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,24793,0.0737698784398193,0.00593248739946981,0.0621422031368585,0.0853975537427801,2.15500460432831e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,28916,0.0646811715759912,0.00520699033238174,0.054475470524523,0.0748868726274594,2.44446825957709e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,29478,0.0344723269319209,0.00277667909146579,0.0290300359126479,0.0399146179511938,2.65754405076618e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,29581,0.0588991367289416,0.0047470326748338,0.0495949526862674,0.0682033207716159,2.91067930975073e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,29581,0.093432644274891,0.00753065333950139,0.0786725637294682,0.108192724820314,2.93216564418988e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,24229,0.0486040380275335,0.0039185563479611,0.0409236675855298,0.0562844084695373,3.19850125809712e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,29581,0.0341814154558802,0.00276267994121515,0.0287665627710985,0.0395962681406619,4.49391259114053e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,29478,0.107093521295418,0.00868376011970096,0.0900733514608037,0.124113691130031,7.36965379537612e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,0.068362677180913,0.00554556586929422,0.0574933680770963,0.0792319862847296,8.1481357759828e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,24805,0.062366568807833,0.00506005947277666,0.0524488522411907,0.0722842853744752,8.37548378198942e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,0.0292596323662215,0.00237661510576546,0.0246014667589212,0.0339177979735218,9.57513611873988e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,24867,0.0557051877490689,0.00452499160849533,0.046836204196418,0.0645741713017197,1.00332124595376e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,24805,0.0416383196666598,0.00338234615336959,0.0350089212060554,0.0482677181272642,1.00485801982838e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,24845,0.0543130472430101,0.00441904080695383,0.0456517272613806,0.0629743672246396,1.28158296756565e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,24240,0.0416570461905728,0.00338970060951841,0.0350132329959167,0.0483008593852289,1.31116799840627e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,29594,0.0270390800113941,0.00220706976476902,0.0227132232724468,0.0313649367503414,2.00814357344602e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,29435,0.0346538894735976,0.00282960002957265,0.0291078734156352,0.04019990553156,2.11651026089677e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MDK,Midkine,29455,0.0443624476562885,0.00362777217700216,0.0372520141893643,0.0514728811232127,2.65015203383468e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,24381,0.101405174165794,0.00830024907030896,0.0851366859879887,0.1176736623436,3.17177504945616e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",24101,0.0637576545657534,0.00522185016194203,0.053522828248347,0.0739924808831598,3.47873298100705e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,0.0699221221698688,0.00572963726504799,0.0586920331303748,0.0811522112093629,3.72551404872395e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,29820,0.0277444897362355,0.00227429818624134,0.0232868652912025,0.0322021141812685,3.78938111375016e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,0.0543958830456189,0.00445891509341474,0.045656409462526,0.0631353566287118,3.95074771894682e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,0.0602412242891575,0.00494388697447021,0.0505512058191959,0.0699312427591191,4.70340983625753e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,28916,0.0327036269989804,0.00269183514055824,0.0274276301234863,0.0379796238744746,7.00813354596415e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,29497,-0.020750738679279,0.0017083731876204,-0.0240991501270149,-0.017402327231543,7.21547427773967e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,0.0418231038506179,0.0034430091614352,0.0350748058942049,0.0485714018070309,7.40055803244817e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,0.0325598801285361,0.0026830737461024,0.0273010555861754,0.0378187046708968,8.27160093123349e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,29478,0.0277783684805748,0.00228918045336072,0.0232915747919878,0.0322651621691619,8.33552571315e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,29820,-0.0216701814479952,0.00178686672693988,-0.0251724402327973,-0.018167922663193,9.07396158365366e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,0.0365963266771889,0.00301892770534198,0.0306792283747186,0.0425134249796592,9.68603348285773e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,29433,0.0644888677784878,0.00532265562594823,0.0540564627516293,0.0749212728053463,1.04658958510988e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,24867,0.0479500652879772,0.00395810410944233,0.0401921812334702,0.0557079493424841,1.10273087537717e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,29725,0.0329779410934181,0.0027231807584783,0.0276405068068006,0.0383153753800355,1.12138768655219e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,29536,-0.0708571846362288,0.00585159989533444,-0.0823263204310843,-0.0593880488413733,1.13714297839597e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,23907,0.0616023702908045,0.00508931130463503,0.0516273201337199,0.0715774204478892,1.25781487291019e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,29732,-0.0309398370387721,0.00255692206264583,-0.0359514042815579,-0.0259282697959863,1.26069123346114e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,0.0232695014421877,0.00192503326964528,0.0194964362336829,0.0270425666506924,1.46973174846563e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,24240,0.0348664938756684,0.00288592258948526,0.0292100856002773,0.0405229021510595,1.6500950314425e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,0.0328270064089717,0.00271930320729117,0.027497172122681,0.0381568406952623,1.78160616056874e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VASN,Vasorin,29065,-0.0237178307405059,0.0019672727516234,-0.0275736853336878,-0.0198619761473241,2.16172364055687e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,0.0660078175089173,0.00548728001788925,0.0552527486738544,0.0767628863439803,3.10260763790998e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,0.0458610381597595,0.00381634608327792,0.0383809998365348,0.0533410764829842,3.58842138394317e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,24845,0.0647555205916379,0.00539359994823329,0.0541840646931007,0.0753269764901751,4.08217013349155e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,29386,0.0553278334684041,0.00461844974895837,0.0462756719604457,0.0643799949763625,5.41684491785733e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,0.0875610006888415,0.00733982906950234,0.0731749357126169,0.101947065665066,1.02020814252372e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,29581,0.0728853885428296,0.00611136102588394,0.0609071209320971,0.0848636561535621,1.027281033225e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,29786,0.0418145145015349,0.00351007944754489,0.0349347587843469,0.0486942702187229,1.20582663024405e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,0.0875182569157653,0.00734769396024486,0.0731167767536854,0.101919737077845,1.23202347919905e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,24381,0.0572788168083572,0.004820729072756,0.0478301878257555,0.066727445790959,1.80987338025648e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,29443,-0.0203750518846847,0.00171895843741691,-0.0237442104220218,-0.0170058933473475,2.45574304307328e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,24845,0.0697877657612713,0.00588906942077238,0.0582451896965574,0.0813303418259852,2.61777821754734e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RETN,Resistin,29362,0.0357032190349582,0.00301361984839882,0.0297965241320965,0.0416099139378199,2.63369763080256e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,24688,0.0795818583569378,0.0067176913089435,0.0664151833914085,0.092748533322467,2.7413651642762e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,0.0601390494026603,0.00507846602670007,0.0501852559903281,0.0700928428149924,2.80757942417254e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,24610,-0.0917652705789465,0.00774786933404154,-0.106951094473668,-0.076579446684225,2.83144449513948e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,24922,0.0504576111887604,0.00426046588560792,0.0421070980529689,0.0588081243245519,2.84859431237325e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,29214,-0.0284950362040991,0.00240675180714664,-0.0332122697461065,-0.0237778026620917,2.88695965811147e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,24938,-0.0182355167462178,0.00154246404810243,-0.0212587462804986,-0.0152122872119371,3.6480274848437e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,29498,0.0550393770481673,0.00465774177155394,0.0459102031759215,0.064168550920413,3.78002268493152e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,27939,0.0337363923950275,0.00285690609963226,0.0281368564397483,0.0393359283503068,4.19607551840101e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,0.0348701576462471,0.00295322085627496,0.0290818447679482,0.040658470524546,4.23168079287167e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,29736,0.0274145227734985,0.00232935940885711,0.0228489783321386,0.0319800672148585,6.62861657911814e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,29581,0.0874420648997335,0.00743445104431718,0.0728705408528718,0.102013588946595,7.23822325691481e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,24966,0.0261951229800815,0.00222806935996614,0.0218281070345479,0.0305621389256152,7.89996486367301e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,29820,-0.0252576103474591,0.00214952112818062,-0.0294706717586931,-0.0210445489362251,8.26773904209965e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,29434,0.0308804423870887,0.00262911927186987,0.0257273686142238,0.0360335161599537,8.76672126730285e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,28931,0.0501463115152315,0.00427109489628365,0.0417749655185155,0.0585176575119474,9.29062546613893e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,24229,0.0755450321307073,0.00645683184784359,0.0628896417089339,0.0882004225524807,1.54952289961962e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,0.0908386493323853,0.00776797024737716,0.0756134276475261,0.106063871017245,1.65515168350389e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,24240,0.0860367315740289,0.0073596068755725,0.0716119020979069,0.100461561050151,1.73414403625244e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,29169,0.0430999072764117,0.00368778061601045,0.0358718572690312,0.0503279572837922,1.74177387084522e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,29443,0.0293495239381104,0.00251197399201305,0.0244260549137648,0.034272992962456,1.80924870617434e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,0.0348394525672833,0.0029861394718435,0.02898661920247,0.0406922859320965,2.26793934682537e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,24845,0.0465120370624803,0.00398706441510987,0.038697390808865,0.0543266833160957,2.30318809149182e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,29536,-0.0376455697830733,0.00322824455933037,-0.0439729291193608,-0.0313182104467858,2.35406981041474e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,24867,0.0604075080860172,0.00518143634631668,0.0502518928472365,0.0705631233247979,2.50742418583353e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,24240,0.0445266307966827,0.00382592513333257,0.0370278175353509,0.0520254440580145,3.19349294049574e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,28774,0.0594193305890981,0.00511121562987123,0.0494013479545505,0.0694373132236457,3.59987150603339e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,29322,0.0699098370322985,0.0060141901568739,0.0581220243248256,0.0816976497397713,3.63692299559806e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,24229,0.027583121407936,0.0023729729543602,0.0229320944173901,0.032234148398482,3.77133531781597e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,24951,0.0606327636338797,0.00521678858904475,0.050407857999352,0.0708576692684074,3.80540654283137e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,28797,0.0488604709649604,0.00420570244619856,0.0406172941704112,0.0571036477595096,3.93321752565713e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,0.0775006176342426,0.00667374655246971,0.064420074391402,0.0905811608770832,4.16202537345762e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,28931,-0.0327561116869561,0.00282129154551345,-0.0382858431161624,-0.0272263802577497,4.28135497430881e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,29163,0.0528768904508612,0.00455656265674117,0.0439460276436485,0.0618077532580739,4.57286981942115e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,24240,0.0426265422875253,0.00367248209385424,0.035428477383571,0.0498246071914796,4.58807604000845e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,0.0541317606215386,0.00466742031959817,0.0449836167951262,0.063279904447951,4.93353567841235e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,24793,0.0328638706783276,0.00283395913890758,0.0273093107660688,0.0384184305905865,5.16544660435331e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,24752,0.0359640389059016,0.00311212365546019,0.0298642765411997,0.0420638012706036,8.25006241220175e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,29478,0.0560054572041801,0.00485838633215143,0.0464830199931633,0.0655278944151969,1.11477866562419e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,-0.0173580062276622,0.00150623903357641,-0.020310234733472,-0.0144057777218525,1.19947599206806e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,0.0470548583186942,0.00408781271007246,0.0390427454069522,0.0550669712304362,1.35482837987099e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,29478,0.0444523716003506,0.00386306184058177,0.0368807703928103,0.0520239728078909,1.41349389144155e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,24240,0.050524508916918,0.00439114018810985,0.0419178741482226,0.0591311436856133,1.47735343934227e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,0.0310716300652403,0.00270232718169367,0.0257750687891207,0.0363681913413599,1.57132094009865e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,29566,0.0275565968515192,0.00239710090580276,0.0228582790761458,0.0322549146268927,1.60825463558659e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,24229,0.0407632791077969,0.00354614876709225,0.0338128275242961,0.0477137306912977,1.67573266498159e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,29409,0.0378510035871413,0.00329907936348003,0.0313848080347204,0.0443171991395622,2.08812209199934e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,29694,0.0554478311059619,0.00483693631073223,0.0459674359369267,0.064928226274997,2.3334871420907e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,-0.0288468612888496,0.0025226145037992,-0.0337911857162961,-0.0239025368614032,3.33003451956794e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,0.0634859749351116,0.00555866311343888,0.0525909952327714,0.0743809546374518,3.81048038298422e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,29566,-0.0236116335492504,0.00206869571513785,-0.0276662771509206,-0.0195569899475802,4.12714407036771e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BGN,Biglycan,28750,-0.0977200676472794,0.00856245881592789,-0.114502486926498,-0.0809376483680607,4.19958002493536e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,24805,0.0327290981758051,0.00286903707784281,0.0271057855032332,0.038352410848377,4.54932512715823e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,0.0364698859630069,0.00319909289212077,0.0301996638944502,0.0427401080315636,4.82286287302316e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,29786,0.0547574335335458,0.00480766825746121,0.0453344037489219,0.0641804633181698,5.43592508200574e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,24240,0.0602133777634543,0.0052856014327315,0.0498535989553006,0.070573156571608,5.46695054945286e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,29395,0.054049111995492,0.00474801539905733,0.0447430018133396,0.0633552221776443,5.83837765758208e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,29434,0.0541258644328259,0.00475655342319764,0.0448030197233585,0.0634487091422932,6.13080907100988e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NBN,Nibrin,28931,0.0426386572754379,0.00374727047422786,0.0352940071459512,0.0499833074049245,6.19041658453864e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,29349,0.0448110389382789,0.00393884745253104,0.037090897931318,0.0525311799452397,6.31315027217283e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,0.0536247213637119,0.00471534085771455,0.0443826532825914,0.0628667894448325,6.80429401299404e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,29227,0.058715746809184,0.00517148893647465,0.0485796284936937,0.0688518651246743,8.20599925810372e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,29566,-0.0325141930646984,0.00286386451177526,-0.0381273675077779,-0.0269010186216189,8.23769491065142e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,24805,0.0548694558817813,0.004837426575258,0.0453880997942756,0.064350811969287,9.54594036766807e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,24195,0.0587752320129372,0.00518318796873515,0.0486161835942163,0.0689342804316581,9.93089103782953e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,28797,0.038118497784588,0.00336383091208127,0.0315253891969087,0.0447116063722673,1.05472639834515e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,24793,0.0292409819003595,0.00258035208470767,0.0241834918143325,0.0342984719863866,1.07601628547689e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,29683,0.0508782082229518,0.0044944905707325,0.0420690067043161,0.0596874097415875,1.20010481843902e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,0.078788720752827,0.00696735118827828,0.0651327124238016,0.0924447290818525,1.4165329481769e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,29434,0.0264943214905718,0.00234385701133943,0.0219003617483465,0.0310882812327971,1.44734026767445e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,24195,0.0649846495630952,0.00574928614131891,0.0537160487261101,0.0762532504000802,1.50287926666326e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,29218,0.0275955781025775,0.00244496381817723,0.0228034490189501,0.0323877071862049,1.75718676758694e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,0.0398188973707232,0.00352961013560885,0.0329008615049298,0.0467369332365165,1.86199166613928e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,29820,0.0179378337694475,0.00159063451713132,0.0148201901158701,0.0210554774230249,1.95218421873645e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,24845,0.030837315053706,0.00273398171965845,0.0254787108831755,0.0361959192242366,1.95911267737783e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,29536,0.0464717027412896,0.00412312682052165,0.0383903741730672,0.0545530313095121,2.09608812525241e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,29820,0.057689998020046,0.00512616644618063,0.0476427117855319,0.06773728425456,2.53567321920949e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,24195,0.039344517061943,0.00349628005619536,0.0324918081518001,0.0461972259720859,2.63996698781016e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,24867,0.0442506182947657,0.00393355213206764,0.0365408561159131,0.0519603804736182,2.74068059570241e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,24229,0.0624332530731392,0.00555399365816541,0.051547425503135,0.0733190806431434,3.02535008894996e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,29760,0.0422175245982501,0.00375736290624056,0.0348530933020186,0.0495819558944816,3.11035697510088e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,0.0258574544019033,0.002302309863979,0.0213449270685045,0.0303699817353022,3.28579495100087e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,29278,0.022059874245242,0.00196602935575834,0.0182064567079556,0.0259132917825283,3.70897574939115e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,29694,0.063070387231905,0.00562207796143219,0.0520511144274979,0.0740896600363121,3.79387696862762e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,24229,0.0363987331260824,0.00324533733146172,0.0300378719564174,0.0427595942957473,4.0288179647144e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,29434,0.0895645980221524,0.00801259266220137,0.0738599164042377,0.105269279640067,5.978479487465e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,29786,0.039582530988531,0.00354226677666636,0.032639688106265,0.0465253738707971,6.2170125467811e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,24240,0.0615883378395724,0.00551086924042644,0.0507870341283366,0.0723896415508083,6.30524337811423e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,24922,0.025052481488459,0.00224184775145928,0.0206584598955988,0.0294465030813192,6.33864171278546e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,24793,0.050275154185032,0.00449952437910274,0.0414560864019906,0.0590942219680733,6.45052268202684e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,0.0155337205194542,0.00139159018393144,0.0128062037589486,0.0182612372799598,7.1081073393125e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,0.0610240291186359,0.00547070482182158,0.0503014476678656,0.0717466105694062,7.95621924160151e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,0.0356061288768153,0.00319585167166969,0.0293422596003427,0.0418699981532879,9.01351707391072e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,29079,-0.0303203021218734,0.00272234142479955,-0.0356560913144805,-0.0249845129292663,9.41376691308576e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,-0.0315194180079841,0.00283177839798834,-0.0370697036680413,-0.025969132347927,1.01594257785006e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,24229,0.0775497291744131,0.00697056181801009,0.0638874280111133,0.0912120303377129,1.10875889546358e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,29581,0.0210261029536321,0.00189044376053065,0.017320833182992,0.0247313727242722,1.11396641999428e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,29169,0.0364284014003984,0.00327588956693534,0.0300076578492051,0.0428491449515916,1.14320105105668e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,0.0353890831089987,0.00318272695383617,0.0291509382794798,0.0416272279385176,1.15863266334728e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,28862,0.0416913556541631,0.00374996604756379,0.0343414222009381,0.0490412891073881,1.17536533444782e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,29725,0.0876113092366241,0.00788316708207183,0.0721603017557633,0.103062316717485,1.22528136971499e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,24922,0.0794402719276782,0.00715335456394487,0.0654196969823463,0.0934608468730102,1.37960768202711e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,28586,0.0304984501758106,0.00274706784393452,0.0251141972016989,0.0358827031499222,1.40067760736747e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,28797,0.0265497986788148,0.00239305560041991,0.0218594097019918,0.0312401876556379,1.52402475005123e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,29542,0.0406668316649167,0.00366708092728008,0.0334793530474477,0.0478543102823857,1.60260989965265e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,28774,0.0535463611688472,0.00482854105992475,0.0440824206913947,0.0630103016462997,1.61081484224816e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,24951,0.0502410275465891,0.00453085876616937,0.0413605443648972,0.0591215107282811,1.66085702523572e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,29536,0.056043033546862,0.00506075440008256,0.0461239549227001,0.0659621121710238,1.9075126628832e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,28797,0.03132804853052,0.00283096496106054,0.0257793572068414,0.0368767398541987,2.08800079977731e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,-0.0247486376497557,0.00223656998809493,-0.0291323148264218,-0.0203649604730897,2.09867740346079e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,29434,0.0268599139311866,0.00242921505302044,0.0220986524272665,0.0316211754351067,2.30534892098616e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,24922,0.0509984032353858,0.00461273358355434,0.0419574454116192,0.0600393610591523,2.38666201761421e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,24845,0.0251788503831085,0.00227768954456936,0.0207145788757526,0.0296431218904644,2.42640415279221e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNC,Tenascin,29594,-0.037702615118241,0.00341196951749771,-0.0443900753725365,-0.0310151548639454,2.48792730749795e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,24867,0.060124875807296,0.00544644404848036,0.0494498454722745,0.0707999061423175,2.87331100728249e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,24922,0.0200022229368559,0.00181226221542921,0.0164501889946146,0.0235542568790971,2.9410010223484e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,29426,0.0768016313902249,0.00696013982393832,0.0631597573353058,0.090443505445144,2.96001961288347e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,24867,0.0523891889635219,0.00474863064986241,0.0430818728897916,0.0616965050372522,3.09819677905875e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,29786,0.036542071299122,0.00331301849784008,0.0300485550433554,0.0430355875548886,3.11178190643344e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,0.0247995428374895,0.00224997448602245,0.0203895928448855,0.0292094928300935,3.47408817163752e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,0.0509817853040204,0.00463038076413756,0.0419062390063108,0.06005733160173,3.96179384257505e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,28868,0.0300427628902052,0.00273313014044947,0.0246858278149242,0.0353996979654861,4.74315006513674e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,24816,0.0665981886063362,0.00605788843194518,0.0547247272797236,0.0784716499329487,4.76067225120749e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,29694,-0.0235962808843819,0.00214691921666813,-0.0278042425490515,-0.0193883192197124,4.79505057337076e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,29349,0.0704707899849419,0.00641588918579228,0.057895647180789,0.0830459327890947,5.1859491017349e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,29478,0.0334001404052671,0.00304329134727687,0.0274352893646044,0.0393649914459298,5.71021904036525e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,24845,0.0843403345459041,0.00769423572947276,0.0692596325161375,0.0994210365756707,6.7810966185976e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,29411,0.047326811700295,0.00432190669139849,0.0388558745851539,0.055797748815436,7.48475592762126e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,0.0342493846299773,0.00312710093748687,0.028120266792503,0.0403785024674515,7.51892077759121e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,0.0389459474896785,0.00355661384703928,0.0319749843494815,0.0459169106298755,7.7235262820797e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,24845,0.052096878522759,0.00475968348184213,0.0427678988983484,0.0614258581471696,8.08884422804658e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,0.0298708453970613,0.00273198849948869,0.0245161479380634,0.0352255428560591,8.99194473997013e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,29566,0.0433411005276462,0.00397043793662023,0.0355590421718705,0.0511231588834219,1.09240064273945e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,-0.0255678944413244,0.00234587695007344,-0.0301658132634683,-0.0209699756191804,1.34405120671588e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,24240,-0.0332581224627494,0.00305512526535253,-0.0392461679828404,-0.0272700769426585,1.55665691994601e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,29434,-0.0206335536930154,0.00189639653636091,-0.0243504909042828,-0.016916616481748,1.61281713676832e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,0.0491441655346901,0.00451997858008125,0.0402850075177309,0.0580033235516494,1.75988672404307e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,29632,0.0460898052479659,0.00424370949135671,0.0377721346449067,0.0544074758510251,1.99745096533578e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,24805,-0.0232997578570731,0.00214643648996902,-0.0275067733774124,-0.0190927423367338,2.17389900674797e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,29218,0.0747403300234633,0.00688966088534484,0.0612365946881874,0.0882440653587391,2.29411005193176e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,28719,0.0356531107523506,0.00328850666060156,0.0292076376975715,0.0420985838071296,2.46630806357001e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,29673,0.0328179270208138,0.00302821266250614,0.0268826302023018,0.0387532238393259,2.5755660773451e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,0.0288840565071156,0.0026697923145807,0.0236512635705374,0.0341168494436938,3.23497452640556e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,0.0322644040839985,0.00298521232175927,0.0264133879333503,0.0381154202346466,3.54861013258456e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,24805,0.0532144567358851,0.00492394511223814,0.0435635243158983,0.0628653891558719,3.65544927382617e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,24381,0.0520523463631159,0.00481884695542239,0.042607406330488,0.0614972863957438,3.88757828830936e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,24867,0.046953598727857,0.00434881014529469,0.0384299308430794,0.0554772666126346,4.09020387692676e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,0.0603379770454265,0.00559266284060586,0.049376357877839,0.071299596213014,4.3750371222355e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,29786,0.0433606524001161,0.00402224014493094,0.0354770617160514,0.0512442430841807,4.78888403989233e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,-0.0202684190386616,0.00188026574121563,-0.0239537398914443,-0.016583098185879,4.93472195457231e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,29409,-0.0135738032058556,0.00126125232839581,-0.0160458577695114,-0.0111017486421998,5.83101998259121e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,24381,0.0533389659415425,0.00496290558889839,0.0436116709873016,0.0630662608957833,6.99356034222335e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,29344,0.0672397977747144,0.00626659393395588,0.0549572736641609,0.079522321885268,8.26433738178471e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,24101,0.030595323019767,0.00285335278527952,0.0250027515606191,0.0361878944789149,9.16452452294612e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,29349,-0.0502740008418612,0.00469930155022595,-0.059484631880304,-0.0410633698034183,1.16239964471481e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,0.0770988759801578,0.00721197473657921,0.0629634054964625,0.091234346463853,1.26344430888834e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,0.0548688772895319,0.00513948258092904,0.044795491430911,0.0649422631481528,1.50988785258717e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,0.0550851005158991,0.00516669133839171,0.0449583854926513,0.0652118155391468,1.72105327220469e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,24845,0.0169317131772255,0.00158785183497431,0.0138195235806758,0.0200439027737751,1.72504637267357e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,24883,-0.0113117946456186,0.00106214990416647,-0.0133936084577849,-0.00922998083345234,1.99013890182566e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,24240,0.0452323000285985,0.0042515462394587,0.0368992693992594,0.0535653306579375,2.24331788406679e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,29434,0.0534118689919572,0.00502410560364807,0.043564622008807,0.0632591159751074,2.38404385784432e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,0.0339763578445619,0.00319904072222386,0.0277062380290032,0.0402464776601207,2.72523282560311e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,29443,0.0574898085315458,0.00541506783237708,0.0468762755800867,0.0681033414830049,2.78257820133068e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,29433,0.0292922982626151,0.0027642344025366,0.0238743988336433,0.0347101976915868,3.43442653006479e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,29820,-0.0229505101925832,0.00217116726431119,-0.0272059980306332,-0.0186950223545333,4.5370056976618e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,29491,0.0798891670451167,0.00757137660047785,0.0650492689081801,0.0947290651820533,5.56405220199603e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,29218,0.0392033369989822,0.00371685819187027,0.0319182949429165,0.046488379055048,5.81286438127907e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,0.0286814579260246,0.00271886003691147,0.0233524922536781,0.0340104235983711,5.82350522622795e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,24867,0.0503946153317514,0.00477801107912041,0.0410297136166754,0.0597595170468274,5.93839370037993e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,29820,0.0319146987467136,0.00302730695298704,0.025981177118859,0.0378482203745682,6.12669385841283e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,28347,0.023765414493602,0.00225452976600017,0.0193465361522416,0.0281842928349623,6.23169458560965e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,29163,-0.0365407561401813,0.00346847809425857,-0.0433389732049281,-0.0297425390754345,6.62615602870216e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,0.0432614800680664,0.00411197555392365,0.0352020079823761,0.0513209521537568,7.6955275163513e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,24867,0.0290348761872532,0.00276141855018357,0.0236224958288934,0.034447256545613,8.39369166739089e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,24822,0.0731205262395001,0.0069637755175982,0.0594715262250076,0.0867695262539926,9.76859018849472e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,0.0633201463001043,0.00603120818041664,0.0514989782664877,0.0751413143337209,9.9092554194465e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,0.0481219986657773,0.00459044948710553,0.0391247176710505,0.0571192796605041,1.17270162293044e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,24381,0.0402216532327909,0.00384324132177739,0.0326889002421072,0.0477544062234746,1.40894474982863e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,29349,0.0705407103958678,0.00674216633290225,0.0573260643833794,0.0837553564083562,1.42280023532376e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,24240,0.0514747239967571,0.00492069150686713,0.0418301686432975,0.0611192793502167,1.4810955466876e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,-0.0215504561835878,0.00206410187973475,-0.025596095867868,-0.0175048164993077,1.79027006746042e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,0.0699169686236801,0.00669678253569734,0.0567912748537133,0.0830426623936469,1.83077496987011e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OPTC,Opticin,29349,-0.0337080815347323,0.00323056240586282,-0.0400399838502234,-0.0273761792192412,1.91924306619252e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,29725,0.0286409827290014,0.00274578213451302,0.0232592497453559,0.034022715712647,1.98260472689964e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,0.044556857283072,0.00427154175544012,0.0361846354424093,0.0529290791237346,1.98503640276051e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,29218,-0.0251085175273379,0.00241379665563527,-0.029839558972383,-0.0203774760822928,2.68566415529657e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,24966,0.0309767314911184,0.00297782771681253,0.0251401891661658,0.036813273816071,2.72186062772083e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,29169,0.0389113034633275,0.00374660009899743,0.0315679672692926,0.0462546396573625,3.18562684254455e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,29443,-0.0234191760879637,0.00226039750292132,-0.0278495551936894,-0.0189887969822379,4.1358377012643e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,0.0423779590133085,0.00409076826011984,0.0343600532234736,0.0503958648031434,4.18924528145794e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPARC,SPARC,29566,0.0519224672567305,0.00502074878190966,0.0420817996441876,0.0617631348692734,5.04161619175596e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,24867,0.0356651381304024,0.00345080778154362,0.0289015548785769,0.0424287213822279,5.48203326926232e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,24381,0.0400090732206811,0.003878956770895,0.0324063179497269,0.0476118284916353,6.82600401626361e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,24195,0.0967043099246449,0.00937828902211061,0.0783228634413081,0.115085756407982,7.03924836710982e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,28797,0.0710308332670634,0.00689124539425661,0.0575239922943204,0.0845376742398063,7.20765039289196e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,29384,0.0835336893319084,0.00812383929455098,0.0676109643145885,0.0994564143492283,9.30511506065552e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,24890,0.0344165718795124,0.00334726399814576,0.0278559344431467,0.0409772093158781,9.52138753584358e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,29349,0.0401148569563337,0.00390637971352477,0.0324583527178251,0.0477713611948422,1.06967759553161e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,24111,0.0289763620115594,0.00282409617812413,0.0234411335024361,0.0345115905206827,1.19431255226798e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,24111,0.0488559239761196,0.0047679061181497,0.0395108279845462,0.058201019967693,1.37358037950169e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,0.0488884545484272,0.00478160488561308,0.0395165089726256,0.0582604001242288,1.7322394866614e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,29694,0.026420820406992,0.00258722990455689,0.0213498497940605,0.0314917910199235,1.9229669123462e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,28916,0.0551747588199126,0.00540893203816547,0.0445732520251083,0.065776265614717,2.1656901005269e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,0.0250823411172115,0.00246001079000723,0.0202607199687973,0.0299039622656256,2.26822935505951e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,0.0318665288697268,0.00312516933421164,0.025741196974672,0.0379918607647816,2.29662053559481e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,29313,0.028179253669069,0.00276496856627232,0.0227599152791753,0.0335985920589627,2.37564394321785e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,0.107099201692605,0.010508794200225,0.0865019650601643,0.127696438325046,2.41976362458136e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,24867,0.0454165999504245,0.00445695037378603,0.0366809772178039,0.0541522226830451,2.45219307682486e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,0.0758729046094967,0.0074524374965543,0.0612661271162503,0.0904796821027431,2.64653964059316e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,24229,0.0307392145771085,0.00302018373232033,0.0248196544617607,0.0366587746924563,2.78453408043032e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,29478,0.0579464357603378,0.00570576360895849,0.0467631390867792,0.0691297324338965,3.42353184798525e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,24867,0.0491444005633524,0.00484051403593904,0.0396569930529119,0.058631808073793,3.59225222345481e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,29375,0.0268759977731755,0.00264773582053383,0.0216864355649292,0.0320655599814218,3.61194145617623e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELL,L-selectin,24966,-0.0168903474392187,0.00166379938655115,-0.020151394236859,-0.0136293006415785,3.62941235485462e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,29443,-0.0330917518742729,0.00326384834766438,-0.0394888946356951,-0.0266946091128507,4.06848090118462e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,0.0568973055386756,0.00561301778951013,0.0458957906712358,0.0678988204061155,4.16969985277713e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,24111,0.048369918383999,0.00477179020775816,0.039017209576793,0.057722627191205,4.24693648040167e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,0.0255608324512802,0.00252412359801414,0.0206135501991725,0.0305081147033879,4.68909006789787e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,24922,0.0344156218029004,0.00340808580089271,0.0277357736331507,0.0410954699726501,6.25478988297068e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,29434,0.0348544840790577,0.00345299304725928,0.0280866177064295,0.0416223504516859,6.42452580178296e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,0.059452009393346,0.00589485340232371,0.0478980967247916,0.0710059220619005,7.12711116102646e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,29079,0.0273721930687659,0.00271620849673427,0.0220484244151667,0.0326959617223651,7.61450269773292e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,0.061966864895384,0.00614979543412805,0.049913265844493,0.074020463946275,7.83681597295525e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,29218,0.0581069778539431,0.00576842197266831,0.0468008707875132,0.069413084920373,7.93145099412627e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,24922,0.0215057201070483,0.00213475838598363,0.0173215936705204,0.0256898465435762,7.99064537327062e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,29400,0.0606723313986014,0.00603066343793934,0.0488522310602403,0.0724924317369625,9.01065078724094e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,29329,0.0562875529206733,0.00559616226141462,0.0453190748883007,0.067256030953046,9.23400279791855e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,24111,0.0344455275923481,0.00342485606430674,0.0277328097063069,0.0411582454783893,9.48259369301572e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,24229,0.0319697875715124,0.00317886755582641,0.0257392071620926,0.0382003679809322,9.52925380075405e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,24805,0.042586751935148,0.00423914039417194,0.034278036762571,0.050895467107725,1.06118487716044e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,0.0469055550834778,0.00467062844302939,0.0377511233351402,0.0560599868318154,1.08271288341764e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,24229,-0.0217904756343531,0.00217043966056637,-0.0260445373690632,-0.017536413899643,1.13509819510077e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,24381,-0.0232694254558585,0.0023203739101919,-0.0278173583198347,-0.0187214925918824,1.27199923941724e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,29443,0.0215277280756439,0.00214863153649889,0.0173164102641061,0.0257390458871818,1.36835905178737e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,29434,0.0598326116493687,0.00597917384195121,0.0481134309191444,0.0715517923795931,1.55111367585598e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,0.0548739726434636,0.00548757865269181,0.0441183184841877,0.0656296268027395,1.66715499438862e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,0.0390492386032131,0.00390717183301364,0.0313911818105064,0.0467072953959198,1.76327912829341e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,24805,0.0717803754688353,0.00718124069252527,0.0577051437114857,0.0858556072261848,1.76605188852421e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,24240,0.0391112470653545,0.0039170238610971,0.0314338802976042,0.0467886138331048,1.96919561132865e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,0.054434552210925,0.00545401748244207,0.0437446779453385,0.0651244264765114,2.01820742716353e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,24761,0.0203121329312321,0.00203633847041964,0.0163209095292096,0.0243033563332546,2.17471805049354e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,24966,-0.0186012196423116,0.00186670764951412,-0.0222599666353593,-0.0149424726492639,2.4047871623742e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,24229,0.0403000483603857,0.00404679215396622,0.0323683357386119,0.0482317609821595,2.56680844816528e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,24951,0.0337671744040738,0.00339137934120789,0.0271200708953063,0.0404142779128412,2.60441272898923e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,29725,0.0382695142092926,0.00384777587703415,0.0307278734903057,0.0458111549282795,2.85820544171558e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,24195,0.0299249856146004,0.00300999604911134,0.0240253933583422,0.0358245778708586,3.03259888079175e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,24951,0.0164876238535817,0.00165852237478187,0.0132369199990092,0.0197383277081541,3.04492281734504e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,24111,0.0480911083578245,0.00484215145148649,0.0386004915129109,0.057581725202738,3.3560460605667e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,29786,0.0332463170567041,0.00335284750015213,0.026674735956406,0.0398178981570023,3.85841648574777e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,0.0240696821657569,0.00242939669401123,0.0193080646454949,0.0288312996860189,4.19009450524076e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,24922,0.0759382583020246,0.00768679809142878,0.0608721340428242,0.091004382561225,5.65614341659476e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,28797,0.031984893487582,0.00323816605286659,0.0256380880239635,0.0383316989512005,5.67097720019297e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,28931,0.0311388316795085,0.00315420855702607,0.0249565829077374,0.0373210804512796,5.97650556259871e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,24793,0.0229513105976137,0.00232653093405819,0.0183913099668597,0.0275113112283678,6.50412388836035e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,29381,0.0289027178308541,0.00293276417207845,0.0231545000535803,0.0346509356081278,7.06949617799888e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,0.0675337361243471,0.00685893892594951,0.0540902158294861,0.0809772564192082,7.72995423170942e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,29732,0.0484943054547227,0.00492813803940494,0.038835154897489,0.0581534560119564,8.18074204144055e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",24966,0.011706984740341,0.00119101092508025,0.00937260332718374,0.0140413661534983,9.24734700421582e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",24852,0.0282213556971908,0.00287503271349055,0.0225862915787494,0.0338564198156323,1.05657232247084e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,0.0327705821928014,0.00333970945599944,0.0262247516590425,0.0393164127265603,1.07808559910658e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,24195,0.0318832861851358,0.00325309412881783,0.0255072216926529,0.0382593506776188,1.22954159421172e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,24805,0.0593818782780761,0.00606382104238118,0.047496789035009,0.0712669675211432,1.32853083231035e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,24170,0.0595849380105904,0.00608470456592952,0.0476589170613685,0.0715109589598122,1.33495220922476e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,0.0396876367678554,0.00405393358900119,0.0317419269334131,0.0476333466022977,1.34700574213669e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,24229,0.0405391657990837,0.00414512278775606,0.0324147251350818,0.0486636064630856,1.51109203370934e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,0.0729897537089593,0.00747216896379375,0.0583443025399235,0.087635204877995,1.69524562164216e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,24240,0.063178589290548,0.00647070991347117,0.0504959978601445,0.0758611807209515,1.77174423465643e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,24951,0.0188321600177432,0.00192990241862887,0.0150495512772306,0.0226147687582558,1.86853651244875e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,0.0668592117547249,0.00685882489363796,0.0534159149631945,0.0803025085462553,2.03761080963911e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,29640,0.0504407017147591,0.00517633903999244,0.0402950771963739,0.0605863262331443,2.10484199757626e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,29443,0.0173933894009348,0.00178682261561349,0.0138912170743324,0.0208955617275373,2.32792553651593e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,28797,0.0637669667151217,0.00655482346193945,0.0509195127297204,0.076614420700523,2.47334211118886e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,28870,0.0347010682711598,0.00357264461549455,0.0276986848247904,0.0417034517175291,2.87124341525488e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,0.0600750312408463,0.00619135662189264,0.0479399722619368,0.0722100902197559,3.20530805405233e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,29408,0.0245414211701909,0.00253182543359749,0.0195790433203398,0.029503799020042,3.47988246191996e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,0.0462415399558493,0.00477371485467289,0.0368850588406904,0.0555980210710081,3.76459883604823e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,24922,0.0628485575174037,0.00648943309811103,0.0501292686451061,0.0755678463897013,3.82999248595424e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,29349,0.0410587021084155,0.00424152145647298,0.0327453200537285,0.0493720841631026,3.95069520531521e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,0.0742036756108227,0.00767602372892339,0.0591586691021329,0.0892486821195126,4.55647659460186e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,0.0451190316463857,0.00466938152108269,0.0359670438650636,0.0542710194277078,4.68193737027772e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,24951,-0.0335287785166981,0.00347115226864362,-0.0403322369632396,-0.0267253200701566,4.90832892190999e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,29694,0.0238625367325228,0.00247109883473758,0.0190191830164372,0.0287058904486085,4.96389918875354e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,29694,0.0437380759890357,0.0045304896651892,0.0348583162452649,0.0526178357328066,5.08554597191939e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,24867,0.0522774164704588,0.00542058856747061,0.0416530628782164,0.0629017700627012,5.68197089466159e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,29379,0.0711621602090287,0.00738063586299203,0.0566961139175644,0.0856282065004931,5.74270565881762e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,24805,0.0331213210330237,0.00343513970881149,0.0263884472037532,0.0398541948622942,5.8126100558797e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,29786,-0.0271468639668003,0.00283057507929696,-0.0326947911222224,-0.0215989368113783,9.4168542833511e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,29291,0.0384662740634371,0.00401203141052103,0.0306026924988158,0.0463298556280583,9.69180928936514e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,24381,0.0384168908534825,0.00400629547644718,0.030564551719646,0.046269229987319,9.70407407719047e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,24801,0.0220645318017771,0.00230544274755059,0.017545864016578,0.0265831995869763,1.15831147928381e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,29566,0.0487753747423938,0.00509821276803165,0.0387828777170518,0.0587678717677359,1.18126832099515e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,0.0350210006720391,0.00366996063302137,0.0278278778313172,0.042214123512761,1.49541971133063e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,24229,0.0239469911999241,0.00250977966761753,0.0190278230513937,0.0288661593484544,1.53653955278262e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,29581,0.0884866575744535,0.0092800328986272,0.0702977930931441,0.106675522055763,1.60701420249605e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,28774,0.0350096580621777,0.00367233056295199,0.0278118901587918,0.0422074259655636,1.63837339101484e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,24726,0.0237002301258409,0.00248679953639961,0.0188261030344976,0.0285743572171841,1.70568597987528e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,29581,0.0628955173202721,0.00660428869905412,0.049951111470126,0.0758399231704181,1.79862831441642e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,28797,0.0297012124685242,0.00312179897364283,0.0235824864801843,0.0358199384568642,1.97027070627865e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,24805,0.0437560104459621,0.00460312417763377,0.0347338870578,0.0527781338341243,2.1606583315755e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,24195,0.0550976255021873,0.00580004976104485,0.0437295279705394,0.0664657230338352,2.2978291691122e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,24966,0.0243539392944135,0.00256404615925688,0.0193284088222701,0.029379469766557,2.319636409069e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,24229,0.0338025960892696,0.00356215661149553,0.0268207691307384,0.0407844230478009,2.53163131917019e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,29368,0.0465088857465341,0.00490260320874236,0.0368997834573991,0.0561179880356692,2.56167131926928e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,29498,0.0629490683528927,0.00664900927678875,0.0499170101703868,0.0759811265353987,3.07436831535166e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,0.0331550786526278,0.0035049323045635,0.0262854113356834,0.0400247459695723,3.36476621623502e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,28774,0.020678975049475,0.00218641671048561,0.0163935982969232,0.0249643518020268,3.37198458435373e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,24845,0.0201887166574542,0.00213444881076573,0.0160051969883533,0.024372236326555,3.39098753436558e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,28774,0.0418096965656764,0.00442818309504081,0.0331304576993964,0.0504889354319564,3.934601253279e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,24326,0.0367179000364832,0.00389764426211656,0.0290785172827347,0.0443572827902316,4.8743495906074e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,24867,0.0769912622565573,0.00817642617955681,0.0609654669446259,0.0930170575684886,5.06765109115732e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,29478,0.0242502539479823,0.00257903534867586,0.0191953446645776,0.0293051632313869,5.6829523897152e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,0.0299013480661532,0.00317996627265589,0.0236686141717477,0.0361340819605588,5.75162358027108e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWC2,Brorin,29114,0.0267608410987419,0.00284861913683811,0.0211775475905392,0.0323441346069446,6.16580622685744e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,29581,-0.0137535308172651,0.00146410844585228,-0.0166231833711356,-0.0108838782633946,6.19005048159908e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,29443,0.0179443542997813,0.00191273694141226,0.0141953898946132,0.0216933187049493,6.95544409704933e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,0.0597620970154508,0.00637770281667353,0.0472617994947706,0.0722623945361309,7.81687700175217e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,0.0204043615376414,0.00217754398695598,0.0161363753232076,0.0246723477520751,7.8282114652358e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,24867,0.0795401834995084,0.00848900743396275,0.0629017289289414,0.0961786380700754,7.86624323989412e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,24788,0.0289683116064113,0.00309334384699594,0.0229053576662993,0.0350312655465234,8.25326246351535e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,28591,0.0564596885896562,0.00603223641345735,0.0446365052192798,0.0682828719600326,8.56663417953666e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,24845,0.0357045122045213,0.0038163063923581,0.0282245516754994,0.0431844727335432,8.97829436053869e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,-0.076716252137172,0.00820155180909717,-0.0927912936830025,-0.0606412105913416,9.03432638712155e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,29383,0.0192976347497851,0.00206446872298719,0.0152512760527302,0.0233439934468399,9.58931966418227e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,24381,0.0495705721848638,0.00530377278382274,0.0391751775285713,0.0599659668411564,9.83294457303586e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,0.0589766731905097,0.00631226674521952,0.0466046303698794,0.07134871601114,9.9886317202075e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,29386,0.0452140157438045,0.00485591801968457,0.0356964164252228,0.0547316150623863,1.3503418546533e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,29694,0.0817416288120532,0.00878162091045192,0.0645296518275675,0.098953605796539,1.3860690051457e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,24845,0.0472136120505816,0.00508315249876435,0.0372506331530035,0.0571765909481597,1.69306585776766e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,0.0234055272647105,0.00252160732961093,0.0184631768986731,0.0283478776307479,1.79880262520602e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,29786,0.023063279647252,0.00248745142247085,0.0181878748592092,0.0279386844352949,1.94911452754339e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",24922,0.0336488599444658,0.00363321449512957,0.0265277595340119,0.0407699603549198,2.17451212433329e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,29566,0.0167619759466858,0.00181228035795336,0.0132099064450973,0.0203140454482744,2.41150037478486e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,28931,0.0525463911298786,0.00568290733263844,0.0414078927579073,0.06368488950185,2.47677212876997e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,29443,0.0344507275447461,0.00372750937409405,0.0271448091715217,0.0417566459179704,2.57042160376632e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,24845,0.0305906537717793,0.00331227447074149,0.024098595809126,0.0370827117344327,2.76934222108031e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAYN,Layilin,29163,0.0230650088131768,0.00249817774606423,0.0181685804308909,0.0279614371954627,2.81150642784542e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,29218,0.0522127483509544,0.0056639566623661,0.0411113932927168,0.063314103409192,3.21153798765184e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,29331,0.0188759753187752,0.00204873295820358,0.0148604587206962,0.0228914919168542,3.36148838042455e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,0.0199343881589903,0.00216577377644589,0.0156894715571564,0.0241793047608243,3.7035537628408e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OGN,Mimecan,29443,0.0276863084330356,0.00301007687423478,0.0217865577595354,0.0335860591065358,3.88497380076359e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,28753,-0.0304224424360484,0.00330818978074678,-0.036906494406312,-0.0239383904657847,3.95534012857167e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,29545,0.016986402713573,0.00184854892002554,0.0133632468303229,0.020609558596823,4.21546528345849e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,0.0227328307655526,0.00247400825731434,0.0178837745812165,0.0275818869498887,4.23218960194141e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,29466,0.0348539828456208,0.00379586958858879,0.0274140784519867,0.0422938872392548,4.49724573090372e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,24381,-0.0141021377597421,0.00153612157067353,-0.0171129360382623,-0.011091339481222,4.62880524084382e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,28534,0.0501680251297571,0.00547026352089141,0.0394463086288099,0.0608897416307043,4.99100519935018e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,29163,0.0154587751207881,0.00168566305811822,0.0121548755268764,0.0187626747146999,4.99828559408319e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,24793,0.031606879530842,0.00345105023041639,0.0248428210792259,0.0383709379824582,5.65148260995965e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,24381,0.0265554469939229,0.00290145189513452,0.0208686012794592,0.0322422927083865,5.98934195852351e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,29089,0.0762541306879861,0.00833400485342251,0.059919481175278,0.0925887802006942,6.06852028972712e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C3,Complement C3,23779,0.0306143704758117,0.00334642683080168,0.0240553738874404,0.037173367064183,6.23135053809392e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,28774,0.0439696418602654,0.0048117182400335,0.0345386741097997,0.053400609610731,6.7661952265455e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,24951,-0.0393197859040695,0.00430290492487313,-0.0477534795568208,-0.0308860922513182,6.835036978014e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,29353,0.0321615351345526,0.00352286397477765,0.0252567217439884,0.0390663485251168,7.31941703018651e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],28826,0.0315154373208423,0.00345243615659417,0.0247486624539177,0.0382822121877669,7.38905928630263e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,29478,0.0158829042629236,0.00174107867354189,0.0124703900627815,0.0192954184630657,7.79901722992181e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,24209,0.0371847193356564,0.00408064832667638,0.0291866486153707,0.0451827900559421,8.66201612450867e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,29453,0.0501331592553687,0.00550574072178159,0.0393419074406768,0.0609244110700606,9.10524763071169e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,24025,-0.0408873252976008,0.00450268949714021,-0.0497125967119956,-0.032062053883206,1.16030111871595e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,0.0550840559736246,0.00606833364066022,0.0431901220379306,0.0669779899093186,1.18222156475927e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,24805,0.0504611652592217,0.00556024312013254,0.039563088743762,0.0613592417746815,1.21514698356437e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,24966,-0.0197662939022671,0.0021807940346571,-0.024040650210195,-0.0154919375943392,1.34990119792591e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,0.0233371172022493,0.00257471705920127,0.0182906717662148,0.0283835626382838,1.35090639427727e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,0.0498320263347798,0.00550731665325912,0.039037685694392,0.0606263669751677,1.53872029955173e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,29531,-0.0181699000014766,0.00200902206069549,-0.0221075832404398,-0.0142322167625134,1.59829189602755e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,24938,0.0542908896729171,0.00600290457130384,0.0425251967131616,0.0660565826326727,1.61612083089292e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,24845,0.0883632475636254,0.00978690888941727,0.0691809061403676,0.107545588986883,1.85987496392493e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,29390,0.0182232405156607,0.0020194938551116,0.0142650325596419,0.0221814484716794,1.92699687151456e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,24922,0.0221203222165722,0.00245265545605943,0.0173131175226958,0.0269275269104487,2.03281044727981e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,0.0380345900501374,0.00421757131350559,0.0297681502756665,0.0463010298246084,2.04799467932136e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,0.0352624637885381,0.00391781397631756,0.0275835483949556,0.0429413791821205,2.37819169821228e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,29218,-0.0271542311041651,0.00301729395280408,-0.0330681272516611,-0.0212403349566691,2.4008229624621e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,24229,0.056920436068843,0.00632719750582655,0.0445191289574229,0.069321743180263,2.50497537886821e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,0.0411855787454687,0.00458689417917847,0.0321952661542789,0.0501758913366585,2.89576358656345e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,29434,0.0237348181478849,0.00264789588484949,0.0185449422135799,0.0289246940821899,3.32227336462074e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,24297,0.0421146926776182,0.0047124807627689,0.0328782303825912,0.0513511549726452,4.28270906526374e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,0.0580769302938694,0.00649928951494746,0.0453383228445724,0.0708155377431664,4.3137089866552e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,0.0172111731797716,0.00192647476762025,0.0134352826352359,0.0209870637243073,4.34059490561713e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,29566,0.0437623542062834,0.00490533248967103,0.0341479025265281,0.0533768058860386,4.86451973028825e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,24845,0.0592623319029535,0.00664922314802386,0.0462298545328267,0.0722948092730803,5.31628720723151e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,24845,0.0178859289970685,0.00200732875973054,0.0139515646279967,0.0218202933661404,5.4301337016145e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,24681,0.0386018935096494,0.00433772207267009,0.030099958247216,0.0471038287720828,6.00749420955668e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,29478,0.0810498677576118,0.00913861834534231,0.0631381758007408,0.0989615597144827,7.79208687641202e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,29383,0.0299993660210537,0.00338471696682714,0.0233653207660726,0.0366334112760349,8.20570224002385e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,0.0595151590107023,0.0067257785263562,0.0463326330990441,0.0726976849223604,9.33367362467861e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,28916,0.0219162514526744,0.00248139917252385,0.0170527090745277,0.0267797938308212,1.08304011129799e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,28797,0.0387043021389242,0.00438216548079413,0.0301152577965677,0.0472933464812807,1.08311864654573e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,28797,0.0241549285363606,0.00273624369918307,0.0187918908859618,0.0295179661867594,1.12708437167586e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,29786,0.0553391139592359,0.00627247225400088,0.0430450683413941,0.0676331595770776,1.17878433863552e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,29478,0.0426024682536099,0.00483168321372028,0.0331323691547182,0.0520725673525017,1.23558156373376e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,28797,0.0325522650868403,0.00369447138131247,0.0253111011794679,0.0397934289942127,1.30775654825283e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,29218,0.0427048813911752,0.004848541698797,0.033201739661533,0.0522080231208173,1.34564139340282e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPART,Spartin,24381,0.0488343811096514,0.00555479330548506,0.0379469862309007,0.0597217759884022,1.57277709213972e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,29642,0.0255933784318675,0.00291253409777157,0.0198848116002352,0.0313019452634998,1.6126319475005e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,29536,0.0360151095357754,0.00409882827078071,0.0279814061250452,0.0440488129465055,1.62210284457784e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",29566,0.0383883253054627,0.00437022082909056,0.0298226924804452,0.0469539581304802,1.66008370327699e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,0.038350049206119,0.00436767498278278,0.0297894062398648,0.0469106921723733,1.71500552105675e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,29349,0.0562496225163066,0.00641714915219392,0.0436720101780065,0.0688272348546067,1.9575391299954e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,29694,0.0178836405854645,0.00204174668415453,0.0138818170845216,0.0218854640864074,2.0726760715636e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,24732,0.0292410598960875,0.00333953415461711,0.022695572953038,0.0357865468391371,2.14941296107113e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,29820,-0.0183887112371848,0.00210567450928611,-0.0225158332753856,-0.014261589198984,2.60871032327066e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,29478,-0.0232999287690322,0.00266833298566635,-0.0285298614209383,-0.0180699961171262,2.63136519151977e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,29478,-0.043766303601483,0.00501294305144696,-0.053591671982319,-0.033940935220647,2.66303695273215e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,0.0180950208005001,0.00207355187340813,0.0140308591286201,0.02215918247238,2.75978406219634e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,0.0350574043958133,0.00401726085544662,0.0271835731191379,0.0429312356724887,2.78807019096942e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,0.025055391121391,0.00287225949487113,0.0194257625114436,0.0306850197313384,2.86946898285272e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,24793,0.0181369846433874,0.00208010986712138,0.0140599693038295,0.0222139999829453,2.97300750899303e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,24195,0.0270886831626856,0.00310860013321728,0.0209958269015797,0.0331815394237915,3.11499976901085e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,29517,0.0167667286175507,0.00192446229833812,0.012994782512808,0.0205386747222934,3.12704542402872e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,28916,0.0304663711970859,0.00350052161905448,0.0236053488237391,0.0373273935704326,3.38945302606173e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,29757,-0.0286880396806538,0.00329806219250589,-0.0351522415779653,-0.0222238377833422,3.53440902324897e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,28931,0.0573790436848679,0.00660023650607707,0.0444425801329568,0.0703155072367789,3.69734917525329e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,28797,0.0372513156289813,0.00428661389697273,0.0288495523909147,0.0456530788670478,3.80806916952382e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,0.0417663116852237,0.00481295349362117,0.0323329228377262,0.0511997005327212,4.27415964229271e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,23498,0.0768416642919332,0.00885742921006107,0.0594811030402135,0.0942022255436529,4.38387704653027e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,24381,0.0428690156408532,0.00495104487478438,0.0331649676862759,0.0525730635954306,5.06748717361245e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,0.0262266644941748,0.00303335587695581,0.0202812869753414,0.0321720420130082,5.64541498826038e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,24240,0.0570326304723079,0.00660522509854784,0.0440863892791541,0.0699788716654616,6.25701613307336e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,0.0171800776199686,0.00199046646613069,0.0132787633463524,0.0210813918935847,6.4400809567786e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,0.0296655928800216,0.00344552253307324,0.022912368715198,0.0364188170448452,7.75018793593253e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,24755,0.0543920630323582,0.00631937833854556,0.0420060814888089,0.0667780445759075,7.92548225749163e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,28916,0.0328162418023446,0.00381732244135602,0.0253342898172868,0.0402981937874024,8.61385541024145e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,29544,0.0183016059629672,0.00212928661208664,0.0141282042032774,0.022475007722657,8.71657531756607e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,0.0511418416011694,0.00595445721061162,0.0394711054683706,0.0628125777339681,9.29422583143883e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,29414,0.0557696371969923,0.00649756349985706,0.0430344127372725,0.0685048616567122,9.67730275439507e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,0.0206107906125149,0.00240446320142048,0.0158980427377307,0.025323538487299,1.06655796905942e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,24922,0.0338618810091496,0.00395265547123991,0.0261146762855194,0.0416090857327798,1.12396187952678e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,24229,0.0555337782654282,0.00649076229741649,0.0428118841624919,0.0682556723683645,1.23865308254933e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,0.0523259168710453,0.00612413832031492,0.040322605763228,0.0643292279788625,1.36881903049358e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,0.0599509307245824,0.00702357013194526,0.0461847332659697,0.0737171281831951,1.46082997001908e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,24445,0.0332073060457904,0.00389639331127261,0.0255703751556961,0.0408442369358847,1.64925177211283e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,28538,0.0743643226678249,0.00872816354919363,0.0572571221114054,0.0914715232242444,1.67232019441183e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,29354,0.0541949963366783,0.00636892169766016,0.0417119098092644,0.0666780828640922,1.83209043092162e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,29218,0.0610758625516717,0.00717915570380338,0.0470047173722171,0.0751470077311264,1.86269452341737e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,29694,0.0162423933522708,0.00190953166260369,0.0124997112935676,0.0199850754109741,1.88437787777253e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,24329,0.0628568267232097,0.00738993367736611,0.0483725567155722,0.0773410967308473,1.90684805806618e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,0.0706152311823159,0.00831524501545675,0.0543173509520206,0.0869131114126111,2.12083157368456e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,29786,0.0383992590783061,0.00452488784030992,0.0295304789112987,0.0472680392453136,2.23193555907604e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,24111,0.0483208518739659,0.00569344306019893,0.037161703475976,0.0594800002719558,2.23871293665909e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,24951,0.043363588791175,0.00510981261157187,0.0333483560724941,0.0533788215098559,2.24935012116574e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,29443,0.044417652693709,0.00523746447155419,0.0341522223294627,0.0546830830579552,2.34055621132036e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,-0.0274283014981758,0.00323660124954744,-0.0337720399472888,-0.0210845630490628,2.47081134573843e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,24195,0.02985589571312,0.00352448432338029,0.0229479064392946,0.0367638849869454,2.56956148605821e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,24240,0.0310848761091664,0.00367768111246189,0.0238766211287411,0.0382931310895917,3.01467367576748e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,0.0300167160663615,0.00355395140686174,0.0230509713089125,0.0369824608238106,3.17962575293361e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,29443,0.0542668872465242,0.00642705538753303,0.0416698586869594,0.0668639158060889,3.21908206657964e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,0.0373396449701319,0.00442237863722894,0.0286717828411632,0.0460075070991006,3.2496647385982e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,29536,0.0523081310885109,0.00619954472988419,0.0401570234179379,0.0644592387590839,3.39042201914999e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,24951,0.0416973286042284,0.00494589306132407,0.0320033782040332,0.0513912790044236,3.61938398707255e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,24805,0.0621627938546071,0.0073747197516012,0.0477083431414687,0.0766172445677454,3.66780754265379e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,24845,0.0428342375495211,0.00508186865883166,0.032873774978211,0.0527947001208311,3.67806705027529e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,24845,0.0224019658248293,0.00266113195880121,0.0171861471855789,0.0276177844640797,4.02639419560562e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,0.0169156265547989,0.00201088582120697,0.0129742903452332,0.0208569627643645,4.25047571656954e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,29443,0.0275720815801643,0.00328116004469685,0.0211410078925584,0.0340031552677701,4.53973291627738e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,29639,-0.0152958822597151,0.00182038184188118,-0.0188638306698022,-0.011727933849628,4.56094964274995e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,29478,-0.0154700546740533,0.00184203537497308,-0.0190804440090005,-0.0118596653391061,4.72854295685088e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,24016,0.0307038651224875,0.00365801183067498,0.0235341619343646,0.0378735683106105,4.9719432942223e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,24867,-0.0279804734872523,0.00333591875668255,-0.0345188742503501,-0.0214420727241545,5.22017678297771e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,29820,0.0149647860016692,0.00178497387576022,0.0114662372051791,0.0184633347981592,5.3492855028999e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,24037,0.0331007470347546,0.00395188035414841,0.0253550615406238,0.0408464325288855,5.77376653272537e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,24381,0.0650965014014674,0.00777433298924414,0.0498588087425489,0.0803341940603859,5.90239623084576e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,24229,0.0344765592904165,0.00412119530833062,0.0263990164860884,0.0425541020947445,6.29587205907989e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAX,Protein max,28774,0.0629307367479316,0.00752721680131292,0.0481773918173583,0.0776840816785049,6.52776447907203e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PI3,Elafin,29014,0.0329466707674962,0.00394118573267634,0.0252219467314505,0.0406713948035418,6.57205673355743e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,29349,0.0357482778629147,0.00427797516573023,0.0273634465380834,0.044133109187746,6.75059179542914e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,0.0656529754975677,0.00785794472780509,0.0502514038310698,0.0810545471640657,6.82717011537716e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,28774,0.0229092645917606,0.00274243277814605,0.0175340963465943,0.0282844328369268,6.91381051701951e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,0.0303997964994314,0.00364907381945875,0.0232476118132923,0.0375519811855706,8.37152774145071e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,28353,-0.0187373010630837,0.00225537204598371,-0.0231578302732117,-0.0143167718529556,1.0174707276306e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",29478,-0.0466342294929865,0.00561498508560633,-0.0576396002607749,-0.0356288587251981,1.03768822651012e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,0.016339365407418,0.00196889667748315,0.0124803279195511,0.020198402895285,1.09613865190839e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,24229,0.0539851216707252,0.00650452727689856,0.041236248208004,0.0667339951334464,1.09831150043516e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,24793,0.0304935800042141,0.00367895679277748,0.0232828246903702,0.037704335318058,1.2028366996581e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,24240,0.0537195723686207,0.00649320016118862,0.040992900052691,0.0664462446845504,1.37044680032485e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,24623,-0.0248253209093495,0.00300115569224259,-0.030707586066145,-0.018943055752554,1.38418152828429e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,29604,0.0193655598879785,0.00234268667098159,0.0147738940128545,0.0239572257631024,1.43789340415786e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,29725,-0.0340105764381859,0.00411922042947156,-0.0420842484799502,-0.0259369043964217,1.56082646129736e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,0.0255635817535755,0.0031003616477916,0.019486872923904,0.0316402905832471,1.71453428005593e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),24484,-0.105504306062046,0.012819494171598,-0.130630514638378,-0.0803780974857136,1.96466550414253e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,28654,0.0414631990886598,0.00504725716643867,0.03157057504244,0.0513558231348796,2.21020059057163e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",29478,0.0429839033193973,0.00523725849363212,0.0327188766718783,0.0532489299669162,2.35293218390415e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,24381,0.0337951524744263,0.00412811488447854,0.0257040473008484,0.0418862576480043,2.81783971694989e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,24922,0.0167203429036877,0.0020434203306986,0.0127152390555185,0.020725446751857,2.91107578283387e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,24111,0.0346377503857031,0.00423720095388791,0.0263328365160828,0.0429426642553234,3.11127372619701e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,24445,0.0329390962800245,0.00403329784809111,0.0250338324977659,0.040844360062283,3.31874888241043e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,0.0197689836774125,0.00242105492568153,0.0150237160230768,0.0245142513317483,3.35731424416449e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,29566,0.0365296792665621,0.00447625336322643,0.0277562226746383,0.0453031358584859,3.45987374081481e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,24867,0.033885730395297,0.00415489210995851,0.0257421418597783,0.0420293189308157,3.63649268352043e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,28797,0.0331754897123671,0.00407131158918864,0.0251957189975574,0.0411552604271769,3.8294893153212e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,24571,0.0327539774174697,0.00402023241417963,0.0248743218856777,0.0406336329492618,3.89752706359169e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,0.014391220296349,0.0017715340984498,0.0109190134633874,0.0178634271293106,4.70065175251587e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,0.0172599350652763,0.00212781808717291,0.0130894116144174,0.0214304585161352,5.19137058110515e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,29478,-0.0206723200623008,0.00255033231212735,-0.0256709713940704,-0.0156736687305312,5.44403944478605e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,29478,0.0309478659188144,0.00382212387885137,0.0234565031162657,0.0384392287213631,5.8468630165193e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,29218,-0.020964100559177,0.00258996358593059,-0.0260404291876009,-0.015887771930753,5.97836372619328e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,0.0481389889249619,0.00595252292218343,0.0364720439974824,0.0598059338524414,6.33970625524745e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,24101,0.0317390665362475,0.00392515149234624,0.0240457696112489,0.0394323634612462,6.44959192743514e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,0.0364962754383582,0.00451521576079426,0.0276464525472015,0.045346098329515,6.60743884560506e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,24845,0.0485953966752466,0.00602170474857342,0.0367928553680427,0.0603979379824505,7.34311616124684e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,29443,0.037521612858454,0.00465348262373518,0.0284007869159331,0.046642438800975,7.7167611039305e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BSG,Basigin,29760,0.0118405686033712,0.00146868678109487,0.00896194251242525,0.0147191946943172,7.78423892916025e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,29478,0.0197411110909126,0.00245061061473969,0.0149379142860229,0.0245443078958024,8.20597811116193e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,28797,0.0302326425202674,0.00375359131388252,0.0228756035450576,0.0375896814954771,8.29824055520708e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,29443,-0.0461640762392022,0.00573374750741749,-0.0574022213537405,-0.0349259311246639,8.4990069998574e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,24805,0.0337002629965803,0.00418884900062579,0.0254901189553538,0.0419104070378069,8.99064254903466e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,23862,0.0465405596850649,0.0057949095274341,0.035182537011294,0.0578985823588357,1.00885739383531e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,29446,0.0249018029740993,0.00310154665280251,0.0188227715346064,0.0309808344135922,1.02044320549398e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,24381,0.0172806085223072,0.00215403971968108,0.0130586906717323,0.0215025263728821,1.08317916336368e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,0.0291726552408359,0.00363674040478433,0.0220446440474586,0.0363006664342132,1.08915779188219e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",24240,0.0501019668923446,0.00624910081201863,0.0378537293007881,0.0623502044839011,1.1278915759942e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,29678,0.0155606332375876,0.00194331755353652,0.011751730832656,0.0193695356425191,1.21559343318491e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,29434,0.038617017511449,0.00482331983882636,0.0291633106273494,0.0480707243955487,1.22522858688426e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,29434,0.0386855332665909,0.00485101029505509,0.0291775530882829,0.0481935134448988,1.58206359109828e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,29725,0.0245676534163613,0.0030810405002469,0.0185288140358774,0.0306064927968452,1.59331835088855e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,29725,-0.0334015395749546,0.00419363557318694,-0.041621065298401,-0.0251820138515082,1.71340909759262e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,0.0390241229023914,0.00490539702368954,0.0294095447359598,0.0486387010688229,1.86223257970614e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,24381,0.0488737021055228,0.00615235454002581,0.0368150872070722,0.0609323170039734,2.04336650778242e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,24240,0.0173473903514741,0.00218397502017378,0.0130667993119335,0.0216279813910147,2.05817038491122e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,0.0379235794451075,0.00477816123339246,0.0285583834276583,0.0472887754625567,2.14716822687295e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,24177,0.0248685178859492,0.00313354925815691,0.0187267613399616,0.0310102744319368,2.17444733303255e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",29349,0.0587522171985143,0.00740966491376246,0.0442292739675399,0.0732751604294887,2.28473816384895e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,24922,0.0304131300838984,0.00383843442400871,0.0228897986128413,0.0379364615549554,2.40874523666761e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,29581,-0.0365509562570662,0.00461489871111734,-0.0455961577308562,-0.0275057547832762,2.45382695677828e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,24904,0.0272095466103985,0.00343763468925931,0.0204717826194503,0.0339473106013468,2.57097807934613e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,0.0556363379531232,0.007030611064387,0.0418563402669247,0.0694163356393217,2.60725866840827e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",28916,0.0524601595139509,0.00664367114028073,0.0394385640790006,0.0654817549489011,2.97527755363443e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,24845,0.0375471245415433,0.00475493101795806,0.0282274597463455,0.0468667893367411,2.98742351020182e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,24805,0.0432092992102642,0.005473010778469,0.032482198084465,0.0539364003360635,3.02325480368323e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,29795,0.0191010617983686,0.00242175410059545,0.0143544237612015,0.0238476998355357,3.19348756366993e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,-0.027634221907017,0.00350534391447255,-0.0345046959793832,-0.0207637478346508,3.31752968704572e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,0.019120963951797,0.00243171527713007,0.0143548020086221,0.0238871258949719,3.87290773005915e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,29135,0.0192493930424869,0.00245724346866179,0.0144331958439098,0.024065590241064,4.8963876342176e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F3,Tissue factor,29541,-0.015315918104146,0.00195552295359177,-0.0191487430931858,-0.0114830931151061,4.95673651809896e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,0.059452590834158,0.00759343436449786,0.0445694594797422,0.0743357221885738,5.09725075602516e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,0.038839207033149,0.00496218651507957,0.0291133214635931,0.048565092602705,5.16256844169974e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,28774,0.0291668135525471,0.00372807423746684,0.0218597880471121,0.0364738390579821,5.31033181431225e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,24816,0.0362265997463305,0.00463096897812783,0.0271499005491999,0.045303298943461,5.37609766954296e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,0.0236318899983818,0.00302615045549284,0.0177006351056159,0.0295631448911478,5.98490619271738e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,29349,0.0181942686688205,0.00233078705091484,0.0136259260490274,0.0227626112886136,6.09594530513191e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,24805,0.0490789441980761,0.00628733831049546,0.036755761109505,0.0614021272866472,6.13561502654403e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,29169,-0.0179133404250103,0.00229933298685729,-0.0224200330792505,-0.01340664777077,6.88629142008151e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,29443,0.0188790563135318,0.00242440658023507,0.0141272194162711,0.0236308932107926,7.08187747208956e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,24381,0.0460889334760951,0.0059300835000152,0.0344659698160654,0.0577118971361249,8.02623547977309e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,0.0446344559083232,0.0057440280226461,0.0333761609839369,0.0558927508327096,8.12167576177923e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,29628,-0.01125541721875,0.00144936907333512,-0.0140961806024869,-0.0084146538350132,8.37845604271882e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,24445,0.0188973722066533,0.00243665999114543,0.0141215186240083,0.0236732257892983,9.14633069750348e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,0.054192443833612,0.00699688927455333,0.0404785408554875,0.0679063468117366,9.90500344432136e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,24195,0.0380179365320681,0.00490901946018408,0.0283962583901073,0.0476396146740289,9.97054786796296e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,29349,-0.0162432183777891,0.00209801585321408,-0.0203553294500887,-0.0121311073054895,1.00862365837467e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,29623,0.032708562428845,0.00422737554796034,0.0244229063548427,0.0409942185028473,1.04753452083636e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,0.036982818563562,0.00478162651658331,0.0276108305910587,0.0463548065360653,1.07981946915421e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,0.043915725996362,0.00568104700379317,0.0327808738689274,0.0550505781237966,1.11416268115459e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,24867,0.0490742031710669,0.00634868566532236,0.0366307792670351,0.0615176270750988,1.11762623050474e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,24421,0.0122926857273503,0.00159049597001137,0.00917531362612801,0.0154100578285726,1.12702819248437e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,0.0472833237199585,0.00611928406851353,0.035289526945672,0.0592771204942451,1.14316483653926e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,24867,0.0423681134408855,0.00548790916961614,0.0316118114684378,0.0531244154133331,1.20447660632354e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,29174,0.0321927466620621,0.00417522947274029,0.0240092968954912,0.0403761964286331,1.2939419146866e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,28916,0.0312754087462687,0.00406386062046287,0.0233102419301615,0.039240575562376,1.44875670268056e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,29581,0.0141701238120494,0.00184631987328362,0.0105513368604135,0.0177889107636853,1.70779784520344e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,28931,0.0362429157124039,0.00472264016066219,0.026986540997506,0.0454992904273018,1.71565563767529e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,0.0143615321466096,0.00187175823454187,0.0106928860069075,0.0180301782863117,1.73573863996136e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,29349,-0.0154604116696613,0.0020156191178101,-0.0194110251405691,-0.0115097981987535,1.7689489140432e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,0.0291406343440883,0.00380003446561481,0.0216925667914832,0.0365887018966933,1.80371173702305e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,28722,0.0496117993459518,0.00647078687895185,0.0369290570632062,0.0622945416286975,1.81560833042933e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,24867,0.0267928186121581,0.00349804550205396,0.0199366494281324,0.0336489877961839,1.93647971466337e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,0.019710286885493,0.00257490486743806,0.0146634733453144,0.0247571004256716,2.00922283543834e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,24951,0.0500846405796791,0.0065568599593763,0.0372331950593015,0.0629360861000566,2.2763099816982e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,24793,0.0385790996575363,0.00507194120249739,0.0286380949006414,0.0485201044144311,2.91890001372244e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,24326,0.0620562507593289,0.00816047483158005,0.046061720089432,0.0780507814292258,2.96369110996673e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,24240,-0.0353129031180247,0.00464677825517583,-0.0444205884981693,-0.0262052177378801,3.08181429252472e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,24240,0.0400441652746299,0.00527071711167546,0.029713559735746,0.0503747708135138,3.12868646509533e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,0.0392398055493212,0.00516902785269439,0.0291085109580402,0.0493711001406022,3.25958931545573e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,0.0198966946593304,0.00262267587724138,0.0147562499399373,0.0250371393787236,3.4077391881224e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,0.0280762397415593,0.00370194773219605,0.0208204221864551,0.0353320572966636,3.44677914987671e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,29443,0.0210834614932194,0.00278157219391149,0.0156315799931529,0.0265353429932859,3.5655684855609e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,29566,-0.0148966890084293,0.00196693058819292,-0.0187518729612874,-0.0110415050555712,3.73695335516202e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,0.0194221523891392,0.00257483679395492,0.0143754722729876,0.0244688325052908,4.75221644238102e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,24845,0.0367510252890998,0.00487291311073365,0.0272001155920618,0.0463019349861377,4.79026911441045e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,29443,0.0148504799392733,0.00196987994136696,0.0109895152541941,0.0187114446243525,4.8805714277158e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,0.0582704862829476,0.00773116766856374,0.0431173976525626,0.0734235749133325,4.97028864652378e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,28931,0.0613189242937314,0.00813838131802366,0.0453676969104051,0.0772701516770578,5.04394268409134e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,24938,0.044861581145502,0.00595564408222127,0.0331885187443483,0.0565346435466557,5.14213476976681e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,24381,-0.0152386730566057,0.00202496580390618,-0.0192076060322618,-0.0112697400809496,5.43781436665602e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,23405,-0.0598236604251651,0.00795120999965732,-0.0754080320244934,-0.0442392888258367,5.51052093623034e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,28931,0.0379128134681466,0.00503987371947665,0.0280346609779724,0.0477909659583208,5.52683018996048e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,24793,0.0219736436533875,0.00292345155805531,0.0162436785995991,0.0277036087071759,5.8239210325635e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,29478,0.0354447186848462,0.00471722321321474,0.0261989611869453,0.0446904761827471,5.90212058438318e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,29725,0.0209948627590467,0.00279849213339019,0.0155098181776019,0.0264799073404915,6.45064841094095e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,29478,0.0358770227557966,0.00478663265472752,0.0264952227525307,0.0452588227590626,6.8028468835122e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,0.0598422841783654,0.00798862937276386,0.0441845706077483,0.0754999977489826,7.02953574514716e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,24240,0.0277870586269344,0.00371055338578665,0.0205143739907925,0.0350597432630762,7.19565390349411e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,-0.0378850248323177,0.00505935323950978,-0.0478013571817569,-0.0279686924828785,7.21973384834672e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,24381,0.0638444370653825,0.00853877085455174,0.0471084461904611,0.0805804279403039,7.85983466012411e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,29349,0.039467729081055,0.00527981130865112,0.0291192989160988,0.0498161592460112,7.92279122862206e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,0.0334427474647497,0.00447731080617695,0.0246672182846429,0.0422182766448565,8.27844375303455e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,29434,0.0362940750028619,0.00486047156911555,0.0267675507273954,0.0458205992783284,8.41936081047008e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,0.047949836866297,0.00642609293841267,0.0353546947070081,0.0605449790255858,8.81791101400696e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,24111,0.037067532842932,0.00497120264036162,0.0273239756678233,0.0468110900180408,9.18808021925244e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,29694,0.0279694418396743,0.00375250841551722,0.0206145253452606,0.0353243583340881,9.33508611304002e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,29640,0.037117269977224,0.00498040254470563,0.027355680989601,0.0468788589648471,9.3970348257591e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,24381,-0.0115298528410727,0.00154849200343438,-0.0145648971678041,-0.00849480851434136,9.95088853459383e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,28931,0.0258323167116443,0.00347642303059314,0.0190185275716818,0.0326461058516069,1.10996382941579e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,0.0188084787571623,0.00254281903813679,0.0138245534424142,0.0237924040719105,1.43358665424973e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,24101,0.034011380825384,0.00459849256952174,0.0249983353891214,0.0430244262616466,1.44711318638975e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,24845,0.0528272212091506,0.00714345380810677,0.0388260517452613,0.0668283906730398,1.45671848984652e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,24240,0.0428322209736564,0.00579711431376708,0.0314698769186729,0.0541945650286399,1.53247982421615e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,24273,-0.0181941211303991,0.00246557308343815,-0.0230266443739379,-0.0133615978868604,1.64277670323622e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,24951,-0.0138627048188403,0.00188173421422663,-0.0175509038787245,-0.0101745057589561,1.79949057376512e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,24636,0.0524780302776613,0.00712469536687803,0.0385136273585803,0.0664424331967422,1.8182070208744e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,0.0148820802476075,0.00202159304949647,0.0109197578705944,0.0188444026246206,1.87560773038258e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGMN,Legumain,29581,0.0188476147096829,0.00256356277390741,0.0138230316728244,0.0238721977465414,2.00146146433965e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,24966,0.01344601455862,0.00183000599962778,0.00985920279934956,0.0170328263178905,2.08107919566886e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAT,Catalase,24587,0.0282275183784733,0.0038460109001502,0.0206893370141789,0.0357656997427677,2.21166797721526e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,24016,0.0295537595911952,0.00402821262917697,0.0216584628380084,0.0374490563443821,2.25884399030161e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,29454,0.0272912597851277,0.00372093781314487,0.0199982216713638,0.0345842978988917,2.28268446045289e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,29349,0.0295944661082569,0.00403565242819048,0.0216845873490036,0.0375043448675103,2.3043710914087e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,24240,0.0618187172024242,0.00843007094952691,0.0452957781413515,0.0783416562634969,2.31912083758679e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,29566,0.0437971085854525,0.00597522312630247,0.0320856712578997,0.0555085459130054,2.36424155008736e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,28916,0.0582268320234903,0.00794423314778626,0.0426561350538292,0.0737975289931514,2.37157859052752e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,29391,0.0151011146925677,0.00206322990575298,0.0110571840772919,0.0191450453078436,2.55915915746571e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,24922,0.0144348619181287,0.00197318185800845,0.0105674254764322,0.0183022983598253,2.64123342660458e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,28916,0.0441563637052247,0.0060420843388985,0.0323138784009837,0.0559988490094658,2.77889649165833e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,0.0617530210221192,0.00845703158185361,0.0451772391216861,0.0783288029225523,2.92123522597688e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,24845,0.0238280067878089,0.00326735512236966,0.0174239907479643,0.0302320228276534,3.12781277051998e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,29478,0.0355881747961198,0.00488614097106928,0.026011338492824,0.0451650110994156,3.33433778327371e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,28277,0.0120113352553733,0.00165116329968914,0.00877505518798261,0.0152476153227641,3.5682938472892e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,0.0165151946457247,0.00227214808995152,0.0120617843894197,0.0209686049020297,3.74407032689376e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,28774,-0.0385568374417531,0.00530724723137697,-0.048959042015252,-0.0281546328682543,3.82685160125996e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,29566,-0.0126222061712723,0.00173814143006113,-0.0160289633741921,-0.00921544896835244,3.9111641218062e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,29023,0.0390058120051203,0.00537450382946297,0.0284717844993729,0.0495398395108677,4.04008383493048e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,29434,-0.0243013881918954,0.00335052196097045,-0.0308684112353975,-0.0177343651483933,4.17649867891074e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,29786,0.0140263984510809,0.00193453528967947,0.0102347092833091,0.0178180876188526,4.25263377783566e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,24240,0.027110397790173,0.00373912096061205,0.0197817207073733,0.0344390748729726,4.2777342992555e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,0.0176073599241887,0.0024288183159073,0.0128468760250104,0.022367843823367,4.28957649556375e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,24845,-0.021836878567192,0.00301447956652903,-0.0277452585175889,-0.0159284986167951,4.48352334119503e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,29456,-0.0330284650404849,0.0045736032401042,-0.0419927273910892,-0.0240642026898807,5.26471838034239e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,29581,0.0219443649775543,0.00303897633190493,0.0159879713670206,0.027900758588088,5.28621289107769e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,29820,0.045358273273544,0.00628952582011841,0.0330308026661119,0.0576857438809761,5.65664005141519e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,29443,-0.0209451417139341,0.00290814776082677,-0.0266451113251545,-0.0152451721027136,6.06576796629386e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,29434,-0.0220066599150741,0.00305844651389935,-0.0280012150823168,-0.0160121047478313,6.37797736506593e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,0.0245329565487516,0.00341007068074006,0.0178492180145011,0.0312166950830021,6.45768942974809e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,29349,-0.0209689402281142,0.00292574482473329,-0.0267034000845914,-0.0152344803716369,7.84434183740284e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,28916,0.0186431665867781,0.00260433274627199,0.013538674404085,0.0237476587694712,8.34977324284093e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,0.0484282225029944,0.00677038486875177,0.0351582681602409,0.0616981768457478,8.72918884884345e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,28774,0.0420653242941151,0.00588436576519818,0.0305319673943267,0.0535986811939036,8.97182865328989e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,24776,0.0484113784454299,0.00677601747857007,0.0351303841874325,0.0616923727034272,9.28108479614171e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,24538,0.016809919683031,0.00235759964507134,0.0121890243786912,0.0214308149873709,1.03076164083493e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,24195,0.031968339066818,0.00448828190461506,0.0231713065337725,0.0407653715998635,1.0885681775857e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,24793,0.020114269246576,0.00283281296190134,0.0145619558412494,0.0256665826519027,1.27698398033971e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,24805,0.0288806761112506,0.00407451896527775,0.0208946189393062,0.036866733283195,1.39587005939361e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,29349,0.0183705198879835,0.00259412907041136,0.0132860269099772,0.0234550128659898,1.45732498260438e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,0.0528620638168197,0.00748027408629563,0.0382007266076802,0.0675234010259591,1.62029674676089e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,24101,0.0504002707094233,0.00713215666645741,0.0364212436431667,0.0643792977756798,1.63072050207965e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,0.0294121751806662,0.00416392885548729,0.0212508746239111,0.0375734757374213,1.65918002443385e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,24407,-0.0156829383079426,0.00222014436119402,-0.0200344212558829,-0.0113314553600023,1.66207642811163e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,29478,-0.0172146164732614,0.00243794541032433,-0.0219929894774971,-0.0124362434690257,1.68828472461576e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,28797,0.0293155868962304,0.00415629593953943,0.0211692468547331,0.0374619269377277,1.78673398048038e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,29694,-0.0116597540096117,0.00165566576960088,-0.0149048589180294,-0.00841464910119397,1.93156557989599e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,24922,0.0163059928956924,0.00231919258968926,0.0117603754199015,0.0208516103714834,2.10512668846285e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,24111,0.0385444184316538,0.00549274090885452,0.0277786462502989,0.0493101906130086,2.32123389969072e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,24240,0.0263728251293876,0.0037633735459642,0.0189966129792978,0.0337490372794774,2.48503996682442e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,24111,0.0199487311443552,0.00284754265961348,0.0143675475315128,0.0255299147571976,2.52407218458449e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,24111,0.0594875142070785,0.00850425516625166,0.0428191740812252,0.0761558543329317,2.72137692590972e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,28916,0.025049161719602,0.00358131427268076,0.0180297857451477,0.0320685376940563,2.72181370785425e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,29434,0.0238879158430067,0.00341624249779287,0.0171920805473327,0.0305837511386808,2.75884964794976e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,-0.0159317831070158,0.00228054238070242,-0.0204016461731925,-0.0114619200408391,2.88916081026552e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,0.0150659027307198,0.00216069761760848,0.0108309354002072,0.0193008700612324,3.18671078825042e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,0.0212358105170313,0.0030478923991389,0.0152619414147191,0.0272096796193436,3.29820978652394e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,24867,0.03391679750379,0.00488582620552692,0.0243405781409573,0.0434930168666228,3.96441378763699e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,0.0366284347330801,0.00527772348868963,0.0262840966952484,0.0469727727709118,4.01153156310669e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,29349,0.0147196071066445,0.00212108672345129,0.0105622771286799,0.018876937084609,4.0122622318357e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,28774,0.0354489631920754,0.00510938233489049,0.02543457381569,0.0454633525684607,4.06069735541251e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,0.0366745224532716,0.0052859318902475,0.0263140959483865,0.0470349489581567,4.07220683391843e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,24016,0.017944736576963,0.00258783676788801,0.0128725765119025,0.0230168966420235,4.1870386449267e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,24922,0.0356420104371638,0.00514768069126721,0.0255525562822801,0.0457314645920476,4.50054449444943e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,0.0300169854640676,0.00433685898461799,0.0215167418542164,0.0385172290739189,4.58400090924926e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,29443,-0.0242684812292397,0.00350707108940222,-0.031142340564468,-0.0173946218940114,4.61306981889813e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,24867,-0.0223121092701995,0.00322426732872055,-0.0286316732344918,-0.0159925453059072,4.62428767641541e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,24925,0.00968189783799822,0.00139921558621358,0.00693943528901961,0.0124243603869768,4.6415680166767e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,24938,-0.0247661296259694,0.0035795448084683,-0.0317820374505673,-0.0177502218013715,4.66528562488882e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,24845,-0.0337888077644017,0.00488492748126941,-0.0433632656276897,-0.0242143499011137,4.72660442340505e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,29192,0.02359814055144,0.0034146490221983,0.0169054284679313,0.0302908526349487,4.91640565257313e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,24109,0.020472844531541,0.00296379930809266,0.0146637978876793,0.0262818911754026,5.05058120417088e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,0.0354997427103639,0.00515154531983723,0.0254027138834829,0.0455967715372449,5.65027261330892e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,24445,0.033492219568753,0.00486055338370239,0.0239655349366963,0.0430189042008097,5.68997001958542e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,24846,0.00988100960146352,0.00143529742945042,0.0070678266397407,0.0126941925631863,5.94574616269291e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,28774,0.0314931362845357,0.00457503460149631,0.022526068465603,0.0404602041034685,5.95169920121464e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,28722,0.0349780238495627,0.00509219383192488,0.02499732393899,0.0449587237601355,6.5994606485743e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,24845,0.0189068358347914,0.00275356138797284,0.0135098555143646,0.0243038161552182,6.74312056495009e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,0.0278063813960544,0.00405491695770974,0.0198587441589433,0.0357540186331655,7.14742297290069e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,24229,0.0214230981935537,0.00312990563099491,0.0152884831568036,0.0275577132303037,7.84947478144926e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,0.0361886918655232,0.00529027211669706,0.025819758516797,0.0465576252142495,8.04347332196386e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,24229,0.0199146087900145,0.00292110654193858,0.0141892399678149,0.0256399776122142,9.48229303283616e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,29349,0.0401118986803145,0.00589390069591053,0.0285598533163299,0.0516639440442992,1.02519289886714e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,0.0371396219803752,0.00545759785715673,0.026442730180348,0.0478365137804024,1.02941476076085e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,24793,0.021269396611356,0.00312959794448175,0.0151353846401718,0.0274034085825403,1.09844437679269e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C2,Complement C2,29545,0.0113517984052561,0.00167132332758136,0.0080760046831966,0.0146275921273155,1.12605459738656e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,29039,0.0333153746027798,0.00491827004557867,0.0236755653134456,0.042955183892114,1.27836706821323e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,29725,0.0137342040514168,0.00202897945274372,0.00975740432403916,0.0177110037787945,1.32066118324727e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,29390,0.0111351605548881,0.00164585031510856,0.0079092939372753,0.0143610271725008,1.35250507847127e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,28774,0.0186191019433528,0.00275353143038085,0.0132221803398064,0.0240160235468993,1.38798654846237e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,29694,-0.0140913088375665,0.00208636520808935,-0.0181805846454216,-0.0100020330297114,1.46476462813343e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,29218,0.01600626819193,0.00237236506760409,0.011356432659426,0.020656103724434,1.53785569678038e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,0.0236830794476843,0.00351750240706791,0.0167887747298312,0.0305773841655374,1.69917302354546e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,28774,0.0215247215057871,0.00319766536436229,0.015257297391637,0.0277921456199372,1.71210340297414e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,29518,0.0182493167550072,0.00271531275082268,0.0129273037633948,0.0235713297466197,1.8390451845671e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,24111,0.0329909326441298,0.00490847095452945,0.0233703295732521,0.0426115357150075,1.84226345722653e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,24793,0.0203121712700142,0.00302366149689145,0.014385794736107,0.0262385478039214,1.88561493143975e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,24195,0.0328280465682602,0.00489095663595566,0.0232417715617871,0.0424143215747333,1.96236151995345e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,24966,0.00889093904803018,0.00132921277700276,0.00628568200510476,0.0114961960909556,2.29645800153796e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,29736,0.0131963591932051,0.00197831361749339,0.00931886450291809,0.0170738538834922,2.59385915763379e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,0.0201919409014912,0.00303237456897232,0.0142484867463055,0.026135395056677,2.8200078932594e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,24938,0.0289919208711323,0.004354309720471,0.0204574738190091,0.0375263679232554,2.82937705596472e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,29683,0.028751942191143,0.0043246578838141,0.0202756127388673,0.0372282716434186,3.01485218756167e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,29786,0.0369356194174816,0.00555647803022569,0.0260449224782392,0.0478263163567239,3.03654852078482e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,24445,0.0360204856837772,0.00542188425164029,0.0253935925505623,0.0466473788169922,3.12682511437936e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",29402,-0.0264545039703891,0.00398449641617302,-0.0342641169460882,-0.0186448909946899,3.20532830311488e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,29478,-0.0188205488659723,0.00283567448600088,-0.024378470858534,-0.0132626268734105,3.25543576888283e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,29820,-0.0112861018245333,0.00170171129587476,-0.0146214559644479,-0.00795074768461881,3.36354675776757e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,24240,0.0142120231628,0.0021441463306125,0.0100094963547995,0.0184145499708005,3.4673321284579e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,0.0401992172222616,0.00606707847372807,0.0283077434137546,0.0520906910307687,3.51474200560108e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,29694,0.0217433031666475,0.00328275794326366,0.0153090975978507,0.0281775087354442,3.56812712877098e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,24805,0.0165164575923659,0.0024992108878395,0.0116180042522005,0.0214149109325313,3.95657893391274e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,24111,0.0292828567580668,0.0044367609934139,0.0205868052109755,0.037978908305158,4.19548020749937e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,0.0250873780381684,0.00380210870491793,0.0176352449765293,0.0325395110998076,4.24538730361175e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,0.0170979021254762,0.00259431167172938,0.0120130512488866,0.0221827530020658,4.4725015142531e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,24229,0.0408508470943302,0.00619988320350535,0.0286990760154597,0.0530026181732007,4.51979822403888e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,0.0222786289802135,0.00338226461093571,0.0156493903427795,0.0289078676176475,4.58106658637468e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,24195,0.0212668478205752,0.00322947716886287,0.014937072569604,0.0275966230715465,4.63500831177516e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,29434,0.0147174536485443,0.00223537185514689,0.0103361248124564,0.0190987824846322,4.65989213985698e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,-0.0279915665935598,0.00425437341805856,-0.0363301384929546,-0.0196529946941651,4.80110173602099e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,29327,0.0207971112989873,0.00316118906397636,0.0146011807335936,0.0269930418643809,4.81954944273327e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,29594,-0.0142208777053653,0.00216260633193487,-0.0184595861159576,-0.00998216929477296,4.91962136679657e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,24111,0.0579689143992476,0.00882898313486716,0.0406641074549079,0.0752737213435872,5.28242495006235e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRN,Progranulin,29313,0.011576883448997,0.00176365174155994,0.00812012603553952,0.0150336408624545,5.32021868471052e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,0.0560206671243338,0.00853712251309464,0.0392879069986683,0.0727534272499993,5.39665046222771e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,0.0416681514771532,0.00635010555660175,0.0292219445862138,0.0541143583680927,5.42041001972364e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,0.0185433291648438,0.00282870205669317,0.0129990731337252,0.0240875851959625,5.65731225177862e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,28628,0.0524751965436529,0.00801696949365239,0.0367619363360942,0.0681884567512116,6.02928041822693e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,29786,0.0110195660671257,0.00168476532924654,0.00771742602180245,0.0143217061124489,6.22178574244281e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,29674,0.0242411601762819,0.00370864069958359,0.016972224405098,0.0315100959474657,6.40388612188609e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,28774,0.0230863275510857,0.00353524997817876,0.0161572375938554,0.0300154175083161,6.6721193846178e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,29434,0.0364554396741501,0.00558427192134165,0.0255102667083205,0.0474006126399797,6.76317412097067e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,24195,0.029020612972021,0.00445018473522439,0.0202982508909812,0.0377429750530608,7.11164718176782e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,28774,0.0339861659180422,0.00521341064781161,0.0237678810483315,0.044204450787753,7.19543679089971e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,29163,0.0352625948854845,0.00541047762714367,0.0246580587362829,0.0458671310346861,7.26722610912046e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,24445,0.0247307337586926,0.00379817527656718,0.0172863102166209,0.0321751573007643,7.59929971362007e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,24240,0.0199268106953645,0.00306702360500469,0.0139154444295553,0.0259381769611737,8.34634444466199e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",24845,-0.0279355546762348,0.00430507115060551,-0.0363734941314216,-0.019497615221048,8.80433451698441e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,24101,0.0355833654749095,0.00548620739621564,0.0248303989783268,0.0463363319714921,8.98739106640033e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,24966,0.0248183307621121,0.00382890075397495,0.0173136852843212,0.032322976239903,9.23011124527626e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,24914,-0.00873721997283127,0.00134853771828185,-0.0113803539006637,-0.00609408604499883,9.40367497966564e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,29618,-0.019197726263626,0.00296355501341097,-0.0250062940899115,-0.0133891584373405,9.44423777241581e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,24805,0.0157230964257165,0.00242969486907649,0.0109608944823266,0.0204852983691065,9.90282535937201e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,24922,-0.0164666143128886,0.00254568830722991,-0.0214561633950593,-0.011477065230718,1.00861507035856e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,24240,0.0260996807508407,0.00405652771973693,0.0181488864201563,0.0340504750815251,1.26614554018656e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,29694,0.0138197341676204,0.00215104422451375,0.00960368748757346,0.0180357808476674,1.34162784513705e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,28797,0.022235613176319,0.0034618274258296,0.015450431421693,0.029020794930945,1.35622576613027e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,24793,0.0156852486023741,0.00244503870120641,0.0108929727480095,0.0204775244567386,1.43239677300527e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,28867,0.0274261971540525,0.00428047229615268,0.0190364714535932,0.0358159228545117,1.5041859359046e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,24845,-0.0141217117777107,0.00221115235790946,-0.0184555703992132,-0.00978785315620817,1.7263381497624e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,0.0308004056007952,0.00482946021631875,0.0213346635768105,0.04026614762478,1.82603264779919e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,29218,0.0106247605856302,0.00166721999636523,0.00735700939275436,0.0138925117785061,1.88447061994397e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,29787,-0.0196519138911739,0.00308524295452071,-0.0256989900820345,-0.0136048377003133,1.92225664832394e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,24805,-0.0230223310043706,0.00361671520620518,-0.0301110928085328,-0.0159335692002085,1.98014255022596e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,29349,0.0614988925080276,0.00966690254203768,0.0425517635256337,0.0804460214904214,2.02342600473231e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,24793,0.0270397606607562,0.00425832868707141,0.0186934364340962,0.0353860848874161,2.19257622884571e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,28884,0.0187302269608122,0.00295266252538862,0.0129430084110505,0.0245174455105739,2.27922482422971e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,28774,0.0278725796705432,0.00439789267605484,0.0192527100254757,0.0364924493156107,2.36655172748383e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,0.0229803262964631,0.00362779570059967,0.0158698467232877,0.0300908058696384,2.41527708289141e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,24195,0.0220009705740113,0.00347373294938317,0.0151924539932203,0.0288094871548023,2.43839348385696e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSPN,Persephin,29434,0.0425551286422035,0.00672515318758806,0.0293738283945309,0.0557364288898761,2.52330778352087e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,0.0262259211392064,0.00414619045311801,0.0180993878510951,0.0343524544273177,2.56443464489835e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,28931,-0.0181179924361015,0.00286668797774402,-0.0237367008724797,-0.0124992839997232,2.65060291274334e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,24240,0.0350033056636896,0.00554055658876736,0.0241438147497056,0.0458627965776737,2.70184962199835e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,29443,-0.0108765241103344,0.00172200591098444,-0.0142516556958639,-0.00750139252480486,2.71910822127493e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,24922,0.0320923737620706,0.00508500881502852,0.0221257564846147,0.0420589910395265,2.815899475169e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,24445,0.0336061503605572,0.00532512863122343,0.0231688982433593,0.0440434024777551,2.8224919120462e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,24920,0.0166787680435511,0.00264390958080192,0.0114967052651794,0.0218608308219229,2.86723790836902e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,24951,-0.0111251939411316,0.00176457962666363,-0.0145837700093923,-0.00766661787287085,2.93536915123999e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,29420,0.042779468563207,0.00681022407158548,0.0294314293828995,0.0561275077435146,3.39675714888452e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,24445,0.0318512179216033,0.00507342598419565,0.0219073029925798,0.0417951328506267,3.48612974498637e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,29373,0.0299352196233863,0.00477379179680293,0.0205785877016526,0.0392918515451201,3.64329533394811e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,0.0275279369319179,0.0043908630649309,0.0189218453246533,0.0361340285391824,3.68642499083891e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,0.0127517656907314,0.00203458932083185,0.00876397062190101,0.0167395607595619,3.7295701891107e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,0.0447015367364244,0.0071363592753352,0.0307142725567674,0.0586888009160814,3.81584699973424e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,0.0366022573952891,0.00584545379589865,0.0251451679553277,0.0480593468352504,3.86153502507369e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,29688,0.0418528713202052,0.00668557581269735,0.0287491427273184,0.054956599913092,3.89804968674562e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,-0.0128202476270493,0.00204795971510398,-0.0168342486686531,-0.00880624658544545,3.90199261269509e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,24195,0.0306831795306807,0.00490595045706761,0.0210675166348282,0.0402988424265332,4.06043537659745e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,28931,0.0175709863898397,0.00281194770251333,0.0120595688929136,0.0230824038867659,4.19679319179518e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,29443,0.0541609268223571,0.00866882219097702,0.0371700353280421,0.071151818316672,4.22013042973065e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,24922,0.0292561683860999,0.00468660899271207,0.0200704147603842,0.0384419220118155,4.3756995520764e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,24845,0.0261062326030943,0.00418237608239231,0.0179087754816054,0.0343036897245833,4.3910443877771e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,29434,0.0178914635225355,0.00286870101856814,0.0122688095261419,0.0235141175189291,4.52733622664774e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,24845,0.0207928707273374,0.00333509166975731,0.0142560910546131,0.0273296504000617,4.60305989009557e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,24732,0.022182093857014,0.00357316308240643,0.0151786942154974,0.0291854934985306,5.45264597808444e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,24111,0.0268346748515345,0.00432395034753988,0.0183597321703563,0.0353096175327126,5.5216398253425e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,24229,-0.0117727724285868,0.00189747526092397,-0.0154918239399978,-0.00805372091717587,5.57809821933709e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,24966,0.0119015288054013,0.00192007198600772,0.00813818771282613,0.0156648698979764,5.79035029940225e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,28797,0.0237690569689989,0.00383777530827421,0.0162470173647815,0.0312910965732164,5.96582902079874e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,29400,0.0389011062541846,0.00628493466584418,0.02658263430913,0.0512195781992392,6.11213950640209e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,-0.0107503468248927,0.00173754099252912,-0.0141559271702498,-0.00734476647953563,6.2086376276928e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,24229,0.0176972905328034,0.00286330386105011,0.0120852149651452,0.0233093661004616,6.4826483537263e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,24111,0.017052458641325,0.00276051859319054,0.0116418421986715,0.0224630750839784,6.62645077224539e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,24381,0.0385916867856971,0.00626994733550692,0.0263025900081036,0.0508807835632907,7.6236246710228e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,0.0202949038253204,0.00329848829696538,0.0138298667632682,0.0267599408873725,7.7324674048254e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,0.0168222685521717,0.00273749794385991,0.0114567725822063,0.0221877645221371,8.11354941262709e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,29165,-0.0211245724567568,0.00343952038850265,-0.027866032418222,-0.0143831124952916,8.26866792406516e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,29349,-0.00666589439330827,0.00108560181289645,-0.0087936739465853,-0.00453811484003123,8.34345553247571e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,0.0490474317875754,0.00801261230212681,0.0333427116754069,0.064752151899744,9.4026843565935e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,24711,0.0212502773518202,0.00347138402197403,0.0144463646687511,0.0280541900348893,9.40607662170546e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,24445,0.0153701253895951,0.00251332903283047,0.0104440004852474,0.0202962502939429,9.77484057128766e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,29349,0.0327795915241163,0.00536095849855226,0.0222721128669538,0.0432870701812787,9.80804312556991e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,24381,0.0416812137566821,0.00682177084347589,0.0283105429034693,0.0550518846098948,1.01123067919072e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,29320,0.0182816995538233,0.00300146764644967,0.012398822966782,0.0241645761408647,1.13659428731869e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,0.020637552624866,0.00339466575598492,0.0139840077431355,0.0272910975065964,1.22385464302751e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,29786,0.0265049904443759,0.00437085761343628,0.0179381095220407,0.035071871366711,1.34353108568288e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,29536,0.0130040583286998,0.00214537778731119,0.00879911786556987,0.0172089987918298,1.36549957564881e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,28931,0.0257452017858407,0.00426084514977948,0.0173939452922729,0.0340964582794085,1.53810998204299e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FST,Follistatin,29536,-0.0218428719683738,0.00361562438956487,-0.0289294957719209,-0.0147562481648266,1.54757602251836e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,28774,0.0160199050076473,0.00265400601503623,0.0108180532181763,0.0212217567971183,1.59792194480316e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,28719,0.028653437445722,0.00474788963648414,0.0193475737582131,0.0379593011332309,1.60925125186478e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,28797,0.0290430454777015,0.00481586467905055,0.0196039507067624,0.0384821402486406,1.65236698774996e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,0.016785976050439,0.00278562985283711,0.0113261415388782,0.0222458105619997,1.70155433136795e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,29349,0.0188479750327,0.00312782530420356,0.012717437436461,0.024978512628939,1.70169754134456e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,29166,0.0302721658842704,0.00503062947006808,0.020412132122937,0.0401321996456038,1.79165012710792e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,24966,-0.00727697972996522,0.00120957170196528,-0.00964774026581716,-0.00490621919411327,1.81087533229069e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,28774,0.0292849451191706,0.00486847800937891,0.0197427282207879,0.0388271620175532,1.81814750159784e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,29566,0.0241251644333884,0.00401251754006081,0.0162606300548692,0.0319896988119076,1.84852294109061e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,28669,-0.0387583304704498,0.00644803192081705,-0.0513964730352512,-0.0261201879056484,1.86749781339374e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,0.0104938506960159,0.00174768227798114,0.00706839343117285,0.0139193079608589,1.94246236810604e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,29443,-0.00843682294535131,0.0014072457805526,-0.0111950246752344,-0.00567862121546821,2.05507486758404e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,24938,-0.014335957135701,0.0023918827466803,-0.0190240473191944,-0.00964786695220764,2.08082075732851e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,29349,-0.0329301788961558,0.00550286552501237,-0.0437157953251801,-0.0221445624671316,2.19993164330083e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,24111,0.0301751367688809,0.00504741080464155,0.0202822115917835,0.0400680619459783,2.2859490853934e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,24445,0.0322176421532253,0.00538985435318058,0.0216535276209913,0.0427817566854592,2.29785907864066e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,28931,0.0350619308568071,0.00588643075941169,0.0235245265683602,0.046599335145254,2.6083330199837e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,0.0282733514038455,0.00475586886953718,0.0189518484195526,0.0375948543881383,2.80249666507128e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,28916,0.0189956354244755,0.0031984932417621,0.0127265886706218,0.0252646821783292,2.90160056920442e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,24764,0.0174597559722522,0.0029429167634095,0.0116916391159696,0.0232278728285348,3.01758036201954e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,29349,0.00890003766044154,0.00150209585585189,0.00595592978297184,0.0118441455379112,3.15625709892282e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,28774,0.0310991967203921,0.00525017985744226,0.0208088441998053,0.041389549240979,3.18830827985222e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,29223,0.0171375361788781,0.00289430926988725,0.0114646900098991,0.0228103823478571,3.23338181502757e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,24915,0.0105692271352194,0.00178492435517587,0.00707077539907471,0.0140676788713641,3.23424257462401e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,29786,0.0310636624859833,0.00524769661418252,0.0207781771221856,0.041349147849781,3.2648489445598e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,0.0190543199298073,0.00322623390693203,0.0127309014722205,0.025377738387394,3.55094243158484e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,24329,-0.0129691386280547,0.00220005856881844,-0.0172812534229388,-0.00865702383317055,3.79841658347711e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,0.0228582045793222,0.00387857809534223,0.0152561915124514,0.0304602176461929,3.82344332714839e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,29673,0.0128358714137315,0.00217837962340932,0.00856624735184921,0.0171054954756137,3.84746706016898e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,-0.0179587907471799,0.00304914109821137,-0.0239351072996742,-0.0119824741946856,3.90872331886126e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,0.0104547150584597,0.00178060943091367,0.00696472057386891,0.0139447095430505,4.36741533632167e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,0.0394209489060045,0.00673685642241448,0.0262167103180721,0.0526251874939369,4.9222839381795e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,29218,0.0148903217178701,0.00254528159175964,0.00990156979802124,0.019879073637719,4.9631253248409e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,29566,0.0124994341507455,0.00213963240821588,0.00830575463064243,0.0166931136708487,5.21614756557785e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,0.0200089641257392,0.00342576530871292,0.0132944641206618,0.0267234641308165,5.2620796525811e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,28984,0.0141999746467498,0.00243929227357187,0.00941896179054896,0.0189809875029507,5.89890855831368e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,29478,0.0146501884255279,0.00252126806927815,0.00970850300974271,0.0195918738413131,6.28733628044785e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,0.0179413804705381,0.00308868842573453,0.0118875511560984,0.0239952097849778,6.36044269796438e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,24805,0.0149357594773196,0.00257159409611632,0.00989543504893164,0.0199760839057076,6.40042545433739e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,0.0393597754748569,0.00678064051745448,0.0260697200606461,0.0526498308890677,6.51310856698059e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,29725,-0.0184612567924192,0.00319390578282917,-0.0247213121267644,-0.012201201458074,7.53793377849918e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,28890,0.0229373031817358,0.00397405096720926,0.0151481632860057,0.030726443077466,7.92455877502538e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,0.0618685739796977,0.0107364810418713,0.04082507113763,0.0829120768217654,8.37216628678322e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,29216,0.0240759111237154,0.00417864953561407,0.0158857580339118,0.032266064213519,8.41323455400236e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",24845,0.0438120289028521,0.00761050489259591,0.0288954393133641,0.0587286184923401,8.67412842325636e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,0.015240987654829,0.00265504304506469,0.0100371032865022,0.0204448720231558,9.55576408198836e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,24523,0.0229392696163632,0.00400553707836543,0.0150884169427669,0.0307901222899594,1.03484351594259e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,29725,-0.0187684711474414,0.00328059798864793,-0.0251984432051914,-0.0123384990896915,1.06882600024594e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,24805,0.0183252671388218,0.00320428364959046,0.0120448711856244,0.0246056630920191,1.08390673935217e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,0.0418158709085017,0.00734186246885817,0.0274258204695397,0.0562059213474637,1.24405833495104e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,24381,0.0513658352056793,0.00902204060401017,0.0336826356218193,0.0690490347895392,1.25985881137948e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,0.0406397968525324,0.00714744111239321,0.0266308122722417,0.0546487814328231,1.3133943006075e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,28774,0.0209271569591452,0.00368485069691797,0.013704849593186,0.0281494643251044,1.36597021826539e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,24195,-0.0127493389153989,0.00224668346603197,-0.0171528385088216,-0.00834583932197626,1.40489664301102e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,24240,0.011897469899022,0.0020976754156462,0.00778602608435544,0.0160089137136885,1.42964145692541e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,28757,0.0445216733167721,0.00785967619543069,0.0291167079737279,0.0599266386598162,1.48801913779394e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,0.0296018228655843,0.00523000490064139,0.0193510132603271,0.0398526324708414,1.52793955011228e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,29820,-0.0128099488799706,0.0022670556915695,-0.0172533780354469,-0.00836651972449443,1.61460311513837e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,28797,0.0147374657230229,0.0026140674118858,0.00961389359572674,0.0198610378503191,1.73895620611479e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,28916,0.0189710655214375,0.00336947580611674,0.0123668929414486,0.0255752381014263,1.81593439409867e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,24240,0.0130558169569864,0.00232206107451856,0.00850457725093004,0.0176070566630428,1.90271844023621e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,29478,0.0252769953219772,0.00450109156034465,0.0164548558637017,0.0340991347802527,1.97475525349767e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,24229,0.0257578522071197,0.00458738876066037,0.0167665702362253,0.034749134178014,1.98799700908886e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,24805,0.0385513984958278,0.00687514221965529,0.0250761197453035,0.0520266772463522,2.076223848925e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,28931,0.0262809243977802,0.00469548359971416,0.0170777765423405,0.03548407225322,2.19985463852993e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,29396,0.0103652116757633,0.0018568285775782,0.00672582766370999,0.0140045956878165,2.39572072717065e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,24793,0.015524470953753,0.00278232268300217,0.0100711184950688,0.0209778234124373,2.43477895799483e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,24793,0.0194881961707892,0.00349566846351887,0.0126366859822923,0.0263397063592862,2.50170653588674e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,24867,0.0506087019089661,0.00908169988499463,0.0328085701343767,0.0684088336835556,2.5356249040226e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,29296,0.0122820231340393,0.00220704780224325,0.00795620944164258,0.0166078368264361,2.64580111679773e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,24229,0.0203809426201619,0.00368485673710386,0.0131586234154384,0.0276032618248855,3.21699513738848e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,0.00915830597179837,0.00165714741469325,0.00591029703899961,0.0124063149045971,3.29321616409941e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,0.0118628233828898,0.00214898858058529,0.0076508057649426,0.0160748410008369,3.41553606842235e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,24867,0.0141612853989686,0.00256695597944286,0.00913005167926063,0.0191925191186766,3.48742705583592e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,24647,0.0173580204267179,0.00314978058933397,0.0111844504716233,0.0235315903818124,3.60645954776574e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,29581,0.0344165547139013,0.00626024442341407,0.0221464756440097,0.0466866337837929,3.880912100917e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,28916,0.0299423158912259,0.00547562345890158,0.0192100939117788,0.0406745378706729,4.58148416234868e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,24922,0.0206719291325251,0.00378383539124118,0.0132556117656924,0.0280882464993578,4.72046663443417e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,29274,-0.0112384941244411,0.00205742296040233,-0.0152710431268296,-0.00720594512205252,4.73527713602905e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,24845,-0.0145707181563535,0.00268155204980474,-0.0198265601739708,-0.00931487613873624,5.57198320633228e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,28916,0.0202152798554937,0.00372441299987845,0.0129154303757319,0.0275151293352555,5.75191665119484e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,24454,0.00975612382093207,0.00180378176040767,0.00622071157053304,0.0132915360713311,6.40775408862992e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,24240,0.0237195727753555,0.00438787737722018,0.0151193331160039,0.032319812434707,6.5163427966626e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,24966,-0.00876001692419685,0.00162494037062779,-0.0119449000506273,-0.00557513379776638,7.07111266121503e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,29218,0.0157226770569187,0.0029267863350171,0.00998617584028523,0.0214591782735523,7.84659200489044e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,28774,0.0174380515686064,0.00325009559776137,0.0110678641969941,0.0238082389402187,8.13953052645653e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,24793,0.0212188495758064,0.00395571123604706,0.0134656555531542,0.0289720435984587,8.20804892999456e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,24101,0.0168866312342989,0.00315004257342939,0.0107125477903773,0.0230607146782205,8.36332407096217e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,29137,-0.0240187954193678,0.00448126613394169,-0.0328020770418936,-0.0152355137968421,8.39359784937682e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,24805,0.0164298669726356,0.00307554618013107,0.0104017964595787,0.0224579374856925,9.26869799992611e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,0.0155186273471315,0.0029087690438649,0.00981744002115633,0.0212198146731067,9.63393767200506e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,24281,0.0163848283158089,0.00307538064026079,0.0103570822608978,0.0224125743707201,1.00328371759196e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,28706,0.0288592807875444,0.00542063363828682,0.0182348388565023,0.0394837227185866,1.02290246457966e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,0.0198467615918051,0.00372811785038978,0.0125396506050411,0.0271538725785691,1.02655733725822e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,24111,0.0138714791503032,0.00261042188213958,0.00875505226130966,0.0189879060392968,1.08266140874274e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,28797,0.0286665828936578,0.00540685421034638,0.018069148641379,0.0392640171459367,1.15449954302171e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,28774,0.0177229758031619,0.00334328683828,0.0111701336001331,0.0242758180061907,1.15978375096348e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,29786,0.0223484298756008,0.00421663788326004,0.0140838196244111,0.0306130401267905,1.16588549514015e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,24111,-0.0136562634833939,0.00257767800367984,-0.0187085123706064,-0.00860401459618144,1.18174712180638e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,24966,0.0124530365316734,0.00235069195906517,0.00784568029190568,0.0170603927714412,1.18326136194405e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,0.0334596107044479,0.00631640914991658,0.0210794487706114,0.0458397726382844,1.18417995761572e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,29478,0.0326689239209827,0.00619419724964147,0.0205282973116854,0.04480955053028,1.34337032148178e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,0.0187666556324972,0.00356088080497746,0.0117873292547413,0.025745982010253,1.37419848378285e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,0.0144739383285159,0.00274752440297054,0.00908879049869368,0.0198590861583382,1.38883696389314e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,28797,0.0221953171278902,0.0042214025177057,0.013921368193187,0.0304692660625933,1.46823628772746e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,28719,0.0159539375324804,0.00303704303539733,0.0100013331831016,0.0219065418818591,1.50613571632042e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,28774,0.0184808405945705,0.00352107095955559,0.0115795415138416,0.0253821396752995,1.54310899964214e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,29694,0.0112337834700714,0.00214161010926898,0.00703622765590425,0.0154313392842386,1.56940067735321e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,24240,0.0231411086578798,0.00441428925586674,0.014489101716381,0.0317931155993786,1.59900765686207e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,28931,0.0306795266364923,0.00586002155225832,0.019193884394066,0.0421651688789186,1.65782042985723e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,-0.0184343574411684,0.00352874995238196,-0.025350707347837,-0.0115180075344998,1.76242075688083e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,29623,0.0307480387222168,0.00588817969382196,0.0192072065223257,0.0422888709221078,1.78201762277005e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,-0.0125341256249336,0.00240214776849487,-0.0172423352511836,-0.00782591599868368,1.82209386599839e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,24229,0.0201001914873189,0.00385308554616822,0.0125481438168292,0.0276522391578086,1.83688832128522e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,29453,0.0350806726698647,0.006728825397271,0.0218921748912136,0.0482691704485159,1.86569667728256e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,24764,0.0262670537653269,0.00504114676771183,0.0163864061006118,0.0361477014300421,1.89809191638021e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,24111,0.0170829406187434,0.00328580083271308,0.0106427709866258,0.023523110250861,2.01977939477246e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,28797,0.019600698078965,0.0037851632051326,0.0121817781969051,0.0270196179610249,2.25426309123636e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,0.0201698321834408,0.00389539571339442,0.0125348565851877,0.0278048077816939,2.261927257247e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,24016,0.0135745563866934,0.00262279452948111,0.00843387910891045,0.0187152336644764,2.2899870413109e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,0.0305028786459778,0.00589980059894299,0.0189392694720496,0.0420664878199061,2.35429936133928e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,28916,0.0194606129083573,0.0037662667316161,0.0120787301143897,0.0268424957023248,2.39354258514146e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,24381,0.0119610959523879,0.0023156224380613,0.00742247597378771,0.016499715930988,2.4182442912456e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,0.0439592965012026,0.00854225618846205,0.027216474371817,0.0607021186305882,2.67657919390015e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,28797,-0.0139166625994171,0.00270465193745834,-0.0192177803968355,-0.00861554480199877,2.68624798500302e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,29725,0.00779535339830347,0.00151585555538346,0.00482427650975189,0.010766430286855,2.72761759680472e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,28774,0.0151633772650847,0.00295180424761011,0.0093778409397689,0.0209489135904005,2.81000633925371e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,24793,0.0249425472140353,0.00485846367645404,0.0154199584081854,0.0344651360198852,2.86043206105997e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,24111,0.0187655500832771,0.00365982948014417,0.0115922843021945,0.0259388158643596,2.95982302809413e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,29395,0.0147718445494637,0.00288256677361492,0.00912201367317843,0.0204216754257489,3.00142721804499e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,29594,0.0109143769695623,0.00213191711977044,0.00673581941481224,0.0150929345243124,3.08243031536145e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,0.0172154390772863,0.00336470635331338,0.010620614624792,0.0238102635297805,3.13300067990669e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",24111,0.0230452511761383,0.00451597468225894,0.0141939407989108,0.0318965615533658,3.36757236758367e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,29497,-0.0121452716063489,0.00238271254161188,-0.0168153881879082,-0.00747515502478965,3.46758299608917e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,24951,-0.0528048353744268,0.0103780405816782,-0.0731457949145162,-0.0324638758343375,3.64230990116744e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LXN,Latexin,29117,-0.0244419390601494,0.00481337788809689,-0.0338761597208193,-0.0150077183994795,3.83944811213642e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,28797,0.0292812211970048,0.00577143140585446,0.01796921564153,0.0405932267524795,3.93038926373592e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,0.0258008830167281,0.00509368132751904,0.0158172676147907,0.0357844984186654,4.10262895944829e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,24381,0.0134614578649214,0.00266340334334517,0.0082411873119649,0.018681728417878,4.35251930832855e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,28797,0.0263054285163826,0.00521161835604622,0.016090656538532,0.0365202004942332,4.50451458964641e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,24445,0.0252493147563462,0.00500429159236161,0.0154409032353174,0.0350577262773749,4.55501275856015e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,24845,0.00807608133786025,0.00160096704697916,0.0049381859257811,0.0112139767499394,4.57907359557633e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,29820,-0.00940991844280653,0.00186786150029407,-0.0130709269833829,-0.00574890990223015,4.7365356854839e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,-0.0110385734607359,0.00219205229827833,-0.0153349959653614,-0.00674215095611033,4.78914988055102e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,24793,0.0144270786317619,0.00287092725213195,0.00880006121758332,0.0200540960459406,5.06318755853091e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,0.0150706088353517,0.00299980407180749,0.00919099285460901,0.0209502248160944,5.09918141974198e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,28580,-0.0240231848231057,0.00478736548165626,-0.033406421167152,-0.0146399484790595,5.2514780079649e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,28452,0.0216319612833676,0.00431473118329567,0.0131750881641081,0.0300888344026271,5.37660037453201e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,24805,0.0179703893187585,0.00359701443463424,0.0109202410268754,0.0250205376106417,5.89545027526843e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,29218,0.0210068973616622,0.00421903108395063,0.0127375964371189,0.0292761982862054,6.42505780271331e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,29279,0.0214690484437776,0.0043126867130198,0.0130161824862588,0.0299219144012964,6.45711043601699e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,-0.0097063779500236,0.00195002343122436,-0.0135284238752233,-0.00588433202482385,6.47462037134262e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,29478,-0.0101501906432342,0.00204046164996883,-0.0141494954771731,-0.00615088580929525,6.57983036713321e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,-0.00730759871203041,0.00146977637253684,-0.0101883604022026,-0.00442683702185822,6.67508499402467e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,29434,0.0118041209045151,0.00237843822557387,0.00714238198239032,0.0164658598266399,6.9810192726158e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,24229,0.0427641377436532,0.00861854318212121,0.0258717931066956,0.0596564823806107,7.02889071542448e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,24793,0.0289417038997231,0.00583947316047141,0.0174963365051991,0.040387071294247,7.23523552995243e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,24111,0.0354103445128633,0.00714868430153085,0.0213989232818629,0.0494217657438638,7.34185069739605e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,29443,0.0203574237538533,0.00411510603652226,0.0122918159222696,0.0284230315854369,7.57817446939181e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,0.0310943198652875,0.0062935507393613,0.0187589604161394,0.0434296793144356,7.83638412856989e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,0.0222487011315066,0.00451053172591021,0.0134080589487226,0.0310893433142906,8.16745904404484e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,24867,0.0135891821099023,0.00275513882212858,0.00818911001853027,0.0189892542012743,8.1789637209602e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,24805,0.0213053861297804,0.00432358734445131,0.0128311549346558,0.029779617324905,8.37350272439695e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,29218,0.0464233997104027,0.0094268389892587,0.0279467952914556,0.0649000041293497,8.49947919278454e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,24177,0.0206425123318442,0.00419929716619112,0.0124118898861096,0.0288731347775788,8.9042346197774e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,28751,0.0305620154323643,0.00622025999346234,0.0183703058451781,0.0427537250195505,9.00473398595715e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,24938,-0.0110671400697102,0.00225313605073256,-0.015483286729146,-0.00665099341027438,9.07771051026255e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,24195,0.0210339632666204,0.0042838181570399,0.0126376796788222,0.0294302468544187,9.16245419070878e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,0.0235356899100461,0.00479637267877899,0.0141347994596393,0.032936580360453,9.30967074006241e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,29581,0.0269469640690971,0.00551192333281059,0.0161435943367883,0.0377503338014059,1.01958324726828e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,24845,0.0246192483076504,0.00503767669183965,0.0147454019916447,0.0344930946236561,1.03009414341145e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,24852,0.0226851956299604,0.00465761120636034,0.0135562776654942,0.0318141135944267,1.11964177856477e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,24867,-0.0124055445787904,0.00255051781449029,-0.0174045594951913,-0.00740652966238939,1.15780107999992e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,24111,-0.0110330408318782,0.0022711065376984,-0.0154844096457671,-0.00658167201798937,1.19320201274835e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,24833,0.0109464381444105,0.00225355476917826,0.00652947079682114,0.0153634054919999,1.19655824696685e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,29434,-0.0122626408192865,0.00252495081535691,-0.017211544417386,-0.00731373722118694,1.20039859509583e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,24229,0.0195767481976243,0.00403256570979503,0.011672919406426,0.0274805769888226,1.21342683585297e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,28916,0.0187669102620195,0.0038742553933108,0.0111733696911303,0.0263604508329086,1.27906294322768e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,28916,0.0214313075497198,0.00442764634332703,0.0127531207167989,0.0301094943826408,1.30286585372737e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,-0.00954474526300297,0.00197526263687085,-0.0134162600312698,-0.00567323049473611,1.35747248367671e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,29333,0.0118102388297377,0.00245011842049734,0.00700800672556286,0.0166124709339124,1.44079417371563e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,-0.0100206179032331,0.00207972167260591,-0.0140968723815407,-0.00594436342492551,1.45704123920134e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLU,Clusterin,24966,-0.0109597238019294,0.00227958795246643,-0.0154277161887636,-0.00649173141509524,1.53515452225932e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",28774,0.0186630356036827,0.00388304889998295,0.0110522597597161,0.0262738114476493,1.54537023399278e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,29434,0.0221346508869629,0.00460818903891146,0.0131026003706964,0.0311667014032293,1.56816253774546e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,24738,-0.00935490881948632,0.00195042781437291,-0.0131777473356572,-0.00553207030331541,1.62534312988646e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,24381,0.0113911418435794,0.00237609565893803,0.00673399435206083,0.0160482893350979,1.64404321137617e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,24805,0.0337657887779896,0.00704976528593433,0.0199482488175583,0.0475833287384209,1.68051582875818e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,24556,0.0212128815089592,0.00442971274567715,0.012530644527432,0.0298951184904864,1.68783869320008e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,24789,0.0195877475297389,0.00409494693525052,0.0115616515366479,0.0276138435228299,1.73350294190064e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,29349,0.0107060719021193,0.00224156558347102,0.00631260335851609,0.0150995404457225,1.7953819164035e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,24240,0.00824451230936659,0.0017262294407028,0.0048611026055891,0.0116279220131441,1.79840779096452e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,29349,0.029229722243112,0.00612107010136901,0.0172324248444288,0.0412270196417953,1.80337743629593e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,29645,0.0168498215413118,0.00352905160048426,0.00993288040436268,0.023766762678261,1.80921090382978e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,0.0127866101815004,0.00267806340622571,0.00753760590529797,0.0180356144577027,1.8111634582691e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,29820,-0.00938911408846142,0.00196689302011763,-0.013244224407892,-0.00553400376903086,1.81840739347693e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,29349,0.0157182146025844,0.00329291945545003,0.00926409246990235,0.0221723367352665,1.82070675174815e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,24111,0.0190917632217963,0.00400477709811914,0.0112424001094827,0.0269411263341098,1.87849825847145e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,29594,0.0156827527755922,0.00328986153018958,0.00923462417642066,0.0221308813747638,1.87882575709884e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,28774,0.0145850075793305,0.00306713492279614,0.0085734231306501,0.020596592028011,1.99155842209438e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,24805,0.0183143411761478,0.00385500080402506,0.0107585396002587,0.0258701427520369,2.03746630566457e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,0.0232391304260904,0.00492661755711939,0.0135829600141363,0.0328953008380444,2.40607719471422e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,-0.0157757002804541,0.00335063575525442,-0.0223429463607528,-0.00920845420015548,2.51174500397347e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,24111,0.0211684675346453,0.00449809745655629,0.0123521965197949,0.0299847385494956,2.53910790628078e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,29434,0.0175042275840439,0.00372799308634258,0.0101973611348125,0.0248110940332754,2.67351711785399e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,24016,0.0258467842072284,0.00550863453854193,0.0150498605116862,0.0366437079027706,2.71972734733571e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,24720,-0.00946879372247174,0.00202003684570597,-0.0134280659400554,-0.00550952150488804,2.78124498159607e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,29443,0.00804286172963693,0.00173079890631376,0.00465049587326196,0.0114352275860119,3.38407507333516e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",24445,0.0152729776313616,0.0032933754432113,0.00881796176266742,0.0217279935000557,3.54500471184748e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,24805,0.037846108435441,0.00816480033051363,0.0218430997876342,0.0538491170832477,3.58275277665679e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,28931,0.00961954537051936,0.00207740943661381,0.00554782287475629,0.0136912678662824,3.66283360906932e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCN,Decorin,28916,-0.00759213039530966,0.00164020836334992,-0.0108069387874755,-0.00437732200314382,3.69459721959372e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,24867,0.0100034325873222,0.00216351604604967,0.00576294113706485,0.0142439240375796,3.78865027437765e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,29457,0.0320735209784215,0.00694047253812429,0.0184701948036979,0.0456768471531451,3.83087173564499e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,29163,0.0105337329528447,0.00228183355103922,0.00606133919280786,0.0150061267128816,3.92220098752519e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENG,Endoglin,29820,-0.00568619492485004,0.00123268104835919,-0.00810224977963405,-0.00327014007006602,3.98800860394575e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,28931,0.010437928194532,0.00226476645941295,0.00599898593408256,0.0148768704549813,4.06665922516129e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,24938,-0.017078309002034,0.00371740758977011,-0.0243644278779834,-0.00979219012608456,4.36653891002732e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,28879,0.0140142622163547,0.00306011875522586,0.008016429456112,0.0200120949765974,4.67706277226727e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,24229,0.00950441780802387,0.00207824148695212,0.00543106449359771,0.01357777112245,4.82482903791232e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,28797,0.0153633878532909,0.00336156258316716,0.00877472519028321,0.0219520505162985,4.89022395013315e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,0.0129997063046345,0.00285064026325679,0.00741245138865118,0.0185869612206178,5.13307439473945e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,-0.0211226267852143,0.0046336116042798,-0.0302045055296027,-0.0120407480408259,5.17104231979718e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,0.0164826840833926,0.00362250711852412,0.00938257013108536,0.0235827980356999,5.38453860007345e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,24111,0.019646209974713,0.00432120889519091,0.0111766405401388,0.0281157794092871,5.48206548774985e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,0.0238873228254378,0.00527699375865573,0.0135444150584726,0.034230230592403,6.01489854890098e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,24381,-0.0303955200242229,0.00671496119004805,-0.0435568439567171,-0.0172341960917287,6.02416543643421e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,24867,0.00965689715878322,0.00213409308024764,0.00547407472149785,0.0138397195960686,6.06582342701362e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,24845,0.015088663746939,0.00334841219682241,0.00852577584116705,0.0216515516527109,6.62953653892095e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,0.0119968569394478,0.00266326541651309,0.00677685672308214,0.0172168571558134,6.68120387947252e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,0.010665848898484,0.00238098196614698,0.0059991242448359,0.0153325735521321,7.50671877594903e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,29491,0.0206561255169129,0.00462255997649699,0.0115959079629788,0.029716343070847,7.90457145595062e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,28797,0.0167819326030311,0.00376414690060658,0.00940420467784225,0.02415966052822,8.2899894636611e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,29594,-0.0109601592249461,0.00246640834998885,-0.0157943195909242,-0.00612599885896791,8.8715545449133e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,0.00925819115366674,0.00208465265794307,0.00517227194409833,0.0133441103632351,8.98136831916171e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,28604,-0.0221942699637609,0.00500505721949679,-0.0320041821139746,-0.0123843578135472,9.26862867741769e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,29374,0.0103960696616001,0.00234892058938857,0.00579218530639851,0.0149999540168017,9.63901545523e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,29454,0.0935410999398223,0.0211462621200748,0.0520944261844756,0.134987773695169,9.74495530824193e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,24195,-0.0101271691253444,0.00229249712665316,-0.0146204634935846,-0.00563387475710423,1.00269706659385e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,28847,0.0281913801983692,0.00638511975686012,0.0156765454749234,0.040706214921815,1.01297861034263e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,0.0142538728778861,0.00323146667172343,0.00792019820130822,0.0205875475544641,1.03346362839339e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,-0.00819861663355747,0.00185887302486563,-0.0118420077622941,-0.00455522550482083,1.03548669094463e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,29478,0.00895017858190061,0.0020296504004437,0.00497206379703096,0.0129282933667703,1.03873161042248e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,24867,0.00869287407143261,0.0019724799344528,0.00482681339990513,0.0125589347429601,1.05212649916961e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,0.00849467525155607,0.00193256558810088,0.00470684669887834,0.0122825038042338,1.10883759946314e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,0.0378095694812156,0.00860521915571004,0.020943339936024,0.0546757990264073,1.11777995851945e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,24229,0.0198573544609472,0.00452336746969742,0.0109915542203402,0.0287231547015541,1.13856810211987e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,29661,0.0134454631554071,0.00307241253738092,0.00742353458214046,0.0194673917286737,1.21183703875529e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,29566,-0.00873085081905466,0.00199751723307302,-0.0126459845958778,-0.00481571704223154,1.24184992228838e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,29566,0.0115382327996108,0.0026420267795353,0.00635986031172159,0.0167166052874999,1.26282968962385e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,0.0377976192252007,0.00867878823177236,0.0207871942909269,0.0548080441594745,1.33411341832439e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,28662,0.0179493207828875,0.0041246040025132,0.00986509693796166,0.0260335446278134,1.35511030009492e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,0.0285760121571512,0.00657568520314888,0.0156876691589794,0.041464355155323,1.39391644873237e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,24381,0.0112720147463288,0.00260037907924235,0.00617527175101383,0.0163687577416438,1.46505051443026e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,29439,-0.0182992641588689,0.00422694288138275,-0.0265840722063791,-0.0100144561113587,1.5014871743468e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,24769,0.027179402689444,0.00628148818864124,0.0148676858397072,0.0394911195391809,1.51811420994735e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,29288,-0.00695896535937533,0.00161085177662237,-0.0101162348415552,-0.00380169587719548,1.56505022515201e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,24229,-0.0133309101713073,0.00308595769942999,-0.0193793872621901,-0.00728243308042454,1.56748369963821e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,0.0147121836124496,0.00341152653805575,0.00802559159786036,0.0213987756270389,1.61961355904494e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,24101,-0.0102830549455036,0.00238931779944942,-0.0149661178324244,-0.00559999205858271,1.68584387845101e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,24381,0.034623547288064,0.0080558788213444,0.018834024798229,0.0504130697778991,1.73074644450947e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,0.016407594347882,0.00383228141507645,0.00889632277433213,0.0239188659214318,1.86401393107066e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,0.0260135091552716,0.0060860714688949,0.0140848090762376,0.0379422092343056,1.92368058343654e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,0.0137522748467294,0.00321846936995327,0.00744407488162095,0.0200604748118378,1.93533969298026e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,28931,0.0172135674344969,0.00404112427398314,0.00929296385748991,0.0251341710115038,2.05440981327141e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,28797,0.0226617895060822,0.00532592162446939,0.0122229831221222,0.0331005958900422,2.09710700799696e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,-0.0104518380220139,0.00246019631324431,-0.0152738227959728,-0.00562985324805511,2.15989869201063e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,29301,0.0202341573176729,0.00476367401341134,0.0108973562513867,0.0295709583839591,2.16744130295193e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,0.00974325301143606,0.00229736329190298,0.00524042095930622,0.0142460850635659,2.23146840490722e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,24922,0.0296921722434949,0.00702566169124607,0.0159218753286526,0.0434624691583372,2.38468108279543e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,-0.00782940818951773,0.00185303268764628,-0.0114613522573044,-0.00419746412173102,2.39454627363047e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,-0.00857261842514377,0.00203174350483135,-0.0125548356946132,-0.00459040115567433,2.45749892423761e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,28931,0.0106288560155216,0.00251913202877471,0.00569135723912313,0.01556635479192,2.45859226983741e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,29753,0.0157790727140519,0.00374776627297594,0.00843345081901904,0.0231246946090847,2.55825424861309e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,28845,0.0132504716212146,0.00315916639080832,0.00705850549523026,0.0194424377471989,2.74540512178081e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,0.0294002294055385,0.00701516499123411,0.0156505060227196,0.0431499527883573,2.78601806239596e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,29121,0.0171314802988024,0.00409854226812576,0.00909833745327595,0.0251646231443289,2.92493857935897e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,29566,-0.0082396717890796,0.00197334517939697,-0.0121074283406977,-0.00437191523746155,2.98204308901981e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,24445,-0.0110678252346972,0.00265207536758446,-0.0162658929551627,-0.00586975751423163,3.01297639431696e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,29311,0.0104116738744332,0.00249631231277729,0.00551890174138972,0.0153044460074767,3.04376097383425e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCT,Secretin,24195,0.0140576447226037,0.00337296656404159,0.00744663025708223,0.0206686591881253,3.08705041328044e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,0.0173114846484631,0.00416073363847566,0.00915644671705078,0.0254665225798754,3.18199906224088e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,29208,0.0135580309176782,0.00325944864827363,0.00716951156706193,0.0199465502682946,3.19704131612473e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,24195,0.0151738334008766,0.00365132965138856,0.008017227284155,0.0223304395175982,3.25406924939518e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,29434,-0.0147021268971781,0.00353826582744619,-0.0216371279189726,-0.00776712587538359,3.25951165738549e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,24016,0.0182895173389098,0.00441095827684293,0.00964403911629764,0.0269349955615219,3.38930289246722e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,0.0215652702140932,0.00520408383696501,0.0113652658936418,0.0317652745345446,3.42578734256626e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,29478,-0.0113879114829177,0.00274870579165815,-0.0167753748345677,-0.00600044813126777,3.43734963433951e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,29478,0.0226036319463274,0.00546159014103824,0.0118989152698925,0.0333083486227623,3.50319496413536e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,29566,0.00945446274877559,0.00228827566533229,0.0049694424447243,0.0139394830528269,3.61084848628786e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MB,Myoglobin,29820,0.0155210188541568,0.00375773130065986,0.0081558655048635,0.0228861722034501,3.63083285587836e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,29328,0.0126029572438646,0.00306668946318532,0.00659224589602135,0.0186136685917078,3.9737154955587e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,24240,0.0282235083357058,0.00687667734922402,0.0147452207312267,0.0417017959401848,4.06980381291082e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",24111,-0.0140619287496943,0.00344090942905026,-0.0208061112306328,-0.00731774626875578,4.38988410232818e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,0.0125578705254625,0.00307505199025899,0.00653076862455489,0.0185849724263701,4.44233306547542e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,29478,-0.00515446907151283,0.00126266499189534,-0.0076292924556277,-0.00267964568739796,4.47262211198194e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,0.025751045419688,0.00630885322761382,0.0133856930935649,0.0381163977458111,4.48462949865539e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,24111,0.0129322388035431,0.00316920254550591,0.00672060181435152,0.0191438757927347,4.50647450510143e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,24229,0.00901602174300745,0.00221396744837427,0.00467664554419389,0.013355397941821,4.66916980146788e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,29349,0.021201498607909,0.00521879981944551,0.0109726509617958,0.0314303462540222,4.86711781825352e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,29725,-0.0174743312129682,0.00430619112498064,-0.0259144658179303,-0.00903419660800619,4.9630743603647e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,0.00663245704993766,0.00163495645214104,0.00342794240374122,0.00983697169613409,4.99316580168799e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,28931,0.0194276784801725,0.00479172891234241,0.0100358898119813,0.0288194671483636,5.03905157414976e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPL,Periplakin,24229,0.00950732316589017,0.00234940741730952,0.00490248462796352,0.0141121617038168,5.21082006135481e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,0.0118053713982003,0.00292363939079224,0.00607503819224753,0.0175357046041531,5.4097125646403e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,28797,0.0126552150877296,0.00313670043293836,0.00650728223917039,0.0188031479362888,5.4845221790044e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,28774,0.0103728568697272,0.00257421792765615,0.00532738973152112,0.0154183240079332,5.60350674010812e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,24845,0.0110891326573781,0.00275550292380048,0.00568834692672917,0.016489918388027,5.73000391220189e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,29725,-0.0172130727800896,0.00428038545467523,-0.025602628271253,-0.00882351728892616,5.80001093795841e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,24381,-0.00738380064091644,0.00183634492010583,-0.0109830366843239,-0.00378456459750903,5.81451683802288e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,-0.0108788132510314,0.00270912124637118,-0.0161886908939189,-0.00556893560814387,5.94415703862191e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,29434,0.0159777992267137,0.00399545481983938,0.00814670777982856,0.0238088906735989,6.37676445943477e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,24101,0.0243499967963582,0.00609678529916957,0.0124002976099858,0.0362996959827305,6.51861345674319e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,29820,0.00909848086406793,0.00228030894011872,0.00462907534143525,0.0135678863867006,6.62252724525745e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,29694,0.0186573298048988,0.00468364879379953,0.00947737816905171,0.0278372814407459,6.80687090596433e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFP,Properdin,24966,0.00658716185760883,0.00165375484358302,0.00334580236418611,0.00982852135103154,6.81992499654936e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,-0.0199053236696096,0.0049986866861522,-0.0297027495744679,-0.0101078977647513,6.84712871575937e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,0.0249038219176958,0.00625762040902172,0.0126388859160132,0.0371687579193783,6.91843166255368e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,0.00817584061610061,0.00205588707345586,0.00414630195212711,0.0122053792800741,7.00487373736994e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,-0.00647802652527798,0.00163143472818595,-0.00967563859252245,-0.00328041445803351,7.18152770095543e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,29199,-0.0361717590807423,0.00912624362442563,-0.0540591965846165,-0.018284321576868,7.40382628580535e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,29349,0.0118698247826042,0.00299794263011679,0.0059938572275753,0.0177457923376331,7.5339583895792e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,24867,0.022031305334826,0.00557082264547356,0.0111124929496978,0.0329501177199542,7.68216033685722e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,24111,-0.0117310643556653,0.00297089099528872,-0.0175540107064312,-0.00590811800489942,7.88103448405432e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,24111,-0.00782480808015642,0.00198366781245184,-0.011712796992562,-0.00393681916775081,8.01541650935028e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,24938,0.0173562185536286,0.00440095241510802,0.00873035182001686,0.0259820852872403,8.04394963960082e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,29349,0.0151040012012,0.00383335422207765,0.0075906269259278,0.0226173754764722,8.1618248361963e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,29443,-0.00950578607652124,0.00241502809796563,-0.0142392411485339,-0.00477233100450861,8.30076983807767e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,24951,0.0204442178055964,0.00521782852027731,0.0102172739058528,0.0306711617053399,8.94703242120752e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,24111,-0.0156103324697099,0.00398960265015838,-0.0234299536640203,-0.00779071127539945,9.15001010144893e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,0.00989244880302728,0.00252999225347377,0.0049336639862187,0.0148512336198359,9.24796873624178e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,24069,0.0275524579773274,0.00706525149861362,0.0137045650400447,0.0414003509146101,9.65680337146195e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,28671,0.0132151064084018,0.0033982881249985,0.00655446168340474,0.0198757511333989,0.00010098741649572
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,0.017391764229679,0.00447699792752363,0.00861684829173267,0.0261666801676253,0.000102723750096963
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,0.0136137741368366,0.00350966784245717,0.00673482516562055,0.0204927231080527,0.000105142609274496
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,24111,-0.011670930713064,0.00301748384883368,-0.017585199056778,-0.00575666236934994,0.000110124239744567
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,24615,0.0178270887896993,0.00461406793750459,0.00878351563219035,0.0268706619472083,0.000111997065872196
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,0.0149284073071143,0.00386685457769404,0.00734937233483397,0.0225074422793946,0.00011339965372668
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,28774,0.00927792531937713,0.0024043728353875,0.00456535456201764,0.0139904960767366,0.000114207116261185
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,0.0246761791146146,0.00639476183344798,0.0121424459210566,0.0372099123081726,0.00011423339712584
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,-0.00717869945446463,0.00186243919268145,-0.0108290802721203,-0.00352831863680899,0.000116285669358564
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,0.00785857141004919,0.0020391275891406,0.00386188133533361,0.0118552614847648,0.000116504042267329
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,29343,0.0299272012847377,0.00778008432909,0.0146782359997213,0.0451761665697541,0.000120000824038548
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,29157,-0.00774510177273471,0.00201685320687878,-0.0116981340582171,-0.0037920694872523,0.000123198538842885
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,24515,0.003753627825074,0.000977502491961946,0.00183772294082859,0.00566953270931942,0.000123334387438662
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,24016,0.0116172007674909,0.00303948170251624,0.00565981663055904,0.0175745849044227,0.000132654203974506
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,28443,0.00982725919908942,0.00257205834376573,0.00478602484530858,0.0148684935528703,0.00013331528138412
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,24445,0.0160035185200468,0.00418905354578077,0.00779297357031646,0.0242140634697771,0.000133609214964126
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,24445,0.0120387754975595,0.00315815610599351,0.00584878952981226,0.0182287614653068,0.000138205570135275
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,24845,0.0655104894977688,0.017190552620185,0.0318170063622062,0.0992039726333314,0.000138827921033438
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,24381,0.0209485541860574,0.00551179003048324,0.0101454457263103,0.0317516626458046,0.000144650169841532
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,0.00948823373252172,0.00249717249152222,0.00459377564913818,0.0143826918159053,0.000145227780042735
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,0.0130312406715405,0.0034355678431315,0.00629752769900276,0.0197649536440782,0.000149120107713554
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,29478,0.0182945364896473,0.00483669390042647,0.00881461644481144,0.0277744565344832,0.000155601190161228
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",29395,0.0296002678259555,0.00783473243903792,0.0142441922454411,0.0449563434064698,0.000158352077233786
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,-0.00802654322826014,0.002124707431608,-0.0121909697942118,-0.00386211666230846,0.000158651341224198
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,24793,0.0139558531478634,0.00369448852923728,0.00671465563055837,0.0211970506651685,0.000158794156333021
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,0.0248314139980132,0.00657515967394387,0.0119441010370832,0.0377187269589431,0.000159386446318042
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,-0.0101750020290493,0.00270901756012004,-0.0154846764468846,-0.00486532761121402,0.000173074240040109
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,24938,0.0125790000796714,0.00335666165625277,0.00599994323341597,0.0191580569259268,0.00017902768065076
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,24867,0.0185373537154014,0.00495210158036828,0.00883123461787956,0.0282434728129232,0.000182006033388793
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,28931,-0.00814084216500146,0.00217661698168495,-0.012407011449104,-0.00387467288089897,0.000184276044021358
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,24101,-0.00754450246097639,0.00202586352850696,-0.01151519497685,-0.00357380994510275,0.000196466154572452
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,21656,0.0281823351997393,0.00757017455192316,0.0133447930779699,0.0430198773215087,0.00019751561128804
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,29725,0.0160682522635435,0.00431783327245713,0.00760529904952754,0.0245312054775595,0.000198510519842168
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,24793,-0.029779961140706,0.00802360463480895,-0.0455062262249315,-0.0140536960564804,0.000206449601611582
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,24111,-0.0107511296214757,0.00289965690304809,-0.01643445715145,-0.00506780209150146,0.000209598492618719
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,-0.00915537172594334,0.00247076451171075,-0.0139980701688964,-0.00431267328299027,0.00021146167024128
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,24867,0.0158680444298139,0.00428686720329081,0.00746578471136393,0.0242703041482639,0.000214750891577725
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,29820,-0.00419235941763296,0.00113505882534435,-0.00641707471530789,-0.00196764411995803,0.000221568396411759
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,24240,0.0127601423204049,0.00345763238618892,0.00598318284347466,0.0195371017973352,0.000224367699588582
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,29478,0.00756102115306214,0.00205252020033662,0.00353808156040236,0.0115839607457219,0.000230216774916825
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,0.00567150629768552,0.00154076294000942,0.00265161093526706,0.00869140166010398,0.000232838452316426
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,-0.0166357039818187,0.00453520324681455,-0.0255247023455752,-0.00774670561806216,0.000244857412426996
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,24845,0.0254732249190174,0.00694733651157919,0.0118564453563222,0.0390900044817127,0.000246292730186066
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,0.0167147453220643,0.00456284469022913,0.00777156972921521,0.0256579209149134,0.00024958313969113
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,24938,-0.00633973619722832,0.00173246038692118,-0.00973535855559383,-0.00294411383886282,0.000253344641089064
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,29434,0.0160067457735265,0.00439607340755528,0.00739044189471819,0.0246230496523349,0.000271892416504507
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,29594,0.0121487008483955,0.00333738204618887,0.0056074320378653,0.0186899696589257,0.000272902344974651
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,24016,-0.00917887632764502,0.00252242188780816,-0.014122823227749,-0.00423492942754103,0.000274364409683973
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',24111,0.0112554382828367,0.00309362560632822,0.00519193209443336,0.01731894447124,0.000275050985739041
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,24805,0.020902159853494,0.00576285305436779,0.00960696786693313,0.0321973518400549,0.0002872520920023
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,24445,0.00760679304095765,0.00210287336600956,0.00348516124357892,0.0117284248383364,0.000298254119862696
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,29820,-0.00900057438435562,0.00248987543147346,-0.0138807302300436,-0.00412041853866763,0.000300994106641723
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,29283,0.00991907435420288,0.00275066151769135,0.00452777777952784,0.0153103709288779,0.00031138761675727
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,24445,-0.00725159888150099,0.00203229922517158,-0.0112349053628373,-0.00326829240016469,0.000360164827503345
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,24966,0.00662777267697093,0.00185863685069216,0.0029848444496143,0.0102707009043276,0.000363243321367748
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,24101,-0.0231851218185689,0.00650475096355222,-0.0359344337071313,-0.0104358099300066,0.000365483076969661
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,24833,0.006595524098624,0.00185565544226299,0.00295843943178853,0.0102326087654595,0.000379715391644606
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,24111,-0.00918223180211354,0.0025940007816368,-0.0142664733341217,-0.00409799027010542,0.000401191831674773
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VIM,Vimentin,28916,0.0295471800670126,0.00835669986205004,0.0131680483373946,0.0459263117966307,0.000407259119282077
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,29694,-0.00794529936720605,0.00225250196023209,-0.0123602032092609,-0.00353039552515116,0.000420419719824253
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,28797,0.00894956052607203,0.00254588798102926,0.00395962008325468,0.0139395009688894,0.000439932107721014
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,29581,-0.00718824104385172,0.00204612320761622,-0.0111986425307795,-0.00317783955692393,0.000443567149948664
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,0.00653145321783991,0.0018661710102443,0.00287375803776109,0.0101891483979187,0.000466206165690155
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,24111,0.00966902948325975,0.00276541981499261,0.00424880664587424,0.0150892523206453,0.000472419583263338
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,24903,-0.00901273811568099,0.00258444155226075,-0.0140782435581121,-0.00394723267324993,0.000488754652571203
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,29378,0.0101657528425161,0.0029172977505499,0.00444784925143833,0.0158836564335939,0.000493505061050251
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,24381,0.00716148269327568,0.00205896016587385,0.00312592076816294,0.0111970446183884,0.000505667065881854
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,28931,0.00882438008308294,0.00254144318617639,0.00384315143817722,0.0138056087279887,0.000516979978866634
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,29242,-0.0123193073030167,0.0035538842871248,-0.0192849205057813,-0.00535369410025211,0.000528167580024408
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,24938,0.0135419812193352,0.00390689128504507,0.00588447430064682,0.0211994881380235,0.000528802300087751
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,24445,-0.00845984074315517,0.00244338788370992,-0.0132488809952266,-0.00367080049108372,0.000536415413496472
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,28650,0.00756156316934043,0.00218540334951628,0.00327817260428852,0.0118449537343923,0.000540899680400202
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,-0.00788121793154265,0.00227898815176351,-0.0123480347089991,-0.00341440115408617,0.000544561669473389
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,24016,-0.00751169877853507,0.00217584242687305,-0.0117763499352063,-0.00324704762186389,0.000556750876706541
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,28931,0.014682538497048,0.00426386636541283,0.00632536042083886,0.0230397165732572,0.000575092374831059
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,28774,0.0357795843764519,0.0104057540960355,0.0153843063482223,0.0561748624046815,0.000585899908151701
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,24867,0.0169917453160352,0.00494639207847421,0.00729681684222577,0.0266866737898447,0.000593128242599547
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,-0.010417222044313,0.00303743603133281,-0.0163705966657253,-0.00446384742290069,0.000605429792700356
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,0.00950133235277243,0.00277187303540071,0.00406846120338703,0.0149342035021578,0.00060958151169022
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,29434,0.0159718223339586,0.00466927722978449,0.00682003896358098,0.0251236057043362,0.000625634393818441
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,28722,0.015091748414426,0.00441400475211023,0.00644029910028991,0.023743197728562,0.000629250937953421
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,0.0137326369439042,0.00402154784014346,0.00585040317722305,0.0216148707105854,0.000639393453981731
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,24938,0.02150072697886,0.00630041002057523,0.00915192333853254,0.0338495306191874,0.000644505206051744
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,-0.0074889743246029,0.0021990336301934,-0.011799080239782,-0.00317886840942384,0.000661329485567239
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,24195,0.0159859440617083,0.00469605987204656,0.00678166671249703,0.0251902214109195,0.000664856776671823
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,28931,0.0141997209519901,0.00417161575328338,0.00602335407555464,0.0223760878284255,0.000665236317262678
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,29114,0.0254399032540198,0.00747722555448174,0.0107845411672356,0.040095265340804,0.00066906620661455
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,28733,-0.00698450849855548,0.00205331680768551,-0.0110090094416191,-0.00296000755549187,0.000670903369691422
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",24922,0.0169731599637315,0.00501746596323555,0.00713892667578977,0.0268073932516731,0.000718573232491479
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,29581,0.00683407913289664,0.00202119996323223,0.00287252720496148,0.0107956310608318,0.000722636739102126
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,24793,0.0108721973847256,0.00321659533452838,0.00456767052905,0.0171767242404012,0.00072588992960669
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,24229,0.00495130437190604,0.00146580666706333,0.00207832330446191,0.00782428543935016,0.000731646237870343
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,24101,-0.0152769918495807,0.00452410601248125,-0.0241442396340439,-0.00640974406511742,0.000734508470601502
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,29761,0.0144951141366188,0.00429813844393399,0.00607076278650814,0.0229194654867294,0.000746065280124607
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,0.0172622040515982,0.00512632385475463,0.00721460929627914,0.0273097988069173,0.000760052277486662
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,29820,0.0149094099637198,0.00443501129914895,0.00621678781738791,0.0236020321100518,0.000775468515195332
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,24867,0.0107437699509967,0.00319956520402259,0.00447262215111243,0.017014917750881,0.000786593285429879
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,24867,0.0150258263786325,0.00447873361902442,0.00624750848534466,0.0238041442719204,0.000795045425198019
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,-0.0148147757478222,0.00442097561974979,-0.0234798879625318,-0.00614966353311265,0.000806383431604175
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,0.00535901060259234,0.00160113506186779,0.00222078588133147,0.00849723532385321,0.000817928603193339
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,29694,0.00558246600829727,0.00166843709520892,0.00231232930168779,0.00885260271490675,0.000821101537402748
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,0.00769830540821374,0.00231229570852072,0.00316620581951313,0.0122304049969144,0.000871939461135663
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,0.00671649339678962,0.00202177420166692,0.00275381596152245,0.0106791708320568,0.000894816210054607
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,0.00868622241421728,0.0026226660348148,0.00354579698598028,0.0138266478424543,0.000927719254565989
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,-0.0139223028851669,0.0042192466005956,-0.0221920262223343,-0.00565257954799954,0.000969241502432011
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,29388,-0.011353579198488,0.00344427275991825,-0.0181043538079278,-0.00460280458904823,0.000980608875284891
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,24101,-0.0225825357973823,0.00688123816189075,-0.0360697625946881,-0.00909530900007642,0.00103310026338425
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,-0.00742454923566577,0.00226812855738047,-0.0118700812081315,-0.00297901726320006,0.00106402141323274
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,24229,0.0180637262096532,0.00552122438416585,0.00724212641668813,0.0288853260026183,0.00107056838976818
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,29433,0.0113216998936621,0.00346081931980513,0.00453849402684403,0.0181049057604801,0.0010714226290086
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,24951,0.00611704157839386,0.00188431022187602,0.00242379354351686,0.00981028961327086,0.00117068698966294
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,-0.00859426564251191,0.00265294195931494,-0.0137940318827692,-0.00339449940225463,0.00119891338906557
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,24111,-0.00931358866834882,0.00288610652370684,-0.0149703574548142,-0.00365681988188342,0.00125243948197745
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,29820,-0.00944024777445403,0.00293279763096835,-0.015188531131152,-0.00369196441775605,0.00128841647388215
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,24845,0.00767170640795723,0.00238718837481825,0.00299281719331345,0.012350595622601,0.00131203985061331
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,24229,0.00862456503571416,0.0026913309229182,0.00334955642679448,0.0138995736446338,0.00135438482637599
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,-0.0117148312536904,0.00365569234039798,-0.0188799882408704,-0.00454967426651033,0.00135452187251615
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,24793,0.0142125717912967,0.0044351751567672,0.00551962848403293,0.0229055150985604,0.00135462965530109
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,29786,0.00958096800379679,0.00299320630135602,0.00371428365313899,0.0154476523544546,0.00137140607168248
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,29443,-0.00774429561791646,0.00242675035947221,-0.012500726322482,-0.00298786491335092,0.0014182181205812
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",29725,0.016719484508409,0.00524537952707941,0.00643854063533338,0.0270004283814847,0.00143672445579507
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,28745,0.0128459104740782,0.00403300753048561,0.00494121571432636,0.02075060523383,0.00144811579168177
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,29594,-0.0133162413820638,0.00418149196791765,-0.0215119656391824,-0.00512051712494517,0.00145120990454989
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,24845,0.00617053704329064,0.00194130576549662,0.00236557774291726,0.00997549634366402,0.00148195275376931
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,24922,-0.00786951825184599,0.00248962387687394,-0.0127491810505189,-0.00298985545317306,0.00157456481351356
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,29566,-0.00852341842831268,0.00269814291181447,-0.013811778535469,-0.00323505832115632,0.00158473947585845
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,29473,-0.00880522163509475,0.00279334638322054,-0.014280180546207,-0.00333026272398249,0.00162200660805062
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,24195,-0.00835282004357981,0.00265704481568025,-0.0135606278823131,-0.00314501220484652,0.00167056359794651
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,24101,-0.00969445850141717,0.0030851467669863,-0.0157413461647103,-0.00364757083812403,0.00167828975647586
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,29566,0.00490865723559484,0.00156361789401981,0.00184396616331602,0.00797334830787367,0.00169521756295646
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERVV_1,,24111,-0.0103934285451714,0.00332163370451918,-0.016903830606029,-0.00388302648431384,0.00175604883366604
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,29327,0.0132384051769701,0.00424440439320281,0.00491937256629258,0.0215574377876476,0.00181626105477494
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,0.0177185820487684,0.0056828288310593,0.00658023753989214,0.0288569265576446,0.00182314277883353
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,29478,0.00896265227210076,0.00288048137008901,0.00331690878672631,0.0146083957574752,0.001863097518419
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,28931,0.0111741966757169,0.00359192996349497,0.00413401394726671,0.018214379404167,0.00186688661709486
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,24229,-0.00968977779945117,0.00312226330617245,-0.0158094138795492,-0.00357014171935317,0.00191500939294363
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,29632,0.0136618429719357,0.00440390640820842,0.00503018641184718,0.0222934995320242,0.00192262135842601
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,24111,-0.0160516540063596,0.00519291417491241,-0.0262297657891879,-0.00587354222353128,0.00199664965609875
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,24801,0.00851624119308093,0.00275860430629054,0.00310937675275148,0.0139231056334104,0.00202304654924545
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,29349,0.00481104502723235,0.00155876314837175,0.00175586925642372,0.00786622079804097,0.00202750480234317
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,-0.00879049797977416,0.00284933073553013,-0.0143751862214132,-0.0032058097381351,0.00203699811955233
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,0.0134605324215064,0.00436332668738763,0.00490841211422668,0.0220126527287862,0.0020379415214632
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,28797,0.00878881601908397,0.00285466906003822,0.00319366466140906,0.0143839673767589,0.00208065698889667
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,24793,0.00884853340678619,0.00287595529277681,0.00321166103294364,0.0144854057806287,0.00209514036362637
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,24793,0.0113643137288909,0.00369884219028487,0.00411458303593251,0.0186140444218492,0.00212577004988704
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,0.0201547526722899,0.00656194789069689,0.00729333480652402,0.0330161705380558,0.00213209907238284
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,28797,-0.0179642834620266,0.00585044343589891,-0.0294311525963885,-0.00649741432766474,0.00213838948619892
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,0.00939264443688347,0.00307643262390619,0.00336283649402734,0.0154224523797396,0.00226733319471368
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,24793,0.0115652131053889,0.00379306464961892,0.00413080639213584,0.018999619818642,0.00229814572036946
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,24111,-0.00747900444387256,0.00245528237853901,-0.012291357905809,-0.0026666509819361,0.00232091065789118
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,28722,0.00789637113022647,0.00259278339876082,0.00281451566865526,0.0129782265917977,0.00232489643374289
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,24229,-0.00924869014553971,0.00303759077684601,-0.0152023680681579,-0.00329501222292153,0.00233127497621775
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,24381,0.00546683704762588,0.00180315046023145,0.00193266214557224,0.00900101194967953,0.00243335265408106
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,0.0144218598047464,0.00476071590011009,0.00509085664053059,0.0237528629689622,0.00245342686549489
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,-0.0061938258010586,0.00204560049154163,-0.0102032027644802,-0.002184448837637,0.00246493489354339
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,0.00870293200984604,0.00288229142450333,0.00305364081781952,0.0143522232018726,0.00253490997766185
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,29218,0.0102219612547435,0.0033929583054142,0.00357176297613167,0.0168721595333553,0.00259157579792083
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,24951,-0.00487202118725419,0.00161913249636352,-0.0080455208801267,-0.00169852149438169,0.00262343382505635
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,-0.0109211800830311,0.00363439088618084,-0.0180445862199455,-0.00379777394611665,0.002658457411666
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,0.0099025388234371,0.00329632359313123,0.0034417445808999,0.0163633330659743,0.00266627261815769
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,0.00595099311543061,0.00198228638219034,0.00206571180633755,0.00983627442452368,0.00268367098367315
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,0.00912769463437515,0.00304187874926237,0.00316561228582091,0.0150897769829294,0.00269610045994501
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,0.00795824169513119,0.00265409818798973,0.00275620924667132,0.0131602741435911,0.00271609971615769
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,24343,0.0124316688017661,0.00414834167041708,0.0043009191277486,0.0205624184757836,0.00273122369464392
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,0.0254574919232298,0.00850167299287135,0.00879421285720198,0.0421207709892577,0.00275205015275745
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,29478,0.00974202460725068,0.00325369322545727,0.00336478588535442,0.0161192633291469,0.00275444835271675
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,24381,0.00833227754714629,0.00278763336520075,0.00286851615135282,0.0137960389429398,0.00280157656773399
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,24111,0.00854896306098303,0.00286549447139505,0.00293259389704873,0.0141653322249173,0.0028533546084584
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,24421,0.00820043176889852,0.00275833147276617,0.00279410208227682,0.0136067614555202,0.00295222961793691
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,29694,0.00572646075491537,0.00192722270936377,0.00194910424456239,0.00950381726526836,0.00296727452410605
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,24111,-0.00996922382968818,0.0033603227062745,-0.0165554563339862,-0.00338299132539015,0.00301264888647318
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,0.0182195196008676,0.0061551362589362,0.00615545253335261,0.0302835866683825,0.00307887125781596
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,24101,-0.0125589752050067,0.00425190881781569,-0.0208927164879255,-0.00422523392208798,0.00314265598266213
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,0.0116418168412511,0.00394284232915861,0.00391384587610025,0.019369787806402,0.00315358142341333
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,24195,0.00708949826333993,0.00241297710868274,0.00236006313032176,0.0118189333963581,0.00330573060461174
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,0.00853676982669855,0.00291123432176134,0.00283075055604633,0.0142427890973508,0.00336719394127704
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,29218,-0.00253625217575389,0.000870878850393765,-0.00424317472252567,-0.000829329628982115,0.00359060409958182
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PALLD,Palladin,24229,-0.00831586618581998,0.00287155441431867,-0.0139441128378846,-0.0026876195337554,0.0037835571090948
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,24445,-0.00866459399337384,0.00299473320145904,-0.0145342710682336,-0.00279491691851412,0.00381581250337093
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,0.0140376096840757,0.00485585202527475,0.0045201397145372,0.0235550796536142,0.00384461579723821
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,24111,-0.0123203488561738,0.00426181874910702,-0.0206735136044236,-0.00396718410792405,0.00384524468558852
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,28774,-0.00677792391420892,0.00234924093325159,-0.011382436143382,-0.00217341168503581,0.00391511821227581
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,24867,0.00528399378126755,0.00183691379250998,0.00168364274794799,0.0088843448145871,0.00402376976736651
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,29293,0.0114991193345998,0.00401365898611508,0.00363234772181426,0.0193658909473854,0.00417310419466803
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,0.0133724152389442,0.00466756388841426,0.00422399001765226,0.0225208404602361,0.00417408663077887
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,24548,-0.00167051354046328,0.000583892929940127,-0.00281494368314593,-0.00052608339778063,0.00422673258968155
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,29349,-0.00429842873451854,0.00150828757892268,-0.007254672389207,-0.00134218507983009,0.00437670949913883
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,29132,-0.013867189390357,0.00486644726628634,-0.0234054260322782,-0.00432895274843578,0.00438117082763623
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,24101,-0.00720945380937122,0.00253031241222347,-0.0121688661373292,-0.00225004148141322,0.00438616976084488
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,0.00807113805186124,0.00283458745609875,0.00251534663790768,0.0136269294658148,0.00441184442672998
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,29725,-0.00667411263924381,0.00235439342800115,-0.0112887237581261,-0.00205950152036156,0.00458927540570914
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,24229,0.00793566712784958,0.00280531555184239,0.0024372486462385,0.0134340856094607,0.00467617700737683
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,-0.0106823257363479,0.00377846604311247,-0.0180881191808483,-0.00327653229184741,0.00470016395214837
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,28872,0.0113823662515973,0.00403111268655887,0.00348138538594194,0.0192833471172527,0.00475158481853353
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,-0.00649134935692729,0.00230127806336281,-0.0110018543611184,-0.00198084435273618,0.00479494426510161
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,29662,0.0128575926230597,0.0045607068179031,0.00391860725996963,0.0217965779861498,0.00481738434595595
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,24445,-0.00697461373033517,0.00247395757972465,-0.0118235705865955,-0.00212565687407486,0.00481802643648257
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,24845,-0.00799739450664609,0.00283870861636075,-0.0135612633947131,-0.00243352561857902,0.00484727784055801
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,24793,0.0105976265450279,0.00376638434268018,0.00321551323337477,0.0179797398566811,0.00490073723269094
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,0.0149303844421904,0.00530788711550787,0.00452692569579496,0.0253338431885858,0.00491402698931158
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,29594,-0.00556608910185206,0.00197897837772918,-0.00944488672220125,-0.00168729148150287,0.00491739919404219
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,29169,-0.00926665957621313,0.00331026050286201,-0.0157547701618227,-0.00277854899060359,0.00512353239963367
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,0.00875813202988267,0.00313784428818807,0.00260795722503405,0.0149083068347313,0.00525589241019466
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,24016,-0.00624607349593519,0.00223813772228529,-0.0106328234316144,-0.00185932356025603,0.00526282595204317
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,28931,0.00988005816077071,0.00354185295820496,0.00293802636268899,0.0168220899588524,0.00528212939484901
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,24111,-0.00770500367066435,0.00276663805775299,-0.0131276142638602,-0.00228239307746849,0.00535744702102154
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,28797,0.0151902602405335,0.00545935590489683,0.00448992266693571,0.0258905978141313,0.00539891045534744
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,24195,0.00975417596938996,0.0035074202457311,0.00287963228775699,0.0166287196510229,0.00542317465062395
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,24016,-0.00932473529449051,0.00336840868363581,-0.0159268163144167,-0.00272265427456431,0.00563943266845934
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,24016,-0.00518183456539475,0.00187226959045693,-0.00885148296269033,-0.00151218616809917,0.00565008994382394
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,-0.00617535091366416,0.00224504263977332,-0.0105756344876199,-0.00177506733970845,0.00595121887384002
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,0.00752357926591792,0.00273754482941572,0.00215799140026311,0.0128891671315727,0.00599505982260293
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,0.00934015324612763,0.00340818733008644,0.00266010607915821,0.016020200413097,0.00613888459228957
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,24445,-0.00561939286946373,0.00205759193894062,-0.00965227306978735,-0.00158651266914012,0.0063177587833611
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,28916,0.0112537620543823,0.0041217619976651,0.00317510853895868,0.0193324155698059,0.00633096779320704
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",24111,0.00778625112414132,0.00286353643852374,0.0021737197046348,0.0133987825436478,0.00655060471078209
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,0.0150419787877995,0.00554373304706415,0.00417626201555373,0.0259076955600452,0.00666503012786169
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,24101,-0.0096185573710087,0.00354790302538636,-0.016572447300766,-0.00266466744125144,0.00671171959647189
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,24845,0.00546759603656597,0.00201987693543584,0.00150863724311172,0.00942655483002023,0.00679620397488483
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,24111,-0.00856312703865118,0.00317516712578238,-0.0147864546051846,-0.00233979947211771,0.00700356966735317
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,24445,-0.00753317272602437,0.00280790734426297,-0.0130366711207798,-0.00202967433126894,0.00730485232478833
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,24195,-0.00828936188263793,0.00310230426902974,-0.0143698782499362,-0.00220884551533964,0.00754508272827909
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,0.00598450691304783,0.00224301492676283,0.00158819765659269,0.010380816169503,0.00763405588999848
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,0.00934835141813504,0.00350899348254661,0.00247072419234369,0.0162259786439264,0.00772416763119832
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,24805,-0.0089088230089746,0.00334707378088746,-0.015469087619514,-0.00234855839843518,0.00778030109454511
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,24502,0.00814812073475768,0.00306263968258501,0.00214534695689105,0.0141508945126243,0.0078078004272912
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,24101,-0.00910705083282695,0.00342316850251453,-0.0158164610977554,-0.00239764056789848,0.00780959863033445
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,29426,-0.0126368712783066,0.0047533359356403,-0.0219534097121616,-0.00332033284445163,0.00785255607780967
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,23603,-0.0133768368628951,0.00503400828137347,-0.0232434930943871,-0.00351018063140306,0.00788239187593938
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,0.0102703547099607,0.00386775806956192,0.0026895488936193,0.017851160526302,0.00792635378537314
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,0.00864205752561042,0.00325850848118168,0.00225538090249432,0.0150287341487265,0.00800232121671238
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,-0.0070868162769967,0.00267212028228732,-0.0123241720302799,-0.00184946052371355,0.00800375899163307
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,29646,0.00430188146919918,0.00162473505177905,0.00111740076771223,0.00748636217068613,0.00810739034890893
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,0.00564611870639814,0.00213262726337386,0.00146616927018539,0.0098260681426109,0.00811418687480153
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,24845,-0.0143242215949315,0.00542111702085463,-0.0249496109558066,-0.00369883223405644,0.00823965352478854
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,28797,-0.0104366951453529,0.00396590284329409,-0.0182098647182093,-0.00266352557249649,0.00850275743292858
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,0.00527922901776314,0.0020151554161082,0.00132952440219108,0.00922893363333521,0.00880442854143879
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,0.00527369850924613,0.00201371156273723,0.00132682384628115,0.0092205731722111,0.00882600737224081
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CGN,Cingulin,24195,0.00750790387774403,0.00287296217074112,0.00187689802309144,0.0131389097323966,0.00897288106756281
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,29341,0.0134795019239959,0.00515811952681184,0.00336958765144471,0.0235894161965471,0.00897291026882614
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,24951,0.0052978568187057,0.00203738662066101,0.00130457904221012,0.00929113459520129,0.00931918414780643
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,24240,0.0131993075596887,0.00507999115526419,0.00324252489537085,0.0231560902240065,0.00937451180556972
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,0.0201747873865078,0.00778315898380512,0.00491979577824974,0.0354297789947658,0.00954486230072166
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,24805,0.0127106653387862,0.00494011784951764,0.0030280343537316,0.0223932963238407,0.0100894025913969
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,24793,-0.0106624561756444,0.00415903693754615,-0.0188141685732348,-0.00251074377805392,0.0103626254763307
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,24016,-0.0048302892150441,0.00188464915368574,-0.00852420155626815,-0.00113637687382005,0.0103843008663924
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,29674,0.0122406295429442,0.00478006271757543,0.00287170661649637,0.0216095524693921,0.0104490247028324
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,24016,0.013326995289928,0.00524740504771333,0.00304208139640985,0.0236119091834461,0.0111000393217463
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,24240,0.00416656661051038,0.00164260191320028,0.000947066860637821,0.00738606636038294,0.0112008166307454
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,24938,0.00791225922813897,0.00312120462458678,0.00179469816394888,0.0140298202923291,0.0112507379971971
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,-0.00746398760339001,0.00294706772877266,-0.0132402403517844,-0.0016877348549956,0.0113255563442706
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,29349,0.00366876058500037,0.00145528897109979,0.000816394201644791,0.00652112696835595,0.0117079648019741
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,24845,-0.00480296698341593,0.00190576078811899,-0.00853825812812914,-0.00106767583870271,0.0117338329919829
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,29497,0.00433347773437133,0.0017258090178495,0.000950892059386302,0.00771606340935635,0.0120448420923843
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,0.00792382543686299,0.00316085403401068,0.00172855153020205,0.0141190993435239,0.0121873167988726
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,0.0088044148725607,0.00351861536110649,0.00190792876479198,0.0157009009803294,0.0123464428609063
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,0.00952779677843846,0.0038515368813656,0.00197878449096189,0.017076809065915,0.0133754889792262
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,29216,0.00915355644988563,0.00370496273803099,0.0018918294833449,0.0164152834164264,0.0134935583576857
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,24229,-0.00780290723598142,0.00315843085217947,-0.0139934317062532,-0.00161238276570965,0.0134992215803544
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,29349,0.00576747238610025,0.0023364441198304,0.00118804191123267,0.0103469028609678,0.0135743707824788
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,28797,0.00721943115802909,0.00292677324147962,0.00148295560472904,0.0129559067113291,0.013642761244019
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,29443,0.00560292615737835,0.00227218264408791,0.00114944817496606,0.0100564041397906,0.0136734313917899
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,0.0148051282334411,0.00603918557524512,0.00296832450596062,0.0266419319609215,0.0142316997522192
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,24016,-0.00815419344838153,0.00334265886636951,-0.0147058048264658,-0.00160258207029728,0.014717507796292
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,-0.00756134246313461,0.00310471774358261,-0.0136465892405565,-0.0014760956857127,0.0148807990594828
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,24111,-0.00947221290195433,0.00389038011308968,-0.0170973579236101,-0.00184706788029855,0.0149081250828837
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,24195,0.00547998510417106,0.0022519789142551,0.00106610643223107,0.00989386377611106,0.0149646015535471
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,29581,0.00582209023599784,0.00239308308425429,0.00113164739085943,0.0105125330811363,0.0149850443436365
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,24951,-0.0104707589790295,0.00431809189383705,-0.0189342190909501,-0.00200729886710891,0.0153214379024233
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,-0.0102885612961746,0.00424587924404142,-0.0186104846144958,-0.00196663797785341,0.0153923062767503
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,24867,0.00528346646286393,0.0021815260211822,0.00100767546134682,0.00955925746438104,0.0154461484072484
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,24793,-0.00905846983920556,0.0037420887153136,-0.0163929637212202,-0.0017239759571909,0.0154978436725673
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,24229,-0.00592101020028561,0.00244892465351648,-0.0107209025211779,-0.00112111787939331,0.0156219865686805
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,24805,0.00533027527167299,0.00221321322721361,0.000992377346334316,0.00966817319701166,0.0160304100367195
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,-0.00711566716041989,0.00297069932853842,-0.0129382378443552,-0.00129309647648458,0.016615105575174
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,0.00767150466966567,0.00320495111166618,0.00138980049079995,0.0139532088485314,0.0166895990654748
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,0.00467260256218004,0.00195518208849611,0.000840445668727655,0.00850475945563242,0.0168613725181225
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,24229,0.00627260409610008,0.00262961843430321,0.00111855196486579,0.0114266562273344,0.0170697498658963
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,24793,0.00631280012619786,0.00264733852690334,0.00112401661346731,0.0115015836389284,0.0171059370216708
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,24229,0.0069944899896051,0.00293695685262619,0.00123805455845776,0.0127509254207524,0.017247941912444
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,24240,0.00508681422204159,0.00213910207275323,0.000894174159445263,0.00927945428463793,0.0174138846940968
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,-0.00700242099527703,0.00294576578096548,-0.0127761219259694,-0.00122872006458468,0.0174549691166262
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,24867,0.00846772524449216,0.00357661912020666,0.00145755176888711,0.0154778987200972,0.0179152577591238
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,24195,0.00890219866537296,0.00376077448067564,0.00153108068324871,0.0162733166474972,0.0179350227489572
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",28916,0.0142846519377459,0.00603785092964241,0.00245046411564677,0.026118839759845,0.017995272389125
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,24016,0.00952755464775021,0.00402786970013914,0.0016329300354775,0.0174221792600229,0.0180181277897566
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,24729,0.00751962729449971,0.00318128899939461,0.00128430085568628,0.0137549537333131,0.0181009267474511
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,28674,0.00756267184028975,0.00321640302132576,0.00125852191849127,0.0138668217620882,0.0187155619273216
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,-0.0144028748923257,0.00613603112244842,-0.0264294958923246,-0.00237625389232681,0.0189187408336541
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,28931,0.00810700903867542,0.00346755799478903,0.00131059536888893,0.0149034227084619,0.0193961468286957
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,24914,0.00248103367350625,0.0010616187996754,0.000400260826142467,0.00456180652087003,0.0194455720157285
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,0.00498713160569015,0.00213560492905533,0.000801345944741697,0.0091729172666386,0.0195392355404031
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,24867,-0.00867993495408305,0.0037212663464007,-0.0159736169930284,-0.00138625291513769,0.0196811970954262
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,29218,0.00714529950763036,0.00307173506024031,0.00112469878955936,0.0131659002257014,0.0200176535884795
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,24805,0.0189358642043067,0.00814042695067278,0.00298062738098807,0.0348911010276254,0.020018504511374
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,0.0117206973818513,0.00507112270062428,0.00178129688862774,0.0216600978750749,0.0208266224103322
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,0.00496921331858624,0.00215160787522964,0.000752061883136144,0.00918636475403634,0.0209208827344651
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,29349,0.0311989260713813,0.0135443353996877,0.00465202868799349,0.0577458234547692,0.0212595544187993
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,29038,-0.0283077391140974,0.0123021061740573,-0.0524198672152497,-0.00419561101294505,0.0213959592477313
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,24229,-0.00766155230949869,0.00333288488590868,-0.0141940066858797,-0.00112909793311767,0.0215261956915269
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,24919,-0.018067409568539,0.00786274337238863,-0.0334783865784207,-0.00265643255865727,0.0215785417024851
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,24229,-0.00468305353282018,0.00203898390141051,-0.00867946197958478,-0.000686645086055583,0.0216410457067613
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,24240,-0.00655953303042394,0.00285616426135973,-0.012157614982689,-0.000961451078158876,0.0216487663938373
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,29218,0.00997607746502845,0.00436215821854954,0.00142624735667135,0.0185259075733856,0.0222053303594492
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,24229,-0.0169762937297508,0.00743076088020179,-0.0315405850549463,-0.00241200240455525,0.0223450812525642
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,-0.00364418483742706,0.00159627712788215,-0.00677288800807608,-0.000515481666778032,0.0224417455226905
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,24307,0.0137330503432933,0.00603163961825715,0.00191103669150927,0.0255550639950773,0.0228047156543856
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,28916,0.021837010449842,0.00959894983197999,0.0030230687791612,0.0406509521205227,0.0229169734770572
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,24938,-0.00821685651671072,0.00362146162635958,-0.0153149213043755,-0.00111879172904594,0.0232808653731295
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,24229,-0.00928778028647053,0.00409382601390615,-0.0173116792737266,-0.00126388129921447,0.023293595121817
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,24229,0.0104707675721178,0.00463179836381913,0.00139244277903232,0.0195490923652033,0.0237912149632602
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,-0.0040401087333502,0.00179346955415627,-0.00755530905949649,-0.000524908407203912,0.0242883934504875
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,24111,-0.00817862821945594,0.00364126556836729,-0.0153155087334558,-0.00104174770545605,0.0247069476916181
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,23970,-0.00658310252975425,0.00293559783194645,-0.0123368742803693,-0.000829330779139199,0.0249376476096515
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,0.00533853912839386,0.00238444248766952,0.000665031852561605,0.0100120464042261,0.0251711688793565
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,24922,-0.00476417574573028,0.0021281727234688,-0.00893539428372912,-0.000592957207731436,0.0251892730022549
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,28931,0.00763862326010544,0.00341247085601401,0.000950180382317966,0.0143270661378929,0.0251997251877172
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,0.0107395359275582,0.00480359894691547,0.00132448199160387,0.0201545898635125,0.0253785273501451
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,24101,-0.00548869509082651,0.00245789914714934,-0.0103061774192392,-0.000671212762413794,0.025552558920291
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,28797,0.00841130740118342,0.00376816508010539,0.00102570384417686,0.01579691095819,0.0256092473976824
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,24016,-0.00757121365967839,0.00339807870091414,-0.0142314479134701,-0.000910979405886681,0.0258839688160645
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,24951,0.00844882696614182,0.00379539393190748,0.00100985485960317,0.0158877990726805,0.0260181403274953
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,24229,-0.00930236176074687,0.00418868802242119,-0.0175121902846924,-0.00109253323680133,0.0263717305520606
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,24951,0.0041636619056709,0.00187553010700462,0.000487622895941854,0.00783970091539995,0.0264282650234106
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,24445,0.00698296862555194,0.00314652044299799,0.000815788557275874,0.013150148693828,0.0264777222749204
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLPS,Colipase,29400,-0.0112567371671468,0.00507429474427484,-0.0212023548659255,-0.00131111946836812,0.0265362355587619
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,24016,-0.00655687927073913,0.00295641526528205,-0.012351453190692,-0.000762305350786307,0.0265745338268741
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,24111,-0.00804717219656487,0.00362875647084876,-0.0151595348794284,-0.0009348095137013,0.0265906226448269
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,24845,0.00820861519554714,0.00370229492731128,0.000952117138017025,0.0154651132530772,0.0266205356993727
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,-0.00661159269356336,0.00299561454302844,-0.0124829971978991,-0.000740188189227617,0.0273170756730848
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,-0.00580186350403974,0.00262982404417279,-0.0109563186306184,-0.000647408377461076,0.0273790522041272
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,28797,0.00749241392449582,0.00339874535823671,0.000830873022351871,0.0141539548266398,0.0274995675319923
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,24229,0.00527530424536557,0.00239675345644566,0.00057766747073208,0.00997294101999906,0.0277439522731567
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,24966,0.00308243868353907,0.00140518719719012,0.000328271777046432,0.0058366055900317,0.0282723431204121
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,29169,-0.00527413317516773,0.00240719643009558,-0.00999223817815506,-0.000556028172180392,0.0284607071688893
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,29518,-0.00710064486267499,0.00324102247919229,-0.0134530489218919,-0.000748240803458103,0.028469309297388
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,24016,0.00462112322662552,0.00210987386612735,0.000485770449015916,0.00875647600423513,0.0285166598291039
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,24195,-0.00593534238375326,0.00271211539880716,-0.0112510885654153,-0.000619596202091235,0.0286460113243682
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,24195,0.0118582568739915,0.00542377308682406,0.00122766162381633,0.0224888521241666,0.0287996874948911
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,28931,-0.00517897588726024,0.00237159241713217,-0.0098272970248393,-0.000530654749681179,0.0289882917346941
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,0.00773424882597719,0.0035470002225416,0.000782128389795662,0.0146863692621587,0.0292294833066037
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,29349,0.00441522771697166,0.00203454507323849,0.000427519373424221,0.0084029360605191,0.0300049808391128
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,29434,-0.00728589310463673,0.00335793700783094,-0.0138674496399854,-0.000704336569288082,0.0300335575254992
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,24016,0.00969724560911372,0.00447599419411083,0.000924296988656493,0.0184701942295709,0.0302827363329859
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,28797,0.00715454070451902,0.00330650449967661,0.000673791885152873,0.0136352895238852,0.0304896140201445
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,29536,-0.00487967665951313,0.00225701620239836,-0.00930342841621391,-0.000455924902812347,0.0306259233838441
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,-0.00301451681177132,0.00139679754434002,-0.00575223999867776,-0.000276793624864888,0.0309246676623359
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,28774,0.00599797236120115,0.00277938046050383,0.000550386658613643,0.0114455580637887,0.0309341430778205
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,-0.0120636569267112,0.00559590510101107,-0.0230316309246929,-0.00109568292872951,0.0311090530219496
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,28774,-0.00544663393543597,0.00253037086251672,-0.0104061608259687,-0.000487107044903203,0.0313659569376045
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,-0.00508058872221198,0.00236110512765209,-0.00970835477241008,-0.000452822672013885,0.0314242627862276
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,24111,-0.00688699992716863,0.0032060620674071,-0.0131708815792865,-0.00060311827505072,0.0317143131925595
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,24966,0.00321452543054805,0.00150176814946002,0.000271059857606414,0.00615799100348968,0.0323245445525909
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,24111,0.00566836206314432,0.0026498755878358,0.000474605910986158,0.0108621182153025,0.0324371869592368
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,28774,0.0103409548529077,0.00483839089225516,0.00085770870408757,0.0198242010017278,0.0325843263010995
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,29713,0.00324421220017458,0.00151906797294475,0.000266838973202863,0.00622158542714629,0.0327153191800968
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,24845,-0.004145636354752,0.00194348925042661,-0.00795487528558816,-0.000336397423915834,0.0329271679232943
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,24229,-0.00409163689546307,0.00192331435407518,-0.00786133302945043,-0.000321940761475707,0.0333978904579685
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,28931,0.0095969710614269,0.00451865393094658,0.000740409356771611,0.0184535327660822,0.0336906358400103
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,24101,-0.00705531854138469,0.00332307331909218,-0.0135685422468054,-0.000542094835964011,0.0337530799864518
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,24606,-0.00472716442103337,0.00222818424584545,-0.00909440554289046,-0.000359923299176282,0.0338870218626705
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,24805,0.00931517248126685,0.00439312380097882,0.000704649831348367,0.0179256951311853,0.0339823681096636
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,-0.00865805779641446,0.00408751562605365,-0.0166695884234796,-0.000646527169349312,0.0341708213234956
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,24349,-0.00559242173094357,0.00264327832055647,-0.0107732472392342,-0.000411596222652895,0.0343792437017372
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,-0.00609517060217848,0.00289536049034457,-0.0117700771632538,-0.000420264041103126,0.035288447369083
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,24149,0.0102875410543786,0.0048909251534307,0.000701327753654406,0.0198737543551027,0.0354416931414828
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,24111,-0.0110074431406419,0.00524490989111009,-0.0212874665272177,-0.000727419754066141,0.0358545632064398
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,24381,0.00797596492983209,0.00380867985153543,0.000510952420822657,0.0154409774388415,0.0362565034364948
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,0.0130167490368523,0.00622147569132268,0.000822656681859818,0.0252108413918447,0.036428554254838
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,0.00726625476480821,0.00347522015338844,0.000454823264166866,0.0140776862654495,0.0365496205752079
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,24111,0.00756215854308423,0.00362352297429714,0.000460053513461833,0.0146642635727066,0.0369019577712381
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,24229,-0.00496892191964249,0.00239988623276925,-0.00967269893587021,-0.000265144903414764,0.0384177765711484
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,24016,-0.00377621424814837,0.00182959774623493,-0.00736222583076884,-0.000190202665527898,0.039032351582057
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,28931,-0.00724182696395553,0.0035094989521606,-0.0141204449101903,-0.000363209017720753,0.0390747034264378
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,-0.00473131086641363,0.00230519238844751,-0.00924948794777075,-0.000213133785056507,0.0401341824091534
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,24229,-0.00709982677628086,0.00347693041720511,-0.0139146103940029,-0.000285043158558838,0.0411642011399248
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,28830,0.0071372784443322,0.00349558171284289,0.000285938287160127,0.0139886186015043,0.0411804691657325
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,29030,0.00426866405993837,0.00209109327108618,0.000170121248609461,0.00836720687126728,0.0412245638935285
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,24016,-0.00543201217636816,0.00266170335744339,-0.0106489507569572,-0.000215073595779119,0.0412813302753849
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,0.0114717156481659,0.00563199970400859,0.000432996228309042,0.0225104350680227,0.0416710629909133
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,-0.00868163511843848,0.00426450456652701,-0.0170400640688314,-0.000323206168045542,0.0417804213392519
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,24111,-0.00757932291262389,0.00372684039492667,-0.0148839300866802,-0.000274715738567614,0.0419914961773744
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,24229,-0.00428242354496149,0.00211126641380257,-0.00842050571601454,-0.000144341373908449,0.0425337078432091
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,24867,0.00545220898847252,0.00269027281751955,0.000179274266134208,0.0107251437108108,0.0427101084723489
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,24101,-0.00784110151476225,0.00386904398628603,-0.0154244277278829,-0.000257775301641631,0.0427117663394732
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,24195,0.00753582782443882,0.00371886095288656,0.00024686035678115,0.0148247952920965,0.0427367479207749
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,29434,-0.00597304813260285,0.00296436161470197,-0.0117831968974187,-0.000162899367787,0.0439186951913689
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,0.00432203978431171,0.00214552530988672,0.000116810176933738,0.00852726939168968,0.0439719841008961
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,28931,0.00780652049044973,0.00387725168588662,0.000207107186111957,0.0154059337947875,0.0440801333756078
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,29478,-0.0110961229883357,0.00551121368563179,-0.021898101812174,-0.000294144164497374,0.0440845910915679
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,-0.00459592406849785,0.00228339978668491,-0.00907138765040027,-0.000120460486595426,0.0441514861155092
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,29523,0.00794873070048948,0.00396035626156497,0.000186432427822136,0.0157110289731568,0.0447508166734102
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,24195,0.00872507088666841,0.00434993371429755,0.000199200806645214,0.0172509409666916,0.0448893511888354
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,0.00498329802090633,0.00250509934215822,7.33033102762112e-05,0.00989329273153644,0.0466814667815847
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,0.00392868560292508,0.00197719433914355,5.33846982037197e-05,0.00780398650764644,0.0469333075350076
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,24445,-0.00505602573408694,0.00254939878768606,-0.0100528473579516,-5.9204110222256e-05,0.0473537292536989
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,24101,-0.0104585126416177,0.00528078461506732,-0.0208088504871496,-0.000108174796085702,0.0476604599628379
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,0.00456972542776084,0.00231399025221085,3.43045334275736e-05,0.0091051463220941,0.0482994307370732
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,-0.00566343497356145,0.00288884810003277,-0.0113255772496257,-1.29269749722053e-06,0.0499550151665061
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,24111,-0.00460509947641566,0.00234991224824327,-0.00921092748297247,7.28530141146447e-07,0.050043547199766
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,24229,0.00371097106164111,0.00189744225997316,-8.01576790627426e-06,0.0074299578911885,0.0505030897935957
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,24101,0.0154897775363331,0.00798377642693947,-0.000158424260468276,0.0311379793331345,0.0523723016126786
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,24016,-0.008834636433806,0.00455394104738652,-0.0177603608866836,9.10880190715738e-05,0.0523916336030476
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,24111,0.0102329538257099,0.00531452030091706,-0.000183505964087571,0.0206494136155073,0.0541822355668728
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,-0.00580482745237535,0.00301508135215684,-0.0117143869026028,0.000104731997852062,0.0542077422561422
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,24793,-0.00766606081608831,0.0039840390390278,-0.0154747773325828,0.000142655700406175,0.0543418105532972
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,28774,0.00762901873209765,0.0039896803251222,-0.000190754705141869,0.0154487921693372,0.0558620123464854
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,29820,-0.0031144942525128,0.0016287706156569,-0.00630688465920033,7.78961541747242e-05,0.0558633431839412
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,28931,0.0081978568867714,0.00429339390330758,-0.000217195163711457,0.0166129089372543,0.0562188783258609
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,0.00817336205470402,0.00428184798148039,-0.000219059988997548,0.0165657840984056,0.0562946214997826
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,24914,0.00309309776495003,0.00162269540952385,-8.73852377167193e-05,0.00627358076761677,0.0566424957770245
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,-0.00951022665641708,0.00499278193748771,-0.019296079253893,0.000275625941058838,0.0568186027091303
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,28916,0.00521627611578136,0.0027627150559936,-0.000198645393966084,0.0106311976255288,0.0590228341407996
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,29466,0.00539557229404226,0.00286098888150864,-0.000211965913714679,0.0110031105017992,0.0593166912907116
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,29443,0.00592597256177369,0.00315406536782757,-0.000255995559168352,0.0121079406827157,0.0602767219723872
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,24111,-0.00506938686441268,0.00270030343250296,-0.0103619815921185,0.000223207863293126,0.0604836189694988
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,-0.00400904837513731,0.00213941706820523,-0.00820230582881956,0.000184209078544939,0.0609562391696596
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",24195,0.00525181079031408,0.00280417092232096,-0.000244364217434997,0.0107479857980631,0.0611002074258451
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,-0.00773199286544295,0.00412855511265423,-0.0158239608862452,0.000359975155359338,0.061106945021956
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,24111,-0.00453526755498021,0.00243204578823762,-0.00930207729992594,0.000231542189965525,0.0622222491895789
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,29725,0.00610247200691406,0.00327432345155051,-0.000315201958124942,0.0125201459719531,0.0623687506637634
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,29725,-0.00835887038328345,0.00450497743940235,-0.0171886261645121,0.000470885397945167,0.0635384059134217
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,0.00793763899558474,0.0042828804879325,-0.000456806760762951,0.0163320847519324,0.0638456202017218
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,28916,-0.00453757656674607,0.00245767897335311,-0.00935462735451815,0.00027947422102602,0.0648610086749028
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,0.00626045308379121,0.00339563060896751,-0.000394982909785122,0.0129158890773675,0.0652401977010031
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,-0.00437444433690457,0.00237340975087826,-0.00902632744862596,0.000277438774816814,0.0653258308148818
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,24229,-0.00721001858237404,0.00391506377453616,-0.0148835435804649,0.000463506415716839,0.0655445148487924
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,28114,0.00371037609433934,0.00201546954145783,-0.000239944206918009,0.00766069639559668,0.0656396078629538
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,24016,-0.00631071765365408,0.00343205590305897,-0.0130375472236496,0.000416111916341496,0.0659632463593028
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,24405,-0.00699920943209897,0.0038076497188378,-0.014462202881021,0.000463784016823117,0.066045567903567
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,24101,-0.00500706647239972,0.00273060654779287,-0.0103590553060737,0.000344922361274315,0.0667134131803574
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,24793,0.00803622208292562,0.00438801003697017,-0.00056427758953591,0.0166367217553871,0.06705216373965
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,0.0114436941837329,0.00625167484758913,-0.000809588517541751,0.0236969768850076,0.0671874097851241
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,24101,-0.0101143638925036,0.00554991678402647,-0.0209922007891955,0.000763473004188242,0.0684013650015161
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,0.01043937478702,0.00573917077722606,-0.000809399936343033,0.0216881495103831,0.0689285863936374
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,0.0134029542781789,0.00737827218803462,-0.00105845921036895,0.0278643677667268,0.0692990729133892
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,24111,-0.00447111187195292,0.00247513032854095,-0.00932236731589319,0.000380143571987341,0.0708660537306932
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,0.0134583019682712,0.00745136302696681,-0.00114636956458374,0.0280629735011261,0.0709068666539191
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,24195,0.0100556930688648,0.00558844494614215,-0.000897659025573802,0.0210090451633034,0.0719722695848921
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,28797,0.00427461946655983,0.00237780611206535,-0.000385880513088245,0.00893511944620791,0.0722325428548882
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,0.00309678948271653,0.00173218820684272,-0.000298299402695193,0.00649187836812825,0.07382014561397
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,28916,0.0062364154984358,0.00348911476815224,-0.000602249447142599,0.0130750804440142,0.0738846435757503
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,29676,-0.00552820269281899,0.00310638852220275,-0.0116167241963364,0.000560318810698403,0.0751477976482667
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,28852,0.00934706380742192,0.00525377711682582,-0.000950339341556682,0.0196444669564005,0.0752317480312548
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,0.00477863503935712,0.00269287899647212,-0.000499407793728239,0.0100566778724425,0.0759833762609671
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,29545,0.0034729671901716,0.00195787295413238,-0.000364463799927868,0.00731039818027107,0.07609875346387
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C5,Complement C5,24966,0.00192833021685854,0.00108875175738635,-0.00020562322761871,0.00406228366133579,0.0765498684113875
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,24445,0.00913542104243452,0.00516963973592791,-0.000997072839984183,0.0192679149248532,0.0772190850821006
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESPL1,Separin,24016,-0.00704317966086046,0.00399028827573231,-0.0148641446812958,0.000777785359574875,0.0775629672044893
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,24195,0.00976872404292493,0.00553741908100432,-0.00108461735584354,0.0206220654416934,0.0777228126949457
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,24111,0.0114582183828682,0.00649973727085111,-0.00128126666799999,0.0241977034337364,0.0779344028126841
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,29443,0.00450641720599125,0.00257243476232652,-0.000535554928168733,0.00954838934015123,0.079816881724398
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,29361,0.00425002983032621,0.00242860055392141,-0.000510027255359744,0.00901008691601217,0.0801302661615156
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,-0.00558222878896144,0.00319070585448891,-0.0118360122637597,0.000671554685836829,0.0802124843000105
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,24195,-0.00435337620882678,0.00248960043254981,-0.0092329930566244,0.000526240638970839,0.0803686441657079
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",24111,0.00709214759032354,0.00405736418828026,-0.00086028621870578,0.0150445813993529,0.0804820981763306
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,24016,-0.00386154675136695,0.00221455170028828,-0.00820206808393198,0.000478974581198086,0.0812216222019721
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,24938,-0.0110868300560165,0.00638327987346602,-0.0235980586080099,0.00142439849597693,0.0824251644875641
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,24195,0.011435133342462,0.00660642119262303,-0.00151345219507919,0.0243837188800031,0.0834802275634883
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,29566,-0.00338461283708954,0.00195768617665573,-0.00722167774333477,0.000452452069155701,0.0838402537794347
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,-0.0053808784573617,0.00312033687061785,-0.0114967387237727,0.000734981809049282,0.084638679231243
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,24101,-0.0116787692397375,0.00678517645061339,-0.0249777150829398,0.00162017660346472,0.0852240761347627
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,29169,0.00493026270730407,0.00286755743000734,-0.000690149855510316,0.0105506752701185,0.0855658542970457
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,-0.00647170998235121,0.00376810412842116,-0.0138571940740567,0.000913774109354274,0.0859012075731933
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,-0.00415387781513505,0.00242318761462929,-0.00890332553980846,0.000595569909538359,0.086501101978892
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,24101,-0.0086524053549742,0.00505274548840315,-0.0185557865122444,0.00125097580229598,0.0868327889980426
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,-0.00621510803005047,0.00363035396433268,-0.0133306018001425,0.00090038574004157,0.0869123270110457
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,24229,0.00362042480357537,0.00211542127163008,-0.000525800888819586,0.00776665049597032,0.0870120073584685
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,24546,-0.00420759255372211,0.00246045489545936,-0.00903008414882246,0.000614899041378241,0.087262384376091
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,24195,0.00851140552712457,0.00499517247215197,-0.00127913251829329,0.0183019435725424,0.0884077132146264
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,0.00419059978649147,0.00246599108994273,-0.000642742749796288,0.00902394232277923,0.0892623965973035
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,24445,0.00648567711422338,0.00382117139816555,-0.00100381882618111,0.0139751730546279,0.0896525505460578
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,24445,0.00553886881650819,0.00327489082319785,-0.000879917196959602,0.011957654829976,0.0907895947998076
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,24111,-0.00560960762344162,0.00332102587331722,-0.0121188183351434,0.000899603088260135,0.091209580747015
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,-0.00418168063389992,0.00247632696018069,-0.00903528147585407,0.000671920208054226,0.0912970801524943
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,-0.00789143738916434,0.00468237712869138,-0.0170688965613995,0.00128602178307077,0.0919343018413429
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,24229,0.00553256469890967,0.00328703537459116,-0.000910024635289005,0.0119751540331083,0.0923594715744838
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,24195,-0.00348799446581881,0.00208429772295962,-0.00757321800281967,0.000597229071182048,0.0942491806227167
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,24016,0.00867656821924244,0.00519882419105544,-0.00151312719522621,0.0188662636337111,0.0951406902472051
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,24381,0.01009401894763,0.00604976616825716,-0.00176352274215406,0.021951560637414,0.095229881120788
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,24195,-0.00709581270545267,0.00426260148809247,-0.0154505116221139,0.00125888621120857,0.0959921343654179
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,24845,0.00826007840371437,0.00496989043915455,-0.00148090685702854,0.0180010636644573,0.0965205359155976
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,-0.00596461197388514,0.00359024793743209,-0.013001497931252,0.00107227398348175,0.096658778316844
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,24240,0.0102486186023492,0.00618024035031635,-0.00186465248427083,0.0223618896889693,0.097272289839593
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,24922,0.00327617963339387,0.00197779392248886,-0.0006002964546843,0.00715265572147203,0.0976368836641248
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,0.0136553136214839,0.00830643944679319,-0.00262530769423072,0.0299359349371986,0.10020060945577
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,0.00732041581888543,0.00445393153198786,-0.00140928998381078,0.0160501216215816,0.100274901444425
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,24229,0.0025624027374513,0.00155993768053322,-0.000495075116393818,0.00561988059129642,0.100472188044684
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,24101,-0.00590106148750516,0.00360149177747767,-0.0129599853713614,0.00115786239635106,0.101329498847028
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,24016,-0.00516316610594691,0.00315847332002609,-0.011353773813198,0.00102744160130422,0.102124417603864
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,-0.0077503089872393,0.00474185052189236,-0.0170443360101483,0.00154371803566973,0.10217789156148
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,24793,0.00925206215258368,0.00569607906528191,-0.00191225281536887,0.0204163771205362,0.104327477658885
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,0.00489768056289801,0.00302029915128137,-0.00102210577361348,0.0108174668994095,0.104904337808406
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,24203,-0.00812022121543864,0.00501918375130246,-0.0179578213679915,0.00171737893711418,0.105710767416295
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,-0.00349979528597987,0.0021669781061439,-0.00774707237402192,0.000747481802062183,0.106311236743909
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",24195,0.00974637942520663,0.00607398060864458,-0.00215862256773675,0.02165138141815,0.108592377709525
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,-0.00434358073892122,0.00270833576549163,-0.0096519188392848,0.000964757361442369,0.108775026089944
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,29434,0.0101938304422901,0.00637999488976007,-0.00231095954163962,0.0226986204262198,0.110102609572419
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,0.00345303541272166,0.0021668095632586,-0.000793911331265201,0.00769998215670852,0.111035847841661
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,28931,-0.00429762891394855,0.00269839718329082,-0.00958648739319857,0.000991229565301468,0.111247444166784
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,24867,-0.00403085268512769,0.00253519038044892,-0.00899982583080758,0.000938120460552199,0.111856417696896
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,24101,-0.0104032764731765,0.00655781017560158,-0.0232565844173556,0.00245003147100256,0.112662888192662
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,-0.00402668257265146,0.00254118383881737,-0.0090074028967335,0.000954037751430572,0.113077286651117
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,29820,0.00297132946115619,0.00188647701204817,-0.000726165482458229,0.0066688244047706,0.115251376571497
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,24101,0.00702161975071721,0.00446030851579147,-0.00172058494023407,0.0157638244416685,0.115443882121716
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,28931,-0.00531486480874066,0.00337860493174387,-0.0119369304749586,0.00130720085747732,0.115707880438208
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,28931,-0.00321404290733429,0.00204836482312451,-0.00722883796065833,0.00080075214598975,0.11664085161273
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,24101,0.00495028557344698,0.00315836367402826,-0.00124010722764842,0.0111406783745424,0.117044245252468
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,24195,-0.00423969255259196,0.00271078205798915,-0.00955282538625068,0.00107344028106677,0.117828106143829
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,24195,0.00565571401509,0.00364581697070342,-0.0014900872474887,0.0128015152776687,0.120845643541254
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",28916,0.00483594383081377,0.0031234893700891,-0.00128609533456087,0.0109579829961884,0.121572957629767
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,24111,0.00509849765485954,0.00330035003021761,-0.00137018840436699,0.0115671837140861,0.122399207031417
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,24706,-0.00796590283588455,0.00517700425660609,-0.0181128311788325,0.00218102550706338,0.123888177713186
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,24195,0.00328361515503345,0.00213938479166774,-0.000909579036635324,0.00747680934670222,0.124836010915296
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,24229,0.00542610549042679,0.00355217552321335,-0.00153615853507138,0.012388369515925,0.12663878020387
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,28916,0.00662009647795602,0.00433708963730327,-0.0018805992111584,0.0151207921670704,0.126923351796411
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,-0.00387485246478258,0.00254234040751823,-0.00885783966351831,0.00110813473395315,0.127489772591201
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,-0.00395608869093441,0.00260125485811863,-0.00905454821284692,0.00114237083097811,0.128313040871036
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,24922,-0.00290222854053817,0.0019088317005035,-0.00664353867352502,0.000839081592448688,0.128417796126198
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,24805,0.00283462387093956,0.00187130455104566,-0.000833133049109945,0.00650238079098906,0.129839635413181
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,24922,-0.00428851405816877,0.00283216907671304,-0.00983956544852633,0.0012625373321888,0.129983903212278
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,-0.00776948908214088,0.00514808828513191,-0.0178597421209994,0.00232076395671766,0.13126089767558
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,29434,-0.00652183824715188,0.00432353720814595,-0.0149959711751179,0.00195229468081419,0.131450218602104
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,29530,0.00530628199771697,0.00352410002768404,-0.00160095405654374,0.0122135180519777,0.132151655701671
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,0.00735083152750527,0.00488543401997203,-0.00222461915163991,0.0169262822066505,0.132427001619256
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,24195,0.00583276410283093,0.00387951349354113,-0.00177108234450968,0.0134366105501715,0.132728824688455
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,0.0104969851336787,0.00698230069384675,-0.00318832422626088,0.0241822944936184,0.132756264443986
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,-0.00295087990436337,0.00196547370448812,-0.00680320836516009,0.000901448556433354,0.133273553071176
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,-0.00394834699212203,0.00263641093499091,-0.00911571242470421,0.00121901844046016,0.13424420107515
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,24229,0.00317576824230759,0.00212590567511858,-0.000991006880924834,0.00734254336554001,0.135229820632232
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,24016,-0.00550170574752227,0.00368638679959941,-0.0127270238747371,0.00172361237969257,0.135597360292881
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,0.0028519985396578,0.00191277499333665,-0.000897040447282027,0.00660103752659763,0.135965189890127
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,28774,0.00637017867311824,0.00427762590569868,-0.00201396810205118,0.0147543254482877,0.136449480900774
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,-0.0037803237180569,0.00253967273655841,-0.00875808228171137,0.00119743484559758,0.136627874380103
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,29757,0.00319472565621924,0.00214894450696538,-0.0010172055774329,0.00740665688987139,0.13711820604029
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,24445,-0.00469603882505001,0.0031591302245967,-0.0108879340652595,0.00149585641515952,0.137160511754699
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,24445,0.00571312505967288,0.00384520527637181,-0.00182347728201586,0.0132497274013616,0.137350502944124
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,28774,-0.00550297213549157,0.00370630155384672,-0.0127673231810311,0.00176137891004799,0.13761809659137
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,28931,0.00414283993470566,0.0027921750917066,-0.00132982324503928,0.0096155031144506,0.137890894152661
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,24016,-0.00472831736927894,0.00319158619566908,-0.0109838263127903,0.00152719157423246,0.138487978921897
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,0.00609038252519931,0.00412323737704695,-0.0019911627338127,0.0141719277842113,0.139665295066329
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,24101,-0.00654526496604798,0.00444028443868488,-0.0152482224658703,0.00215769253377439,0.140477336375066
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,29120,0.00452067502702952,0.0030991348134103,-0.00155362920725468,0.0105949792613137,0.144661412273744
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,29434,0.00253483520284201,0.001740764191795,-0.000877062613076182,0.0059467330187602,0.14535842768167
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,24101,-0.00774562741618364,0.00533687456816898,-0.0182059015697948,0.00271464673742756,0.14669782056517
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,-0.00585301473632189,0.00404197197623449,-0.0137752798097415,0.0020692503370977,0.147613508590228
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,29820,0.00313818009396594,0.00217447592996476,-0.001123792728765,0.00740015291669687,0.148977701049587
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,24016,-0.00829283366038936,0.00577326306824166,-0.019608429274143,0.00302276195336429,0.150895745044566
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,24111,-0.00728491155233654,0.00508831533662062,-0.017258009612113,0.00268818650743987,0.152244326897224
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,24016,-0.00427303719444348,0.00298837084295393,-0.0101302440466332,0.00158416965774621,0.152762030431873
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,24111,0.0114244873988263,0.00798997899421061,-0.00423587142982648,0.0270848462274791,0.152772467320034
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,24229,-0.00223916944406955,0.00157490391307669,-0.00532598111369986,0.000847642225560752,0.1551025347501
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,24016,0.0060758152660939,0.00428415685601124,-0.00232113217168813,0.0144727627038759,0.156143728899545
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,24016,-0.00411598228780711,0.00293467505911503,-0.00986794540367257,0.00163598082805834,0.160768703519984
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,24111,-0.00611940638021833,0.00436741852669037,-0.0146795466925314,0.00244073393209479,0.161182243555584
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,0.00343932960601428,0.00245978792388316,-0.00138185472479671,0.00826051393682526,0.162058918460373
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,-0.00490999411405978,0.00353805098488962,-0.0118445740444434,0.00202458581632388,0.165220523962045
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,0.00568882628929366,0.00410331392775935,-0.00235366900911466,0.013731321587702,0.165635874791206
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,24016,-0.00603221641585041,0.00435768348832132,-0.0145732760529602,0.00250884322125937,0.166288252145805
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,28797,0.00456052187163354,0.00332294243549657,-0.00195244530193974,0.0110734890452068,0.169938813918752
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,29693,0.00314096801726623,0.00230521339966825,-0.00137725024608353,0.00765918628061599,0.173034783393498
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,0.00660298746204952,0.00490366704069605,-0.00300819993771475,0.0162141748618138,0.178140469513832
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,24195,0.00581482914279547,0.0043357110337805,-0.00268316448341431,0.0143128227690052,0.179885079882922
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,29454,-0.00345266419803587,0.00257591068724799,-0.00850144914504193,0.0015961207489702,0.180136589302774
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,-0.00328060084031973,0.00244813271180538,-0.00807894095545827,0.00151773927481882,0.180244351553732
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,29581,-0.00201603489625693,0.00150692156583886,-0.00496960116530109,0.000937531372787234,0.180955654637856
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,24195,0.00336424949683257,0.00253996829255785,-0.00161408835658081,0.00834258735024594,0.185341525734893
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,-0.00424464495622811,0.00320727188897177,-0.0105308978586128,0.00204160794615656,0.185699955497353
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,0.0136162793630359,0.0103324471739803,-0.00663531709796553,0.0338678758240374,0.187577336763783
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C7,Complement component C7,24374,-0.00307328748302015,0.00233438133154403,-0.00764867489284646,0.00150209992680615,0.188007965971555
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,0.0110919523417998,0.00845346712949107,-0.00547684323200267,0.0276607479156023,0.189490501141114
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,23970,-0.00753080564589899,0.0057400344588156,-0.0187812731851776,0.00371966189337958,0.189539734368893
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,0.00581084726738729,0.00444695820898359,-0.00290519082222054,0.0145268853569951,0.19132656130155
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,-0.00530800926312205,0.00407242033228121,-0.0132899531143932,0.00267393458814913,0.192447074775188
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,24195,0.00471164438965122,0.0036174003487999,-0.00237846029399659,0.011801749073299,0.192759770377502
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,28797,-0.00811011676860121,0.00623125792957626,-0.0203233823105707,0.00410314877336826,0.193090394159094
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,24195,0.00773112065761562,0.00595297797154173,-0.00393671616660616,0.0193989574818374,0.194059970861383
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,-0.0033328870161507,0.00257350135406757,-0.00837694967012313,0.00171117563782172,0.195303210923995
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,24229,-0.0056541598099272,0.00436792301722619,-0.0142152889236905,0.00290696930383613,0.195514322956314
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,24101,-0.00850426631341328,0.0065757410780392,-0.0213927188263701,0.00438418619954356,0.195927064413574
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,28774,-0.00606815971835718,0.00469561671832721,-0.0152715684862785,0.00313524904956415,0.196262605693512
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,29725,-0.00229952586596982,0.00178439656818003,-0.00579694313960267,0.00119789140766303,0.197517502640944
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,24101,-0.0048878764486687,0.00380372620978648,-0.0123431798198502,0.0025674269225128,0.198796531191853
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,24101,-0.00711286136796697,0.00556035566244708,-0.0180111584663632,0.0037854357304293,0.200835513990098
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,0.00500530559613034,0.00391795760521936,-0.0026738913100996,0.0126845025023603,0.201427711675269
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,24016,0.00544735330281233,0.00426922734558488,-0.00292033229453404,0.0138150389001587,0.201982836398238
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,28797,0.00284013224769188,0.0022312198941046,-0.00153305874475314,0.0072133232401369,0.203061831068256
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,0.00265627874098405,0.00211698962511323,-0.00149302092423788,0.00680557840620598,0.209581889334846
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,24195,0.00567973274166682,0.00452797321998145,-0.00319509476949683,0.0145545602528305,0.209721363268952
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,24966,0.00654550769382883,0.00522046194980383,-0.00368659772778668,0.0167776131154443,0.20992001403562
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,29443,0.00467647934331533,0.00373504102298918,-0.00264420106174347,0.0119971597483741,0.210559524793692
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,24445,0.00627589554123744,0.00501350730083954,-0.00355057876840807,0.0161023698508829,0.210655672448165
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",24867,0.00202646904565292,0.00162945028296391,-0.00116725350895635,0.00522019160026218,0.213639412556457
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,24240,0.0065285932230643,0.00525812544457479,-0.00377733264830228,0.0168345190944309,0.214388854376306
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,29313,0.00615951456621482,0.00498176142764275,-0.00360473783196497,0.0159237669643946,0.216314999538585
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,24229,0.00282428177177172,0.0022872293096202,-0.00165868767508388,0.00730725121862731,0.216915135304849
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,29674,0.00272725920360036,0.00221382520381716,-0.00161183819588129,0.007066356603082,0.217988118531095
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,0.00764559681897058,0.00622227552593388,-0.00455006321185982,0.019841256849801,0.219178849451991
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,24867,0.00314641342494503,0.00257026807516266,-0.00189131200237379,0.00818413885226385,0.220904351518358
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,24229,-0.00245774882080473,0.0020092917417179,-0.00639596063457181,0.00148046299296236,0.221269233268076
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,24101,-0.00377587690592415,0.00309700232199741,-0.00984600145703908,0.00229424764519078,0.222778800552568
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,24229,-0.00606026585078311,0.00498515245206626,-0.015831164656833,0.00371063295526676,0.224125140118136
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,-0.00548748411734686,0.00453499339949468,-0.0143760711803564,0.00340110294566272,0.226278576649264
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,29116,0.00254334071740003,0.00211077702122895,-0.00159378224420871,0.00668046367900877,0.228239728958936
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,29519,0.00263862901968476,0.00219183403023607,-0.00165736567957794,0.00693462371894745,0.22865904843247
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,-0.00527749628188823,0.0043902556550498,-0.0138823973657858,0.00332740480200938,0.229339249929765
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,24016,-0.00598260094824832,0.00497757341402977,-0.0157386448397467,0.00377344294325002,0.229409815124845
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,24111,0.00408992682857498,0.00341116527859594,-0.00259595711747306,0.010775810774623,0.230546613997951
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,24826,-0.00205507453320843,0.00171457220151196,-0.00541563604817188,0.00130548698175502,0.2306976221813
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,29536,-0.00708175661101503,0.00592984550446847,-0.0187042537997732,0.00454074057774318,0.232387238381057
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HLA_DRA,,29322,-0.00307546886524451,0.00258868368810634,-0.00814928889393294,0.00199835116344392,0.234825894047192
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,0.00316806118485459,0.00266780529047467,-0.00206083718447576,0.00839695955418493,0.235033945275639
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,24445,-0.00484887736846285,0.00408877146252356,-0.012862869435009,0.00316511469808332,0.235673008638048
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,-0.00254113742608896,0.00214692168691908,-0.00674910393245035,0.00166682908027243,0.23657362237343
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,28797,0.00334723660905244,0.00282825370919906,-0.00219614066097772,0.00889061387908259,0.236621052777437
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,28774,0.00253389634294048,0.00214589420533047,-0.00167205629950723,0.0067398489853882,0.237687419044112
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,-0.00581092640293491,0.00495188127530268,-0.0155166137025282,0.00389476089665834,0.240615398194457
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,28490,-0.0022113165376496,0.00188595815454915,-0.00590779452056593,0.00148516144526674,0.240999670157348
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,-0.0052730095069236,0.00450493537879116,-0.0141026828493543,0.00355666383550708,0.241812938901879
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,0.00200456608167288,0.00171345430249872,-0.00135380435122462,0.00536293651457038,0.242053397358637
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,0.00382314753359598,0.00328240575257405,-0.00261036774144916,0.0102566628086411,0.244136002545136
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,-0.00413313034051812,0.00355605490662368,-0.0111029979575005,0.00283673727646429,0.24513343646186
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,28797,-0.00405867866036096,0.00351058128291679,-0.0109394179748779,0.00282206065415595,0.247638710170708
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,0.003709554116631,0.00322793766513342,-0.0026172037070305,0.0100363119402925,0.250483572088489
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,29579,0.0125224074438983,0.0109121198214155,-0.00886534740607618,0.0339101622938728,0.251155932264656
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,24922,-0.00867307213963284,0.00761007852401614,-0.0235888260467045,0.00624268176743878,0.254429624460266
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,24101,-0.00460902986931625,0.00405434827062486,-0.012555552479741,0.00333749274110847,0.255628390596861
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,24101,-0.00392140561379568,0.00346576689327684,-0.0107143087246183,0.00287149749702692,0.257869274092309
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,24195,0.00186240961426501,0.00164603314089679,-0.00136381534189269,0.00508863457042272,0.25787557311657
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,24016,-0.00332860343137441,0.00294284580576402,-0.00909658121067189,0.00243937434792306,0.258031378673486
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,24111,-0.00301987430099445,0.00268385421955678,-0.00828022857132574,0.00224047996933684,0.260515258198048
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,24195,-0.00293444556142632,0.00261081346483051,-0.00805163995249413,0.00218274882964148,0.261041858472415
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,28626,-0.00538157622874473,0.00481217313192064,-0.0148134355673092,0.00405028310981972,0.263437362023413
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,28931,0.00361063311820218,0.00324583551319893,-0.00275120448766772,0.00997247072407208,0.265979994590047
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,-0.00383229495998487,0.00344623633862274,-0.0105869181836854,0.00292232826371571,0.266139244657112
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,24229,0.00521180183254807,0.00471904979345909,-0.00403753576263174,0.0144611394277279,0.269422986501542
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,24445,-0.0133695788441996,0.0121224157771642,-0.0371295137674415,0.0103903560790422,0.270089824229171
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,24793,0.00294963236616237,0.00267539024445635,-0.00229413251297208,0.00819339724529683,0.270252691653106
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",24016,0.00726110150253214,0.00665655553403552,-0.00578574734417748,0.0203079503492418,0.275363203436348
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",24240,0.00665914464375598,0.0061130306012496,-0.00532239533469324,0.0186406846222052,0.276016554064307
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,24016,0.00572304878506396,0.00527744224970157,-0.00462073802435111,0.016066835594479,0.27818238620162
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,0.00294865672869475,0.00272084578381691,-0.0023842010075864,0.0082815144649759,0.278495935334845
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,24101,0.00842645396166523,0.00779518637291992,-0.00685211132925781,0.0237050192525883,0.279716068435826
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,24229,0.00272688291481001,0.00252703497244798,-0.00222610563118803,0.00767987146080806,0.280561047515667
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,24845,-0.00310642805696797,0.00288500576477996,-0.00876103935593668,0.00254818324200075,0.281602723488867
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,28931,-0.0109190676414587,0.0101854112856194,-0.0308824737612728,0.00904433847835532,0.283715452227696
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,24016,-0.00520694451095505,0.00486342224214904,-0.0147392521055672,0.00432536308365706,0.284344859795983
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,24016,0.00602368012797987,0.00564602356940029,-0.0050425260680447,0.0170898863240044,0.28603271852207
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,24016,-0.00608823393604639,0.00571394404525023,-0.0172875642647368,0.00511109639264406,0.28665834159526
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,24195,-0.00255096900456295,0.00241439339511143,-0.00728318005898134,0.00218124204985544,0.290719686341253
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,24016,-0.00318640984817009,0.00302472680955593,-0.00911487439489971,0.00274205469855952,0.292143678128964
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,28931,0.00379977720834481,0.00361385407845827,-0.00328337678543339,0.010882931202123,0.293061975786743
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,24805,0.00862102550866004,0.00821216763573102,-0.00747482305737276,0.0247168740746928,0.293826360619649
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,29662,-0.00305862675739353,0.00291542934754587,-0.00877286827858344,0.00265561476379639,0.294132782496152
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,29736,-0.0034900343406201,0.00332926771483486,-0.0100153990616964,0.00303533038045623,0.294514053168074
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARTN,Artemin,28931,0.00335591905280892,0.0032072248168081,-0.00293024158813497,0.0096420796937528,0.295402549802293
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,24111,-0.00381535761480766,0.00365844244832129,-0.0109859048135174,0.00335518958390206,0.297009125348847
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,24195,-0.00520134075350922,0.00499393110647402,-0.0149894457221983,0.00458676421517985,0.297638964729898
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,24845,-0.00228097225080612,0.00219185864079864,-0.00657701518677145,0.00201507068515921,0.298045065623806
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,28774,-0.00407866644784227,0.0039470202685596,-0.0118148261742191,0.00365749327853454,0.301447278269839
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,24381,0.00328731247338728,0.0031837640831126,-0.00295286512951342,0.00952749007628798,0.301837010063794
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,24134,-0.00292948884300392,0.0028415685006568,-0.00849896310429124,0.00263998541828341,0.302578929329815
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,24111,-0.00376397400511091,0.00367086354409091,-0.0109588665515291,0.00343091854130728,0.305201416649037
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,29725,0.00215445470881619,0.00210867935372473,-0.00197855682448428,0.00628746624211666,0.306927410228639
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,24111,-0.00487554838984241,0.00479213808169593,-0.0142681390299664,0.00451704225028162,0.308970707006117
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,-0.00630174411405573,0.00621297558224416,-0.0184791762552543,0.00587568802714283,0.310455721325308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,28931,0.00316231198192246,0.00312165747665857,-0.00295613667232833,0.00928076063617326,0.311057473560796
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,24195,-0.00345726375451422,0.0034160669802633,-0.0101527550358303,0.00323822752680185,0.311519631761348
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,28931,-0.00472331438638442,0.00467869427309614,-0.0138935551616529,0.00444692638888401,0.312725674189663
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,28916,0.00352566487104262,0.00349969862652723,-0.00333374443695075,0.010385074179036,0.313741626677887
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,24111,-0.00358768280547029,0.003574070548006,-0.0105928610795621,0.00341749546862147,0.315480950872512
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,29413,0.0091844107321252,0.00916741579784091,-0.00878372423164299,0.0271525456958934,0.316422434541482
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,-0.0018597225620328,0.00185762562301753,-0.00550066878314716,0.00178122365908157,0.316774639556332
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,28774,0.00233648912581945,0.00233452105990624,-0.00223917215159678,0.00691215040323569,0.316911124248231
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,28334,-0.00342157999420198,0.00343443741482664,-0.0101530773272622,0.00330991733885823,0.319134131090117
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,24195,-0.00489568017991352,0.00492668491900984,-0.0145519826211728,0.00476062226134577,0.320375587009243
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,28774,0.00408547542808724,0.00412648588516006,-0.00400243690682648,0.012173387763001,0.322152315495138
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,24229,0.00340469906974365,0.00344230805069755,-0.00334222470962355,0.0101516228491109,0.322636581835019
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,24195,-0.00259977736981619,0.00263779870691067,-0.0077698628353611,0.00257030809572872,0.324346191939788
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,24240,-0.00442285533635368,0.00450834744290967,-0.0132592163244566,0.00441350565174928,0.326584327027988
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,24101,-0.00544750326580583,0.00556572227904534,-0.0163563189327347,0.00546131240112303,0.327708680896456
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,28774,0.00336522537733119,0.00344830159151369,-0.00339344574203564,0.010123896496698,0.32911822716437
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,23037,0.00371997282927464,0.00382201436781824,-0.00377117533164912,0.0112111209901984,0.330413636239651
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,28774,0.00266101899564616,0.00274054631124637,-0.00271045177439672,0.00803248976568904,0.331565797326721
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,-0.00379129674087386,0.00391478595279798,-0.0114642772083579,0.00388168372661017,0.332826560854383
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,24195,0.00398941431547446,0.00415852407326908,-0.00416129286813295,0.0121401214990819,0.337400009423099
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,24229,-0.00378773067544309,0.00395905446837857,-0.0115474774334651,0.00397201608257891,0.338715080511797
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,23902,0.00300987296371474,0.00315891107552662,-0.00318159274431744,0.00920133867174691,0.340691030152558
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,24229,-0.00281666160696514,0.0029621887807626,-0.00862255161725984,0.00298922840332955,0.341678978306328
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,24805,0.00373699631530121,0.00393926574547433,-0.00398396454582847,0.0114579571764309,0.342806366593022
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,24229,-0.00204214554830054,0.00215963573264935,-0.00627503158429326,0.00219074048769218,0.344363497112941
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,24845,-0.00640175517610561,0.00680703899499991,-0.0197435516063054,0.00694004125409421,0.346990258072685
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,24016,-0.00631281894336415,0.00671537225507922,-0.0194749485633194,0.00684931067659113,0.347198834349455
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,29123,-0.00173181424485789,0.00184279952303757,-0.00534370131001153,0.00188007282029574,0.347341528253433
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,24240,-0.0012127787320139,0.00129490164734558,-0.00375078596081124,0.00132522849678344,0.348984080360673
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,0.00178385111163573,0.00190823059433546,-0.00195628085326177,0.00552398307653322,0.349890748751504
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,24793,-0.00181584883795993,0.00195090269024993,-0.0056396181108498,0.00200792043492993,0.351979725217117
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,-0.00694005323010761,0.00747839336400488,-0.0215977042235572,0.00771759776334196,0.353407944805679
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,29434,0.00230289961304716,0.0024860250812952,-0.00256970954629144,0.00717550877238575,0.354277929098776
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,24381,-0.00345392344979588,0.00373128501104989,-0.0107672420714537,0.0038593951718619,0.354628780558026
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,-0.00648786330389831,0.00704225859589543,-0.0202906901518533,0.00731496354405673,0.356913907634561
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,24016,-0.0036866258741293,0.00400819237807154,-0.0115426829351495,0.00416943118689092,0.357700802566769
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,0.00447763030474379,0.00488162350575486,-0.00509035176653574,0.0140456123760233,0.359023513019967
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,-0.00311490779892828,0.00340802272807783,-0.00979463234596082,0.00356481674810426,0.3607298095159
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,24229,-0.00667475482918159,0.00732372072366421,-0.0210292474475634,0.00767973778920026,0.362099784360269
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,0.00463534661337171,0.00509390106896619,-0.00534869948180202,0.0146193927085454,0.362840600423994
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,29434,0.00381789306331913,0.00419613747810241,-0.0044065363937616,0.0120423225203999,0.362904377039409
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,-0.00335408863466385,0.00369207088338692,-0.0105905475661022,0.00388237029677451,0.363645765147977
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,24101,0.00480556331625695,0.00529266159912671,-0.0055680534180314,0.0151791800505453,0.363904616796132
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,24101,-0.00347984675726869,0.00383744284565218,-0.011001234734747,0.00404154122020958,0.364514255738324
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,28774,-0.00328940084997844,0.00366423509314914,-0.0104713016325508,0.00389249993259388,0.369350549155983
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,-0.00585707520332168,0.00652558712170418,-0.0186472259618619,0.00693307555521852,0.369431610970895
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,29786,0.00163106820269056,0.00182289960019071,-0.00194181501368323,0.00520395141906436,0.370919534271966
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,29218,-0.00224005285273374,0.0025100373851672,-0.00715972612766145,0.00267962042219397,0.372165540829943
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,24445,0.0054964326775644,0.006162971704308,-0.00658299186287929,0.0175758572180081,0.372483307268219
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,0.00497759741724868,0.00559985525302451,-0.00599811887867935,0.0159533137131767,0.374075157228723
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,24922,0.0019382725474843,0.00218207673146427,-0.00233859784618568,0.00621514294115428,0.374404295517867
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,29725,0.00201343093294929,0.00227291982027626,-0.00244149191479217,0.00646835378069076,0.375713852067831
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NENF,Neudesin,24793,0.00698548789431489,0.00790020666301855,-0.00849891716520148,0.0224698929538313,0.376588286731617
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,-0.00244308931457589,0.00276938938644125,-0.00787109251200073,0.00298491388284896,0.377690325029528
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,24101,0.00364601590534958,0.00414918674503144,-0.00448639011491204,0.0117784219256112,0.37955631847901
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,24101,-0.00447365804806987,0.00510182406352292,-0.0144732332125748,0.00552591711643504,0.3805636998804
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,-0.00589427014124987,0.0067300207460398,-0.0190851108034879,0.00729657052098815,0.381138003533011
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,24229,0.00189750822234601,0.00217142107314239,-0.00235847708101308,0.00615349352570509,0.382205623701004
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,28916,-0.00332584239166513,0.00381980282037933,-0.0108126559196086,0.00416097113627836,0.383933778088049
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,-0.00311810521674072,0.00360725627058033,-0.0101883275070782,0.00395211707359673,0.387378104709128
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,24229,-0.00358638718964111,0.0041557446487975,-0.0117316467012842,0.00455887232200199,0.38814871849589
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,0.00534219222926934,0.00624511054408497,-0.0068982244371372,0.0175826088956759,0.392326967014397
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,28797,-0.0101193359249503,0.0118618959981531,-0.0333686520813304,0.0131299802314298,0.393613173195347
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,24195,0.00633380582710909,0.00742532345505558,-0.00821982814479985,0.020887439799018,0.393667385629198
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,0.00391142855171344,0.0046097760560178,-0.00512373251808145,0.0129465896215083,0.396163853868123
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,24240,-0.0034849711046161,0.00412186681752257,-0.0115638300669603,0.00459388785772813,0.397849193868568
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,24657,0.00181106885503424,0.00214681320217356,-0.00239668502122594,0.00601882273129442,0.398896664468685
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BSND,Barttin,24016,-0.00205356565250728,0.00243850129890706,-0.00683302819836512,0.00272589689335055,0.39971656877158
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,-0.00294460297244119,0.00350619115865039,-0.00981673764339596,0.00392753169851357,0.401012289902235
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,0.00359155956561042,0.00429080356500682,-0.00481841542180294,0.0120015345530238,0.402580307976736
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,24966,0.00116491266957094,0.0013935764561759,-0.00156649718453382,0.00389632252367569,0.403210240706986
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,29478,-0.00156789827109235,0.00188535230572776,-0.00526318879031876,0.00212739224813406,0.405629733799074
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,27585,-0.00289127196107883,0.0035118903994155,-0.00977457714393321,0.00399203322177556,0.410355446484032
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,-0.0020993255938408,0.00255121300523221,-0.00709970308409593,0.00290105189641433,0.410587961147027
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,24845,0.00230235658053418,0.00281243864873975,-0.00321002317099572,0.00781473633206409,0.413003386549425
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,29478,-0.00185740149282782,0.00227691369467793,-0.00632015233439657,0.00260534934874092,0.414647432004027
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,-0.00235749431259126,0.00292781873649747,-0.0080960190361263,0.00338103041094378,0.420707961164204
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,24938,-0.00253739355102054,0.00315696052295602,-0.00872503617601432,0.00365024907397325,0.421551501241403
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,0.00401463007960281,0.00501892988617379,-0.00582247249729782,0.0138517326565034,0.423777958988178
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,28916,0.00349115164606304,0.0043659967970497,-0.00506620207615437,0.0120485053682804,0.423935804078464
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,-0.00348220323200813,0.00436988348452674,-0.0120471748616805,0.00508276839766427,0.425536398192175
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,24229,-0.00516682252681966,0.00651947905484686,-0.0179450014743195,0.00761135642068018,0.428064853147676
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,-0.00356623783324268,0.00450691708506708,-0.0123997953199742,0.0052673196534888,0.428787827892489
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,0.00435820306029327,0.00555171752855985,-0.00652316329568404,0.0152395694162706,0.432450177367039
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,24793,0.00196864307626302,0.00250907852242222,-0.00294915082768453,0.00688643698021058,0.432690940029538
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,24445,0.00218221108892549,0.00279217886150778,-0.00329045947962976,0.00765488165748075,0.434490086809118
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,28916,-0.00597953814165538,0.00769443420575663,-0.0210606291849384,0.00910155290162761,0.437091312435803
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,0.00201016593258822,0.00260876881242479,-0.00310302093976437,0.00712335280494081,0.440984747538198
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,28774,0.00469619296352396,0.00610957860583319,-0.00727858110390909,0.016670967030957,0.442101073120917
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,28931,0.00176227881033799,0.0022931753819412,-0.00273234493826677,0.00625690255894274,0.442203321795932
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,0.00489898224852675,0.00638175338133893,-0.00760925437889754,0.017407218875951,0.442698563141849
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,-0.00228295286751547,0.00298422574672564,-0.00813203533109773,0.00356612959606678,0.444274985518956
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,29392,0.00429859205704476,0.00564721498915762,-0.00676994932170417,0.0153671334357937,0.446550918360059
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,24101,-0.00188885100692541,0.00249991407179044,-0.00678868258763467,0.00301098057378385,0.449916612250763
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,24229,0.00408515272735098,0.0054194432803737,-0.00653695610218148,0.0147072615568834,0.450979270491093
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,24445,-0.00241429024572795,0.00321717610092905,-0.00871995540354889,0.003891374912093,0.452998357170598
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,28797,-0.00486586576915421,0.0065489396423318,-0.0177017874681245,0.00797005592981611,0.457487410251572
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,24445,-0.00356894974130203,0.00482540600078281,-0.0130267455028363,0.00588884602023227,0.459539853041209
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,24229,-0.00198772348378376,0.00272033935623794,-0.00731958862201011,0.00334414165444259,0.46497588205927
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,24016,-0.00175039333158556,0.00240691665536577,-0.00646794997610247,0.00296716331293134,0.467089280617673
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,0.00182908352575814,0.00252616361217424,-0.00312219715410338,0.00678036420561966,0.469038287447217
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,24111,-0.00295546630016603,0.00408240479745304,-0.010956979703174,0.00504604710284192,0.469102054262992
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,24445,0.0022714523992641,0.00314256789595372,-0.00388798067680519,0.00843088547533339,0.469808840942898
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,29478,0.00237745320832006,0.00331695068523734,-0.00412377013474512,0.00887867655138524,0.473528690331419
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,29333,-0.0013265477103959,0.00186721988239578,-0.00498629867989163,0.00233320325909982,0.477436970900217
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,29590,0.00208487701207498,0.00294598607552443,-0.0036892556959529,0.00785900972010286,0.479136591785974
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,24016,-0.00205971117639581,0.00291251863991163,-0.00776824771062261,0.003648825357831,0.479453759083829
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,28797,0.00523858617166913,0.00741623534839301,-0.00929723511118117,0.0197744074545194,0.479965465701503
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,29566,0.00398779256530183,0.00567673245630112,-0.00713860304904836,0.015114188179652,0.482385232997185
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,-0.00394872902631932,0.0056295644081858,-0.0149826752663635,0.00708521721372484,0.483043265987233
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,23970,0.00178940733276545,0.00255360254645274,-0.00321565365828192,0.00679446832381282,0.483473100135629
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,29694,0.00639742322341448,0.00918827839824191,-0.0116116024371397,0.0244064488839686,0.486271981425892
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,24404,-0.00270707883752101,0.00391315530152558,-0.0103768632285111,0.00496270555346912,0.489076262975449
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,0.00260027668913798,0.0037634956969544,-0.00477617487689264,0.00997672825516861,0.489622006727831
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,24445,-0.00414748757105628,0.00600394908040103,-0.0159152277686423,0.00762025262652974,0.489702033394469
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,24016,-0.00203312761213775,0.00294846832473122,-0.00781212552861093,0.00374587030433544,0.49048147968015
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,24016,-0.0024285039982954,0.00352791956795004,-0.00934322635147749,0.00448621835488668,0.491228247184372
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,24805,-0.00719086149341424,0.0105870055577887,-0.0279413923866801,0.0135596693998516,0.497007476034814
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,24111,0.00162862239576346,0.00240909524457464,-0.00309320428360283,0.00635044907512974,0.499027628081027
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,-0.00190091283977857,0.00281203077591406,-0.00741249316057012,0.00361066748101298,0.499050588387389
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,24229,0.00155804228095687,0.00232659968650684,-0.00300209310459652,0.00611817766651027,0.503077780113913
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,24101,0.0056735505681,0.00852842626099803,-0.0110421649034561,0.0223892660396561,0.50589585002052
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,24421,0.00478992597257177,0.00722989543814224,-0.00938066908618701,0.0189605210313306,0.507646435402477
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,24229,0.00502412123762964,0.00762669831935813,-0.00992420746831229,0.0199724499435716,0.510059743568097
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,-0.00328839459507413,0.00501593725017288,-0.013119631605413,0.00654284241526472,0.512093497039567
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,24195,0.00308192575021649,0.00473784345295012,-0.00620424741756574,0.0123680989179987,0.515381126734829
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,24229,-0.00269381374421722,0.00414282867692118,-0.0108137579509827,0.00542613046254829,0.515546364954628
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,29497,-0.00137361358786483,0.0021305097226512,-0.00554941264426118,0.00280218546853152,0.519104129147169
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,0.00346056843534847,0.00537167595461693,-0.00706791643570071,0.0139890533063976,0.519435616575249
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,24101,0.00203201245009572,0.00317026324445193,-0.00418170350903007,0.00824572840922151,0.521554662889086
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,0.00253577873701457,0.00398288958743768,-0.00527068485436328,0.0103422423283924,0.524346121105817
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,24101,0.00218299352123705,0.00343674530556421,-0.00455302727766879,0.0089190143201429,0.525309158647459
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,0.00140029852986725,0.00220886627230198,-0.00292907936384462,0.00572967642357912,0.526122087818954
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,0.00379488064893577,0.00604402862933119,-0.00805141546455337,0.0156411767624249,0.530093257420291
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,0.00154730731969044,0.00247553683505949,-0.00330474487702616,0.00639935951640703,0.531950203698362
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,29478,0.00361384064213408,0.00578252327313666,-0.00771990497321377,0.0149475862574819,0.532002730183744
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,24445,0.00382495129541034,0.00612843659503567,-0.00818678443085957,0.0158366870216803,0.532546952026343
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,24938,0.00395803114196863,0.00635679899188606,-0.00850129488212804,0.0164173571660653,0.533523319078867
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,24111,-0.00371222125586161,0.00602354740670096,-0.0155183741729955,0.00809393166127227,0.537712330657013
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,29820,0.00137563885494026,0.00227646281573263,-0.0030862282638957,0.00583750597377621,0.545656872219324
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TTN,Titin,24111,0.00290709855613289,0.00483344104194296,-0.00656644588607531,0.0123806429983411,0.547542457829287
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,0.00375068821676773,0.00628196269201467,-0.00856195865958102,0.0160633350931165,0.550474097759437
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,24016,0.00158115367009682,0.00265875823849419,-0.00363001247735179,0.00679231981754544,0.552052105592838
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,-0.00219628763510238,0.00369852568843287,-0.00944539798443082,0.00505282271422605,0.55263281997781
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,24101,0.00199240943032203,0.00340598117804587,-0.00468331367864788,0.00866813253929194,0.558570876820749
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,-0.00106521001292611,0.00182429628518193,-0.00464083073188269,0.00251041070603047,0.559291618921552
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,28797,-0.00211848309714724,0.00362848565753162,-0.00923031498590921,0.00499334879161472,0.559327341012247
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,24445,0.00252133230492345,0.00433068760378435,-0.00596681539849387,0.0110094800083408,0.560436415511654
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,24938,-0.00110423942781866,0.00189958237323461,-0.00482742087935851,0.00261894202372118,0.561039211605302
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,24445,-0.00306614579949317,0.00528991000187706,-0.0134343694031722,0.00730207780418587,0.562175206458084
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,24793,0.00231801461909959,0.00400522337990297,-0.00553222320551023,0.0101682524437094,0.562764550784852
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,0.000775070313576843,0.00134207077191455,-0.00185538839937567,0.00340552902652936,0.563594649886988
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,24111,-0.00198889410119037,0.00344398321455404,-0.00873910120171627,0.00476131299933554,0.563608351015841
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,24111,0.00407399188195282,0.0070649188866883,-0.00977324913595625,0.0179212328998619,0.564180689051113
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,24805,0.00105535890641739,0.00184132802632479,-0.0025536440251792,0.00466436183801398,0.566547691103481
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,-0.00257574488719204,0.00453183076598202,-0.0114581331885168,0.00630664341413273,0.569789956623399
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,24445,0.00220803458798537,0.00388873461272904,-0.00541388525296356,0.00982995442893429,0.570174063612578
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,24111,-0.00199548296444127,0.00351917121017661,-0.00889305853638742,0.00490209260750489,0.570697669522019
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,24101,-0.00263203243989604,0.00467079449679408,-0.0117867896536124,0.00652272477382035,0.573093913731425
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,24195,-0.00109757944559724,0.00196610111793607,-0.00495113763675194,0.00275597874555746,0.576677636858313
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,24195,-0.00264114851562848,0.00481213381621169,-0.0120729307954034,0.00679063376414643,0.583112196213105
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,24195,-0.00255660449905878,0.00471063045107937,-0.0117894401831743,0.00667623118505677,0.587320127815914
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,24016,0.00206389157120825,0.00381764558646632,-0.00541869377826574,0.00954647692068223,0.588775266055379
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,24111,0.0015500034064235,0.00287541546342951,-0.00408581090189833,0.00718581771474533,0.589854766852097
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,24111,-0.00235567188045786,0.00438953978017131,-0.0109591698495936,0.0062478260886779,0.591510362917735
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,24445,0.000888909956154277,0.00165705678721208,-0.0023589213467814,0.00413674125908995,0.591660038760571
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,0.00112334353737935,0.00209616634358836,-0.00298514249605384,0.00523182957081255,0.592029950908939
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,28722,-0.00203838297735892,0.00384909619471062,-0.00958261151899175,0.0055058455642739,0.596411112196718
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,-0.00135898955048587,0.00256824149505123,-0.00639274288078629,0.00367476377981455,0.596705023374629
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,0.00241564915221968,0.00458609493064862,-0.00657309691185161,0.011404395216291,0.598382888704839
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,24445,-0.00116273524683195,0.00220871658813366,-0.00549181975957393,0.00316634926591002,0.598594074850674
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,0.00159759470373951,0.00304198580362697,-0.00436469747136936,0.00755988687884838,0.599461064398457
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",24111,0.00146800858118835,0.00281984271631127,-0.00405888314278174,0.00699490030515844,0.602650612311342
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,24867,0.00138499643298735,0.00268748789137495,-0.00388247983410755,0.00665247270008225,0.606313166480354
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VIT,Vitrin,24922,-0.00139218098112008,0.0027045185621697,-0.0066930373629727,0.00390867540073254,0.606724530963933
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,0.00230627462674644,0.00448157601865805,-0.00647761436982335,0.0110901636233162,0.606828482583505
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,28797,-0.00212896151769032,0.00413989674304872,-0.0102431591340658,0.00598523609868517,0.607077849871822
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,24111,0.00176332958143016,0.0034460433979428,-0.00499091547853772,0.00851757464139804,0.608867873929674
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,0.00261643675461931,0.00513301524261375,-0.00744427312090364,0.0126771466301423,0.610247346232926
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,24229,-0.000960118723093762,0.00188373588657824,-0.00465224106078711,0.00273200361459959,0.610274279799915
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,24016,0.00229083305580688,0.00456109391831133,-0.00664891102408333,0.0112305771356971,0.615492638561613
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,29218,0.00201999882011928,0.00402187670015852,-0.00586287951219142,0.00990287715242998,0.615493495535525
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,24845,-0.00081320230391968,0.00162162503895534,-0.00399158738027215,0.00236518277243279,0.616042230360157
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,29820,0.000701376997764509,0.00140142403973509,-0.00204541412011627,0.00344816811564529,0.616744701226718
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,24951,-0.0022731663159706,0.00458768792187837,-0.0112650346428522,0.00671870201091101,0.620256672126431
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,24445,-0.00214238873722767,0.00432476358808799,-0.0106189253698801,0.00633414789542479,0.620338429325676
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,28916,0.00216549713272658,0.00437889463040347,-0.00641713634286423,0.0107481306083174,0.620935301254496
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,-0.00119318334753424,0.00242381908766206,-0.00594386875935187,0.00355750206428339,0.622529929381497
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,29461,-0.00657037150362585,0.0134301990120346,-0.0328935615672137,0.019752818559962,0.624686984068207
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,24229,0.00219709850261267,0.00449492711443283,-0.00661295864167568,0.011007155646901,0.624991169850555
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,24922,-0.000909009164554267,0.00191004663332095,-0.00465270056586334,0.0028346822367548,0.634143092552747
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,28931,-0.0020961948914896,0.0044130516846086,-0.0107457761933225,0.00655338641034325,0.634791313131262
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,24101,-0.00285901967884772,0.00610194096782852,-0.0148188239757916,0.00910078461809617,0.63940080825783
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,-0.00267417239745077,0.00572882298714041,-0.013902665452246,0.00855432065734443,0.640652405715118
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,-0.00165515252063791,0.0035510969202125,-0.0086153024842544,0.00530499744297858,0.641150850933912
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,24016,-0.00389466713123217,0.0083955233402964,-0.0203498928782131,0.0125605586157488,0.642724977764262
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,24867,0.00526317738116116,0.0113973961665789,-0.0170757191053335,0.0276020738676558,0.644237612964955
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,24111,-0.003259947721264,0.00709142787274046,-0.0171591463518353,0.0106392509093073,0.645733861416892
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,24756,-0.00193499722819066,0.00422516106722055,-0.0102163129199429,0.00634631846356161,0.64697798004011
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,0.00134273466201601,0.00293649638836326,-0.00441279825917597,0.00709826758320799,0.647490177752401
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,24101,0.00242880595926774,0.00539784190018935,-0.00815096416510338,0.0130085760836389,0.652744264948732
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,-0.00145961961268554,0.00326424182763998,-0.0078575335948599,0.00493829436948883,0.654767687573726
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,24445,-0.00190221343765658,0.00427505992682408,-0.0102813308942318,0.00647690401891862,0.656355515335245
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,-0.00243514658448998,0.00550980362335371,-0.0132343616862632,0.00836406851728328,0.658517572552729
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,24195,-0.00134431977674227,0.00305480786239942,-0.00733174318704513,0.00464310363356058,0.659892599321809
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,24867,-0.0011306964048707,0.00257949567402033,-0.00618650792595053,0.00392511511620914,0.661143567490692
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,29349,0.000720472139855316,0.00164468112789875,-0.00250310287082624,0.00394404715053687,0.661344637820574
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,29349,0.00059719891219233,0.0013691196144856,-0.00208627553219945,0.00328067335658411,0.662700700356853
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,24111,0.00148907042928745,0.00342462111996309,-0.00522318696584019,0.0082013278244151,0.663701924758622
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,0.00157897713031206,0.00367539551847931,-0.00562479808590739,0.00878275234653151,0.667485106120822
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,-0.00135322964228436,0.00318443660424293,-0.0075947253866005,0.00488826610203177,0.670876176549595
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,-0.00211326770460044,0.00500498107348551,-0.011923030608632,0.00769649519943115,0.672858779025917
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,29434,-0.00169118094974327,0.00401107878629897,-0.00955289537088925,0.0061705334714027,0.673300042147293
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,28931,0.00146380049304236,0.0034925801573571,-0.00538165661537756,0.00830925760146227,0.675133578041618
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,24867,-0.000656930622921741,0.0015767804810328,-0.00374742036574603,0.00243355911990254,0.676954251435681
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,28931,-0.00122805964708599,0.0029490060335088,-0.00700811147276324,0.00455199217859126,0.677097214096981
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,29349,-0.00114560523429822,0.00279644291599319,-0.00662663334964486,0.00433542288104842,0.682054582099627
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,24016,-0.00157468585234254,0.00385211641757897,-0.00912483403079731,0.00597546232611223,0.682701392629269
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,28916,-0.000957548215085615,0.00234991193481076,-0.00556337560731471,0.00364827917714348,0.683656592318841
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,0.00137067228991602,0.00337286233541634,-0.00524013788750001,0.00798148246733205,0.684465171346727
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,28719,0.00101206839187427,0.00249101539509093,-0.00387032178250396,0.00589445856625249,0.684534405063153
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,24016,-0.00182951608601635,0.00455961156915326,-0.0107663547615567,0.00710732258952404,0.688244173582923
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEB,Nebulin,24111,0.00108981067017952,0.00272881919436303,-0.00425867495077202,0.00643829629113106,0.68962355490967
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,0.00159162228639899,0.00400504473659111,-0.0062582653973196,0.00944150997011757,0.691072800084458
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,24195,0.00118403224531555,0.00299722888773716,-0.00469053637464929,0.00705860086528039,0.692815142310859
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,24938,-0.0013433924270126,0.00340408099830282,-0.00801539118368613,0.00532860632966094,0.693110685971074
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,0.0011836991710835,0.00300410746436741,-0.00470435145907662,0.00707174980124362,0.693564648845961
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,-0.00157096776402172,0.00398916197069356,-0.00938972522658109,0.00624778969853765,0.693724985578928
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F2,Prothrombin,24966,-0.000417368544079932,0.00106357459115984,-0.00250197474275321,0.00166723765459335,0.694750843897313
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,0.00189037537018459,0.004823239327456,-0.00756317371162918,0.0113439244519984,0.695112914662073
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,0.00153169282689358,0.00391176428527746,-0.00613536517225026,0.00919875082603741,0.695386357604945
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,24229,-0.00131535367722108,0.00336740024307499,-0.00791545815364805,0.00528475079920589,0.6960860122165
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,-0.00202886059227217,0.00530890203189225,-0.012434308574781,0.00837658739023664,0.702344581294676
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,24229,-0.00204069671100108,0.00539791003334798,-0.0126206003763631,0.00853920695436096,0.705394449452038
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,24195,-0.00163754820238353,0.00433274552526955,-0.0101297294319118,0.00685463302714478,0.705473278921805
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,28931,-0.00129920771747144,0.0034520511812326,-0.00806522803268733,0.00546681259774446,0.706653389259804
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,24445,0.00111779611163087,0.00298836009858206,-0.00473938968158997,0.00697498190485171,0.70837035897602
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,-0.0014591799046502,0.00391676351362572,-0.00913603639135662,0.00621767658205621,0.709488618135295
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,24101,-0.00204489114024897,0.00551081706764198,-0.0128460925928273,0.00875631031232931,0.710589705676319
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HLA_A,,24867,0.000864716759768229,0.00235166072567824,-0.00374453826256111,0.00547397178209757,0.713096548412065
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,29599,0.00289604182687173,0.00803538402521131,-0.0128533108625424,0.0186453945162859,0.718542278467655
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",24793,0.00111725269982607,0.00311577539008517,-0.00498966706474086,0.007224172464393,0.719912855415392
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,24101,-0.00103638113087816,0.00289306030070982,-0.00670677932026941,0.00463401705851308,0.720174301426358
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,29478,0.00298300355430637,0.00837008681494378,-0.0134223666029835,0.0193883737115962,0.721552114519591
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,24229,0.000433931170208207,0.00122017347113453,-0.00195760883321547,0.00282547117363188,0.722120232195458
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTTG1,Securin,24445,0.00104862417089668,0.00297939689957502,-0.00479099375227036,0.00688824209406373,0.72487239442202
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,-0.00142297222735917,0.00406896435556277,-0.0093981423642622,0.00655219790954386,0.726556693521654
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,28916,-0.00177346517010528,0.00511747492734224,-0.0118037160276961,0.00825678568748551,0.728931315930354
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,24111,-0.00106236651984829,0.00308433753000895,-0.00710766807866583,0.00498293503896925,0.730519075171921
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRL,Prolactin,29694,0.00182867525649596,0.00542476108852827,-0.00880385647701946,0.0124612069900114,0.736045527755301
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,-0.00113136963743171,0.00336583721765681,-0.00772841058403906,0.00546567130917564,0.736772799074391
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,24805,-0.00105028774579858,0.00313167132956428,-0.00718836355174457,0.00508778806014742,0.737344225355042
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,24867,0.0018076511884802,0.00544616732257487,-0.00886683676376654,0.0124821391407269,0.739958105691142
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,0.00115250000787212,0.00351962693067997,-0.00574596877626061,0.00805096879200485,0.743330778394604
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,24833,-0.00110998873679,0.00339748559868153,-0.0077690605102058,0.0055490830366258,0.743890833339629
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,24445,-0.000942806504410879,0.00289045836323404,-0.00660810489634959,0.00472249188752784,0.744291804892046
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,24195,-0.000963471344269606,0.00296467577569829,-0.00677423586463826,0.00484729317609905,0.745196209126752
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,-0.00119337084874132,0.00369323663071263,-0.00843211464493807,0.00604537294745543,0.746604650726891
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,-0.000626129070023376,0.0019379905454036,-0.00442459053901443,0.00317233239896768,0.746636169140236
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,0.00109435512131322,0.00340821629929466,-0.00558574882530431,0.00777445906793076,0.748142086818788
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,23801,-0.000900343019958578,0.00281866213011223,-0.00642492079497854,0.00462423475506138,0.749409247960491
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,24867,0.000771069276832071,0.00243348061450385,-0.00399855272759547,0.00554069128125961,0.751353553329531
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,0.00112309318601003,0.00359353833991774,-0.00592024196022875,0.00816642833224881,0.754639050307078
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,28774,0.000895983095440452,0.0028679336434335,-0.00472516684568921,0.00651713303657011,0.754728051383206
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,29478,-0.00100383868572583,0.00322356834877895,-0.00732203264933258,0.00531435527788091,0.755494158517849
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,24016,0.00141909552245212,0.00457342461296212,-0.00754481671895363,0.0103830077638579,0.756341865624185
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,0.00124490617467113,0.00401335621495534,-0.00662127200664133,0.00911108435598359,0.756418512205671
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,24445,-0.00173669634702246,0.00562537582920157,-0.0127624329722575,0.00928904027821261,0.75753306059487
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,0.00122280429723355,0.00396100073030749,-0.00654075713416912,0.00898636572863623,0.757544093061199
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,0.0012670793451257,0.00416496784775093,-0.00689625763646613,0.00943041632671753,0.760960570696928
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,24229,0.00201992502397364,0.00665422671161197,-0.0110223593307858,0.0150622093787331,0.76146940604918
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,28931,0.00197624200695462,0.0065785229935532,-0.0109176630604096,0.0148701470743189,0.763867997548085
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,24805,-0.0011707395956677,0.0039917010358994,-0.00899447362603052,0.00665299443469512,0.769300347769715
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",27986,-0.000612891174978714,0.00209328820641318,-0.00471573605954855,0.00348995370959112,0.769685822370312
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,28931,0.00114436051097896,0.00398753695783236,-0.00667121192637247,0.00895993294833039,0.774126396227581
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,-0.000670050465419228,0.002342850557072,-0.00526203755728035,0.00392193662644189,0.774882147197324
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,-0.000844570705987587,0.00295586253643852,-0.00663806127740709,0.00494891986543191,0.77508939416095
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,24101,-0.00101405243889533,0.00355626638310308,-0.00798433454977737,0.00595622967198671,0.775535321551589
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,24867,0.00154723768069747,0.00550240341347553,-0.00923747300971457,0.0123319483711095,0.778564664396682
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,29349,0.000524527251299676,0.00187063229484478,-0.0031419120465961,0.00419096654919545,0.779171812267785
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,29349,-0.00172168813641247,0.00615710682460061,-0.0137896175126297,0.0103462412398047,0.779766306306275
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,-0.000979249107037939,0.00351411758338901,-0.0078669195704804,0.00590842135640452,0.780507048817855
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,24240,0.00511647613012354,0.0189873556111358,-0.0320987408677026,0.0423316931279497,0.787572208003041
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,28931,0.00100023771943565,0.00374895874226268,-0.00634772141539921,0.00834819685427051,0.789621867713569
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,24229,0.00052188997114775,0.00195905743856252,-0.00331786260843479,0.00436164255073029,0.789934585395699
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,28931,-0.00141511948119489,0.0054921705388777,-0.0121797737373952,0.0093495347750054,0.796670194317542
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,24445,-0.00122791739192583,0.00476901515975617,-0.0105751871050479,0.00811935232119627,0.796811818159191
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,24195,0.00067161602136477,0.00261068867194145,-0.00444533377564046,0.00578856581837,0.796983139509303
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,29434,0.000993498990027537,0.00402052906249488,-0.00688673797246244,0.00887373595251751,0.804827503571416
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,0.000857668203221273,0.00349878298554221,-0.00599994644844147,0.00771528285488401,0.806355310647595
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,24445,-0.00129750411112037,0.00536744542099841,-0.0118176971362773,0.00922268891403652,0.808986859051799
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,24793,-0.000707444715802046,0.00293449015398845,-0.0064590454176194,0.00504415598601531,0.809495681292239
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",24101,-0.00141956086437941,0.00604892062093581,-0.0132754452814136,0.0104363235526548,0.814459084525585
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,0.000464488912416965,0.00201990668419526,-0.00349452818860574,0.00442350601343967,0.818128190944346
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",24111,0.000646883547612506,0.00285547853174354,-0.00494985437460484,0.00624362146982985,0.820782436657104
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,24793,0.000738537909566375,0.00326510711725097,-0.00566107204024552,0.00713814785937827,0.821054720215769
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,24101,-0.000611630731398787,0.00270720591253154,-0.00591775431996061,0.00469449285716303,0.821260165997231
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,24805,0.00420974414266487,0.0186451122366811,-0.0323346758412302,0.0407541641265599,0.821372279267495
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,24951,0.000519447617735661,0.00231305539368899,-0.00401414095389475,0.00505303618936607,0.822314041513044
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,24793,-0.000603387268689296,0.00272727665971317,-0.00594884952172711,0.00474207498434852,0.824906080679947
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,24229,-0.000669182217304047,0.00309247905802707,-0.0067304411710371,0.00539207673642901,0.828685413406377
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,-0.00056806363156023,0.00262776161466981,-0.00571847639631306,0.0045823491331926,0.828850959283478
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,24240,0.00064962041849251,0.00301955704466027,-0.00526871138904162,0.00656795222602664,0.82966180855525
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,24793,-0.000531880309204656,0.0024745605716114,-0.00538201902956299,0.00431825841115368,0.829816415255458
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,28797,-0.00213193929660875,0.00993392576122565,-0.021602433788611,0.0173385551953935,0.830071387394274
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,28931,-0.000442613295023348,0.00206747946687802,-0.00449487305010427,0.00360964646005757,0.830483431471106
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,24101,0.000750078215577455,0.00354046659361726,-0.00618923630791237,0.00768939273906728,0.832219160024359
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,28931,0.000932560051243991,0.00447259660791793,-0.00783372930027516,0.00969884940276314,0.834835921385863
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,-0.000723403370684356,0.00362488119645126,-0.00782817051572882,0.00638136377436011,0.841821633623626
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,-0.00081527434454973,0.00413055859720081,-0.00891116919506331,0.00728062050596385,0.843534751361395
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,24059,-0.00119758086147717,0.00613452854923219,-0.0132212568179723,0.0108260950950179,0.845222601950729
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,24016,-0.000840606986031852,0.00434913400834845,-0.00936490964239482,0.00768369567033111,0.846740178052752
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,-0.000681149276067836,0.00354769051991386,-0.00763462269509899,0.00627232414296332,0.84774543025089
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,0.000890427809694261,0.00464739568631065,-0.00821846773547462,0.00999932335486314,0.848059360418387
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,-0.000350101082570073,0.0018462682629874,-0.00396878687802538,0.00326858471288523,0.849603499884511
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,24938,0.00122637297474068,0.00656778715119606,-0.0116464898416036,0.0140992357910849,0.851877424955798
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,29434,0.000506757726581035,0.00278212125904805,-0.00494619994115315,0.00595971539431522,0.855467862384499
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,23913,0.00042691631358407,0.00248877616763035,-0.00445108497497142,0.00530491760213955,0.863803271319509
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,24867,0.00054827297627285,0.00325056930811674,-0.00582284286763597,0.00691938882018167,0.86605772260464
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,29820,0.000856649831630676,0.00519603134249303,-0.00932757159965567,0.011040871262917,0.869050431610471
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,0.00144809139168924,0.00884159060160026,-0.0158814261874473,0.0187776089708258,0.869904090290083
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,-0.000305014366641144,0.0018805774507168,-0.00399094617004607,0.00338091743676378,0.87115611733261
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,0.00160318936622122,0.0098995340222991,-0.017799897317485,0.0210062760499275,0.871349736269405
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,0.000734730163156419,0.00454208514347203,-0.00816775671804877,0.0096372170443616,0.871495762834115
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,24101,0.000725823787243628,0.00456308214463672,-0.00821781721624435,0.0096694647907316,0.873619492877056
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,29497,-0.000367434254698313,0.00235296768331543,-0.00497925091399655,0.00424438240459993,0.875909709198331
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,24111,-0.000729080588282139,0.00469649278548337,-0.00993420644782954,0.00847604527126526,0.876633910780988
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,0.000733501418275809,0.00473776360171604,-0.00855251524108763,0.0100195180776392,0.876964377571322
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,24381,0.000360216774177675,0.00246773606547016,-0.00447654591414383,0.00519697946249918,0.883945849818492
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,0.000511873465564932,0.00352710986186535,-0.00640126186369115,0.00742500879482102,0.884613021006076
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,24195,-0.00049358675691155,0.00347898146064136,-0.00731239041976861,0.00632521690594551,0.887178501786281
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,24229,0.000473637766142728,0.00339147729004794,-0.00617365772235123,0.00712093325463669,0.888933509936917
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,-0.000836523025215816,0.00603863144656152,-0.0126722406604764,0.0109991946100448,0.88982384778558
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,28774,0.000419576465374544,0.00320970170662023,-0.00587143887960111,0.0067105918103502,0.895996675140572
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,29454,-0.000217725481936853,0.0016666116270625,-0.00348428427097935,0.00304883330710565,0.896061304827337
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,28916,-0.000309138364443965,0.00240089331002571,-0.00501488925209436,0.00439661252320643,0.897548670202401
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,24195,0.000379952286826883,0.00301040951391094,-0.00552045036043856,0.00628035493409232,0.899564509609654
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,24016,0.000778146136439998,0.00628036026960634,-0.0115313599919884,0.0130876522648684,0.901394292881125
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPGN,Epigen,24793,-0.000424955645306242,0.00344975194391538,-0.00718646945538038,0.00633655816476789,0.901962072507488
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,0.000562802885892437,0.0045916957698587,-0.00843692082303061,0.00956252659481549,0.90244885610025
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,29789,-0.000502490318818744,0.00412201398867953,-0.00858163773663063,0.00757665709899314,0.902975807834894
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,24793,-0.000383527407134486,0.00319224999712633,-0.0066403374015021,0.00587328258723313,0.904370616809422
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,28931,0.00027260928627955,0.00244581214590903,-0.00452118251970215,0.00506640109226125,0.911252660156629
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,24016,-0.000254710637120412,0.00229471640702617,-0.00475235479489171,0.00424293352065089,0.911618271468471
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,24101,-0.000462207890146,0.0043248658365373,-0.0089389449297591,0.0080145291494671,0.914891264779906
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,29454,-0.000187970501213353,0.00180563266482759,-0.00372701052427543,0.00335106952184872,0.917088880116288
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,24240,-0.000267748723194312,0.00273599624747561,-0.00563030136824652,0.00509480392185789,0.922043073670336
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,28774,-0.000367862000728605,0.00379669584986721,-0.00780938586646833,0.00707366186501112,0.922814396168195
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,29565,0.000255047568033829,0.00276540216399529,-0.00516514067339693,0.00567523580946459,0.926517500787849
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,24445,-0.000347242807447274,0.00379546646976503,-0.00778635708818673,0.00709187147329218,0.927104927102117
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,24111,0.0002563809449234,0.00288218374316446,-0.00539269919167894,0.00590546108152574,0.929119435297484
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,0.000366822167883596,0.00415135320978159,-0.00776983012328831,0.0085034744590555,0.929589643328705
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,28774,0.000298915249094393,0.00339943939284047,-0.00636398596087293,0.00696181645906171,0.929932329965492
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,24195,-0.000237309604852841,0.00272098905453972,-0.0055704481517507,0.00509582894204502,0.93050176386212
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,24754,-0.000320366653952978,0.00371925321729368,-0.00761010295984859,0.00696936965194264,0.931357921912608
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,24445,-0.0003111894625141,0.00385559736171171,-0.00786816029146905,0.00724578136644085,0.935672378810506
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,24229,0.000125992518442683,0.00167835057141879,-0.00316357460153815,0.00341555963842352,0.940160233919146
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,24101,0.000393519743103035,0.00527593562311375,-0.00994731407819992,0.010734353564406,0.940543404414291
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,0.0009762122074292,0.0132854809542115,-0.0250633304628253,0.0270157548776837,0.94142495525467
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,24111,-0.000588336634211603,0.00815775433684517,-0.0165775351344281,0.0154008618660049,0.942507067878513
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,0.000182723893102273,0.00272737345891472,-0.00516292808637057,0.00552837587257512,0.946585116238442
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,24793,-0.000201259794776021,0.00301135644945488,-0.00610351843570758,0.00570099884615554,0.946714712844787
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,28954,-0.000195315392332506,0.00296871235207177,-0.00601399160239318,0.00562336081772817,0.947544451388352
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,24751,-0.000171120216602712,0.00290059913205927,-0.00585629451543889,0.00551405408223346,0.952956739912149
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,28931,0.000273248459298494,0.00467161884378533,-0.00888312447452075,0.00942962139311774,0.953357798685807
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,24016,0.000222359867889312,0.0038908723934179,-0.00740375002320977,0.00784846975898839,0.954426897339056
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,28797,-0.000306407468176854,0.00622986815404662,-0.0125169490501082,0.0119041341137545,0.960773306044535
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,0.000436144402675991,0.00896477011590589,-0.0171348050244996,0.0180070938298515,0.961197819336816
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,24229,-0.000221825398435232,0.00478121106299871,-0.0095929990819127,0.00914934828504223,0.962995619003827
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,24229,-0.000196343289178396,0.00441300684583327,-0.00884583670701162,0.00845315012865482,0.964512633787178
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,24101,0.000296189893776538,0.00696357463410928,-0.0133524163890776,0.0139447961766307,0.966073222189739
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,-0.000137607240978966,0.00361775010074499,-0.00722839743843914,0.00695318295648121,0.969658743593626
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,23975,-0.000128225226572527,0.00348578650818732,-0.00696036678261968,0.00670391632947463,0.970656610302998
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,24421,0.000207487973126294,0.00709728800994504,-0.013703196526366,0.0141181724726186,0.976677545770479
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,24922,7.31812129928449e-05,0.00353732557618426,-0.0068599769163283,0.00700633934231399,0.983494476942884
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,29694,-4.33256585849386e-05,0.00209615876933537,-0.00415179684648225,0.00406514552931238,0.98350977887299
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,29589,4.54599954772337e-05,0.002448587327202,-0.00475377116583868,0.00484469115679315,0.985187606821673
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,28916,3.4138484369717e-05,0.00196805484794566,-0.00382324901760379,0.00389152598634322,0.986160462924468
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,24229,-5.03835982300114e-05,0.00293664987248125,-0.00580621734829326,0.00570545015183324,0.986311644329682
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,28931,-3.61740176400993e-05,0.00226260874520216,-0.00447088715823634,0.00439853912295614,0.987244276707199
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,24229,9.44172991406595e-05,0.00628692782796398,-0.0122279612436687,0.0124167958419501,0.988017916263459
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,24195,-4.07206602245938e-05,0.00361400556369945,-0.00712417156507551,0.00704273024462632,0.991010151440388
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,-1.71206709594147e-05,0.00187568997602255,-0.0036934730239636,0.00365923168204477,0.992717352787439
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,24016,2.45380633615545e-05,0.00299993458982224,-0.00585533373269004,0.00590440985941315,0.993473817819687
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,29395,-9.58826025167475e-06,0.00209358377169038,-0.00411301245276482,0.00409383593226147,0.996345867271723
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,24229,-1.41099293814796e-05,0.00342780946895902,-0.00673261648854115,0.00670439662977819,0.996715702291604
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,28797,8.52226914716394e-06,0.00228586913754779,-0.0044717812404465,0.00448882577874083,0.997025327456266
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,28916,7.50404667863211e-06,0.00239369159335454,-0.00468413147629626,0.00469913956965352,0.997498716456308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,-1.1216801229494e-05,0.0123984011915039,-0.0243120831365771,0.0242896495341181,0.999278163296033
